Fc gamma Receptors and severe cartilage destruction in experimental arthritis.,Fc gamma receptors and severe cartilage destruction in experimental arthritis by Nabbe, K.C.A.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/26925
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.


Fcγ Receptors and severe cartilage destruction                        
in experimental arthritis
een wetenschappelijke proeve op het gebied van de 
Medische Wetenschappen
Proefschrift
ter verkrijging van de graad van doctor
aan de Radboud Universiteit Nijmegen
op gezag van de Rector Magniﬁcus Prof. Dr. C.W.P.M. Blom
volgens besluit van het College van Decanen
in het openbaar te verdedigen op vrijdag 20 mei 2005
des namiddags om 1.30 precies
door
Karin Catharina Anna Maria Nabbe
geboren op 3 september 1977
te Boxmeer
Promotor
Prof. Dr. W.B. van den Berg
Copromotores
Dr. P.L.E.M. van Lent
Dr. J.S. Verbeek (LUMC, Universiteit Leiden)
Manuscriptcommisie  
Prof. Dr. G.J. Adema (voorzitter)
Prof. Dr. W.J. van Venrooij
Prof. Dr. T.W.J. Huizinga (LUMC, Universiteit Leiden)
ISBN 90-9019272-7
© 2005 by Karin C.A.M. Nabbe
Printing: PrintPartners Ipskamp, Enschede
Cover illustration: Jak Peters
The research described in this thesis was performed at the Laboratory of Experimental Rheumatology and Advanced 
Therapeutics, Department of Rheumatology of the Radboud University Nijmegen Medical Centre, The Netherlands. 
This work was supported by the Dutch Arthritis Association (Nationaal Reumafonds, grant number 99-1-402).
voor mijn ouders

Table of contents
  
  9 CHAPTER 1 
General introduction                              
  29 CHAPTER 2 
Role of activatory FcγRI and FcγRIII and inhibitory FcγRII in inﬂammation and car-
tilage destruction during experimental antigen-induced arthritis. 
Am J Pathol 2001, 159:2309-2320
  49 CHAPTER 3 
The inhibitory receptor FcγRII reduces joint inﬂammation and destruction in experi-
mental immune complex-mediated arthritides not only by inhibition of FcγRI/III but 
also by efﬁcient clearance and endocytosis of immune complexes 
Am J Pathol 2003, 163:1839-1848
  67 CHAPTER 4 
Coordinate expression of activating Fcγ Receptors I and III and inhibiting Fcγ Recep-
tor type II in the determination of joint inﬂammation and cartilage destruction during 
immune complex-mediated arthritis
Arthritis Rheum 2003, 48:255-265
  85 CHAPTER 5 
FcγRI up-regulation induced by local adenoviral-mediated interferon-γ production ag-
gravates chondrocyte death during immune complex-mediated arthritis
Am J Pathol 2003, 163:743-752
  103 CHAPTER 6 
Joint inﬂammation and chondrocyte death become independent of Fcγ receptor type III 
by local overexpression of interferon-γ during immune complex-mediated arthritis
Arthritis Rheum 2005, 52:967-974
  119 CHAPTER 7 
Local IL-13 gene transfer prior to immune complex-mediated arthritis inhibits chondro-
cyte death and matrix metalloproteinase-mediated cartilage matrix degradation despite 
enhanced joint inﬂammation
Arthritis Res Ther 2005, 7:R392-401
  135 CHAPTER 8 
NADPH-oxidase driven oxygen radical production determines chondrocyte death and 
partly regulates metalloproteinase-mediated cartilage matrix degradation during inter-
feron-γ-stimulated immune complex-mediated arthritis
Arthritis Res Ther, conditionally accepted
  153 CHAPTER 9  
Summary and Final considerations
Nederlandse samenvatting
Curriculum Vitae
List of publications
Dankwoord
Appendix: colour ﬁgures
List of abbreviations
AIA  Antigen Induced Arthritis
(m)BSA  (methylated) Bovine Serum Albumin
CD  Cluster of Differentiation markers
CIA  Collagen type II Induced Arthritis
DC  Dendritic Cell
FcγR  Fcγ Receptor
GAG  Glycosaminoglycan
G-CSF  Granulocyte Colony Stimulating Factor
IC  Immune Complex
ICA  Immune complex-mediated arthritis
IFN  Interferon
Ig  Immunoglobulin  
IL  Interleukin
ITAM  Immunoreceptor Tyrosine-based Activation Motif
ITIM  Immunoreceptor Tyrosine-based Inhibition Motif
MMP  Matrix Metalloproteinase
NADPH  Nicotinamide Adenine Dinucleotide Phosphate 
NK  Natural Killer
PG  Proteoglycan
PLL  Poly-L-Lysine
PMN  Polymorphonuclear Neutrophil
RA  Rheumatoid Arthritis
ROS  Reactive Oxygen Species
Th  T helper
TNF  Tumour Necrosis Factor
Chapter 1
 
General introduction

11 General introduction
Introduction
 Rheumatoid arthritis (RA) is consid-
ered to be a systemic autoimmune disease, 
which affects about 1% of the population 
worldwide. RA is characterized by chronic 
inﬂammation of the synovial joints, which 
often results in progressive destruction of 
cartilage and bone. During arthritis, exac-
erbations and remissions occur, which lead 
to recurring swelling, redness, and pain 
in the affected joint. Histopathological 
features include IgG-immune complexes 
in synovium and articular cartilage layers 
and variable amounts of macrophages and 
T cells in the synovium, accompanied by 
pannus formation. Although the antigenic 
trigger is unknown, it is often thought 
that components of the articular cartilage 
are involved, as destructive forms of RA 
tend to decline when the cartilage is fully 
destroyed. Cartilage is a tissue with poor 
regenerative capacity and destruction of 
cartilage will eventually result in com-
plete loss of the cartilage matrix. As the 
function of cartilage is to facilitate move-
ment of joints, erosion of cartilage and 
bone destruction will ultimately lead to 
invalidity of RA patients. 
  Therapeutic interventions developed 
so far are promising, but still not able to 
fully prevent cartilage destruction and 
bone erosions. The next chapters will 
focus on the development of severe carti-
lage destruction in experimental arthritis 
models initiated by immune complexes 
and the receptors involved in the cellular 
interaction with IgG complexes (Fcγ re-
ceptors). Furthermore, attention is given 
to regulation of Fcγ receptors and its 
impact on the development and severity 
of cartilage damage.
Joint inﬂammation and the 
role of the macrophage
 Diarthrodial joints are covered by syn-
ovium, which is subdivided in synovial 
lining layer and sublining. The synovial 
lining consists of macrophage-like type 
A cells and ﬁbroblast-like type B cells [1]. 
In healthy joints, synovium has two main 
functions. The ﬁrst is production of syno-
vial ﬂuid, which is essential for smooth 
movement of the joints [2]. The second 
is phagocytosis of particles present in the 
joint space by macrophages, hereby taking 
care of the ﬁrst line of host defense [3,4]. 
 The antigenic trigger in RA is not 
identiﬁed yet, but a characteristic event 
is activation of the synovial cells resulting 
in inﬁltration of inﬂammatory cells. The 
synovial lining becomes hyperplastic and 
is predominantly inﬁltrated by macro-
phages and lymphocytes [5-8]. The syno-
vial joint space is inﬁltrated by a broad 
spectrum of inﬂammatory cells such as T 
cells, macrophages, B cells, polymorpho-
nuclear neutrophils (PMNs), and mono-
cytes [9-11]. Accumulation and activation 
of the inﬂammatory and resident cells re-
leasing cytokines and enzymes determines 
the severity and prolongation of inﬂam-
mation and breakdown of cartilage and 
bone [8,12]. It is shown that especially 
the macrophage has a prominent role in 
this process. Elegant studies have shown 
that the number of macrophages in joints 
of RA patients correlates well with joint 
inﬂammation [13] and particularly with 
cartilage damage [14,15]. Experimental 
arthritis models in the mouse have been 
used to extend the knowledge about the 
role of synovial macrophages. Macro-
phages can be selectively depleted from 
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the synovial lining and when in such a 
joint arthritis was induced by intra-ar-
ticular deposition of immune complexes, 
both inﬂammation and cartilage damage 
were almost fully prevented [16-18].
Destruction of articular    
cartilage
 Apart from the synovium, articular 
cartilage is also a main target tissue for de-
struction in RA. Cartilage covers the end 
of bones and is essential for smooth move-
ment of the joints [19]. It is composed of 
a relatively low number of chondrocytes 
distributed throughout the cartilage 
matrix. Chondrocytes produce and main-
tain the extracellular matrix composed of 
a network of collagen ﬁbers in which pro-
teoglycans (PG) are entrapped [20]. These 
PGs are predominantly responsible for 
hydration, as they are highly hydrophilic 
by the presence of glycosaminoglycans 
(GAGs) [21]. All constituents of the ex-
tracellular matrix together, account for 
the strength and elasticity essential for 
normal joint function. Destruction of the 
cartilage matrix evolves in consecutive 
processes. PG depletion is the ﬁrst step of 
degradation, and is caused by a disbalance 
in PG degradation by enzymes [22,23] 
and PG synthesis by chondrocytes [24]. 
PG depletion is a reversible process, which 
can be completely restored. When pro-
gression of cartilage destruction occurs, 
this leads to degradation of collagen ﬁbers. 
The collagen network is difﬁcult to repair, 
as collagen turnover is slow in cartilage 
[25] and therefore collagen damage is usu-
ally irreversible. Another characteristic of 
cartilage damage is chondrocyte death 
[26,27]. Loss of chondrocytes in the carti-
lage matrix might be due to an overload of 
destructive mediators like cytokines, oxi-
dative metabolites, and enzymes. When 
chondrocytes are absent, repair of the 
cartilage matrix is impossible, eventually 
leading to erosion of the cartilage layer.
Immune complexes in     
rheumatoid arthritis 
 Activation of macrophages leading to 
joint inﬂammation and cartilage destruc-
tion can be mediated by immune com-
plexes present in synovium, synovial ﬂuid, 
serum, and even in cartilage of most RA 
patients [28-30]. Immune complexes are 
formed, by binding of speciﬁc antibodies 
to the antigen and the ratio of antibody 
to antigen determines the size and the 
action of the immune complex [31,32]. 
In RA, the most commonly used diag-
nostic factor is rheumatoid factor, which 
consists of autoantibodies directed against 
the Fc portion of IgG [33,34]. The an-
tibodies themselves can consist of several 
classes, like IgG, IgA, or IgM [35]. More 
speciﬁc for RA are antibodies directed 
against citrullinated proteins present in 
RA synovium [36]. These antibodies can 
be detected very early in the disease and 
are therefore more valuable as a predict-
able diagnostic factor [37]. Besides RA, it 
has been shown that immune complexes 
are involved in several other diseases like 
SLE, glomerulonephritis, and alveolitis 
[38-40]. Activation of cells by immune 
complexes can happen via various path-
ways. Immune complexes are able to 
interact with components of the comple-
ment system, resulting in activation of the 
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classical [41] or alternative [42,43] com-
plement pathway. Furthermore, immune 
complexes can stimulate cells via speciﬁc 
receptors binding immunoglobulins, re-
sulting in release of a broad spectrum of 
cytokines and enzymes [44]. 
Receptors for IgG-containing 
immune complexes:       
Fcγ receptors
 In many RA patients, IgG-containing 
immune complexes are abundantly present 
in the joint [28,34,35]. These IgG con-
taining immune complexes can activate 
macrophages by binding to Fcγ receptors 
(FcγRs) [45-48]. These receptors recog-
nize the Fc region of IgG, and crosslinking 
of these receptors results in intracellular 
signaling hereby triggering a wide variety 
of effector functions as phagocytosis, oxi-
dative burst, and cytokine release [48,49]. 
Apart from the macrophage, FcγRs are 
expressed on other haematopoetic cells, 
like B cells, T cells, dendritic cells, and 
PMNs [50], but also on endothelial cells 
[51]. Three distinct classes of FcγRs have 
been deﬁned: the high afﬁnity activating 
FcγRI (CD64), the low afﬁnity inhibi-
tory FcγRII (CD32), and the low afﬁnity 
activating FcγRIII (CD16) (Figure 1). 
 In human a total of eight genes en-
coding FcγRs have been identiﬁed. 
However, only 5 genes are functional 
and transcription results in expression of 
FcγRIA, FcγRIIA and B, and FcγRIIIA 
and B [47] (Figure 1, Table 1). Activating 
FcγRI and FcγRIIIA are associated with 
the common γ-chain that contains an 
immunoreceptor tyrosine-based activat-
ing motif (ITAM) [52-54], whereas Fc-
γRIIA contains an ITAM motif within 
its molecular structure [55]. In contrast, 
FcγRIIB contains an immunoreceptor 
tyrosine-based inhibiting motif (ITIM), 
which inhibits ITAM-mediated cellular 
activation upon coligation with activat-
ing receptors [56-59]. FcγRIIIB is ex-
clusively expressed on PMNs [46] and 
is not associated with either ITAM or 
ITIM motifs. This receptor is linked to 
the membrane by a glycosyl phosphati-
dylinositol anchor [46-48] and may func-
Figure 1 
Schematic representation of the human leu-
kocyte IgG Fc receptor family. Crosslinking of 
FcγRI, IIA or IIIA by immune complexes leads 
to activation of the cell. Binding of immune 
complexes to FcγRIIB leads to inhibition of 
signal transduction activated via FcγRI, IIA, 
and IIIA.
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tion to facilitate FcγR signal transduction 
[60]. 
 On the contrary, in the mouse, three 
genes encoding FcγRI, FcγRIIB, and 
FcγRIIIA are found, whereas FcγRIIA is 
not expressed [48] (Table 1). Furthermore, 
FcγR mediated activation of murine cells 
is completely dependent on ITAM struc-
tures in the common γ-chain. All three 
classes of FcγRs are expressed on the mac-
rophage. Moreover, FcγRs differ in af-
ﬁnity for the various isotypes of IgG, like 
IgG1, IgG2a, IgG2b, and IgG3 [48,61] 
(Table 1). In the mouse, the high afﬁnity 
receptor FcγRI is able to bind monomeric 
IgG2a, whereas IgG1 is preferentially 
bound by FcγRIII [62,63]. 
 In the past years, mice deﬁcient for 
one or more FcγRs have been developed, 
which has facilitated research regarding 
Table 1  General characteristics of IgG Fc receptors.
      Receptor  Distribution   IgG speciﬁcity         Regulation 
class subclass      Human     Mouse    Up   Down
      
FcγRI  FcγRIA  monocyte,            3>1>4>>2d     2a=3>>1,2bd    IFN-γ   IL-4, 
(CD64)   macrophage,    G-CSF       IL-13 
   DCa,     IL-10
   neutrophilb
FcγRII  FcγRIIA  monocyte,            3>1>>2,4d       -    
(CD32)   macrophage,        
   DC,
   neutrophil,
   eosinophil
   B cell
 FcγRIIB  monocyte,            3>1>4>>2d     2a=2b>1d   IL-4
   macrophage,    IL-13
   DC,
   neutrophil,
   eosinophil,
   B cell
FcγRIII FcγRIIIA  monocyte,            1=3>4>>2d    1,2a,2b>>3 IFN-γ       G-CSF  
(CD16)   macrophage,    TGF-β      TNF-α  
   DC,       IL-4
   neutrophil,      IL-13
   eosinophil,
   NK cellc,
   mast cell
 FcγRIIIB  eosinophil            1=3>>>2,4d 
a DC = dendritic cell
b FcγRI is not expressed on murine neutrophils
c NK cell = natural killer cell
d Ligand speciﬁcity as described in reference 48
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the role of these receptors in immune 
complex-dependent diseases. Using these 
mice, it was shown that immune complex-
mediated inﬂammation is determined by 
the coordinate expression of activating 
and inhibiting FcγRs [64]. Induction of a 
passive immune complex arthritis resulted 
in a tremendous rise in chronicity and 
joint destruction in mouse strains suscep-
tible to collagen type II-induced arthritis 
(CIA) as compared to other strains. This 
was shown to relate to enhanced expres-
sion of activating FcγRs on their macro-
phages [65,66]. Furthermore, it was found 
that deletion of the FcγRIIB gene ren-
dered C57Bl/6 mice susceptible for CIA, 
whereas normally it is difﬁcult to induce 
CIA in C57Bl/6 mice [67]. Based on 
these studies, it was suggested that suscep-
tibility to autoimmune arthritis is linked 
to disturbed FcγR expression. Recently, 
it was demonstrated in our lab that both 
FcγRII and III expression are enhanced 
on monocyte-derived macrophages from 
RA patients [68], which were hyperreac-
tive to immune complexes as signiﬁcantly 
increased levels of TNF-α and MMP 
levels were found after stimulation [68].  
Mediators involved in cartilage 
destruction released after FcγR 
activation
 Severe cartilage damage is character-
ized by chondrocyte death, matrix met-
alloproteinase (MMP) aggrecan degra-
dation, and erosion of the cartilage layer 
(Figure 2). These parameters of irrevers-
ible cartilage damage are mainly found in 
experimental models in which immune 
complexes trigger onset of arthritis, indi-
cating that activation of FcγRs is a crucial 
step in degradation of cartilage compo-
nents. Moreover, we have demonstrated 
that severe cartilage destruction is not 
found when arthritis is induced in mice 
lacking functional activating FcγRI and 
III (FcR γ-chain-/-) [69], underlining the 
importance of these receptors in irrevers-
ible cartilage damage. 
 Activation of macrophages via FcγRs 
leads to production of proinﬂammatory 
cytokines, enzymes, and oxygen radicals 
mediating cartilage destruction (Figure 3). 
Crosslinking of activating FcγRs results in 
production of cytokines such as TNF-α 
and IL-1, which are considered to be key 
mediators in RA [70]. Both cytokines 
stimulate cells to produce chemokines, 
which recruit inﬂammatory cells. Besides 
the prominent role in onset and continua-
tion of inﬂammation, IL-1 can also gener-
ate cartilage destruction [71,72]. Intra-ar-
ticular injection of IL-1 into knee joints 
of rabbits or mice will cause inhibition 
of proteoglycan synthesis in the cartilage 
[73-75]. In addition, IL-1 and TNF-α can 
stimulate chondrocytes to produce latent 
Figure 2. 
Parameters of severe cartilage destruction. Irreversible cartilage damage is 
characterized by chondrocyte death, MMP-mediated degradation, and ero-
sion of the cartilage surface.
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MMPs, which then accumulate in the 
cartilage matrix [76-80] (Figure 3). 
 Binding of immune complexes to 
FcγRs can also induce synthesis and 
secretion of latent MMPs [81] (Figure 
3). In the synovium, MMPs are pro-
duced by macrophages and ﬁbroblasts 
[82]. The MMP-family can be divided 
in four groups: stromelysins, colla-
genases, gelatinases, and membrane type 
metalloproteinases [83]. Removal of a 
propeptide activates the latent MMPs 
[84,85]. These enzymes are then capable 
to degrade a wide variety of substrates 
as gelatin, collagen, or aggrecan, but are 
also able to activate other MMPs [86,87]. 
Many MMPs have been found to cleave 
aggrecan at a speciﬁc site, resulting in 
the neoepitope VDIPEN, which remains 
in the cartilage. This neoepitope can be 
detected by a monoclonal antibody and 
ﬁngerprints of MMP activity in the car-
tilage can be visualized [88,89] (Figure 
2). Presence of the VDIPEN neoepitopes 
is detectable in experimental models in 
which immune complexes trigger ar-
thritis onset [90,91]. The latter suggests 
that IC-binding to FcγRs is important 
in activation of latent MMPs (Figure 
2). Furthermore, presence of MMPs in 
serum, synovial ﬂuid, and synovium of 
RA patients implies involvement of these 
enzymes in degradation of the cartilage 
matrix in RA [92-94].  
Figure 3. 
After FcγR-mediated activation of macrophages (MΦ) (1), IL-1 and TNF-α are produced (2). These cytokines stimulate chondrocytes (CH) (3) to produce and 
release latent MMPs (pro-MMP), which accumulate in the cartilage matrix (4). The main factors responsible for activation of latent MMPs are still not identiﬁed 
yet (5). Reactive oxygen species (ROS) may be important candidates, since they have been shown to activate latent MMPs (6). Once pro-MMPs are activated, 
degradation of extracellular matrix proteins like collagen and proteoglycans occurs, eventually leading to severe cartilage destruction (7). When the macro-
phage is in close proximity with the cartilage surface, ROS might also induce chondrocyte death (Ch†) (8).
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 Additionally, binding of immune 
complexes to FcγRs results in release 
of reactive oxygen species (ROS) [95]. 
Oxygen radical production is mediated 
through activation of nicotinamide ad-
enine dinucleotide phosphate (NADPH)-
oxidase that is assembled at the plasma 
membrane [96]. ROS are capable of 
damaging articular cartilage either di-
rectly or indirectly [97]. Proteoglycans 
can be degraded by oxygen radicals as 
shown by in vitro studies in which the 
release of 35S-labelled proteoglycan was 
increased in presence of ROS [98,99]. 
Superoxide-dismutase can convert ROS 
into hydrogen peroxide, which has a rel-
atively long life-time and can easily pene-
trate through cell membranes. Hydrogen 
peroxide is able to inhibit proteoglycan 
synthesis by chondrocytes directly by re-
duction of intracellular ATP levels [100-
102]. In addition, oxygen radicals can 
induce irreversible cartilage destruction 
by fragmentation of collagen ﬁbers [103]. 
Proline and 4-hydroxyproline residues 
present in collagen are oxidized by ROS 
and become target sites for cleavage [104]. 
MMP-mediated cartilage destruction 
can also be stimulated by oxygen radicals, 
as on one side the natural inhibitors of 
MMPs are inactivated and on the other 
side production and activation of latent 
MMPs are increased [105-108] (Figure 
2). Moreover, chondrocyte death can be 
induced, as an overload of the oxidative 
burst causes apoptosis of cells [109,110] 
(Figure 2 and 3). In addition, ROS have 
been demonstrated to induce increased 
expression of inﬂammatory mediators 
like IL-1 and TNF-α by activation of 
the transcription factors AP-1 and NFκB 
[111,112].  
Modulation of FcγR expression 
and cartilage destruction by 
cytokines
 Stimulation of macrophages after bind-
ing of immune complexes to FcγRs results 
in various mediators involved in cartilage 
destruction and may therefore determine 
severity of cartilage destruction. FcγR 
expression is under tight regulation of 
cytokines (Table 1). Granulocyte-colony 
stimulating factor (G-CSF) found in syn-
ovial ﬂuid of RA patients is able to trigger 
a strongly increased FcγRI expression on 
human neutrophils [113-115]. On the con-
trary, FcγRIII level is strongly reduced by 
G-CSF [115,116], whereas no effects on 
FcγRII are found [117]. TNF-α selective-
ly downregulates FcγRIII on monocytes/
macrophages [118,119]. T helper 1 (Th1) 
and T helper 2 (Th2) cytokines are able to 
differentially modulate FcγR expression 
on monocytes. Interferon (IFN)-γ, a pro-
totypic Th1 cytokine, induces increased 
expression of activating FcγRs by up-reg-
ulation of FcγRI [120-122] and FcγRIII 
[123]. On the contrary, the Th2 cytokine 
IL-4 decreases expression of FcγRI and 
FcγRIII, whereas levels of the inhibiting 
FcγRII are increased [59,124]. 
 RA is classiﬁed as a Th1 condition since 
T cell clones derived from synovium of 
RA patients were found to produce IFN-γ 
[125,126]. As IFN-γ favours expression of 
activating FcγRI and III, stimulation with 
ICs may elevate cartilage destruction. On 
the other hand, shifting FcγR balance 
towards the inhibiting FcγRII with Th2 
cytokines might reduce cartilage destruc-
tion. Previous studies in which IL-4 was 
overexpressed during CIA, demonstrated 
that cartilage damage indeed was de-
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creased [127,128]. IL-4, however, is hardly 
detectable in RA synovium and synovial 
ﬂuid [129]. In contrast, IL-13, which has 
many functions overlapping IL-4, is de-
tected in synovial ﬂuid and synovium of 
RA joints [130,131]. IL-13 is like IL-4 
able to decrease expression of FcγRI and 
FcγRIII on human monocytes [132] and 
overexpression of IL-13 might therefore 
protect against degradation of the carti-
lage matrix.
Experimental arthritis models
 Since RA is a complex disease involv-
ing several mechanisms, animal models 
are used to study the pathogenesis of 
chronic arthritis and to identify mecha-
nisms underlying cartilage destruction. 
Furthermore, these models can be used 
to develop therapeutic treatments that se-
lectively inhibit progression of destructive 
arthritis. Several experimental arthritis 
models have been developed, based on 
auto-antigens or foreign particles such as 
bacterial or yeast components that are de-
posited in the murine knee joint. In this 
thesis, the potential of, and mechanisms 
by which immune complexes may di-
rectly contribute to arthritis and cartilage 
destruction were studied using animal 
models in which joint inﬂammation is 
elicited by intra-articular immune com-
plex deposition.    
Antigen-induced arthritis
 Antigen-induced arthritis, a T cell-de-
pendent IC model, is based on an immune 
response against the foreign antigen meth-
ylated bovine serum albumin (mBSA) to 
which the mice are sensitized prior to 
induction of arthritis. Inﬂammation is in-
duced 21 days after immunization by local 
injection of 60 µg mBSA into the knee 
joint. The inﬂammatory response is char-
acterized by an acute phase directly after 
induction, followed by a chronic phase, 
resulting in cartilage damage character-
ized by chondrocyte death and erosions of 
the cartilage layer [133]. Joint inﬂamma-
tion is induced by immune complex depo-
sition in the knee joint and propagated by 
antigen speciﬁc T cells. 
Immune complex-mediated arthritis
 Immune complex-mediated arthritis 
(ICA) is passively induced by systemic ad-
ministration of polyclonal anti-lysozyme 
serum, one day before intra-articular in-
jection of poly-L-lysine (PLL)-lysozyme. 
Immune complexes are formed and de-
posited directly in the knee joint. PLL is 
highly cationic and by coupling to the 
antigen, the formed immune complexes 
have an increased retention in the joint 
[134]. An acute inﬂammation develops, 
which reaches maximal inﬂammation at 
day 3 and wanes thereafter. Irreversible 
cartilage destruction can be detected 3 
days after arthritis onset. In this arthritis 
model, no B or T cells are involved.
Aim and structure of this thesis
 The aim of this thesis was to investigate 
the role of FcγRs in joint inﬂammation 
and cartilage destruction in experimental 
immune complex-mediated arthritides 
and to study whether the severity of carti-
lage damage could be modulated by regu-
lation of FcγR expression.
 First, the individual role of FcγRs in 
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inﬂammation and cartilage destruction 
was determined in a T cell dependent 
IC-mediated arthritis model (chapter 
2). Therefore, antigen-induced arthri-
tis (AIA) was elicited in knee joints of 
FcγRI-, FcγRII-, and FcγRIII-deﬁcient 
mice and their wild-type controls. The 
results indicated that both FcγRI and Fc-
γRIII could mediate joint inﬂammation, 
whereas irreversible cartilage damage was 
speciﬁcally provoked by FcγRI. The in-
hibiting FcγRII negatively regulated both 
the inﬂammatory response and severe car-
tilage destruction. In chapter 3, we fur-
ther elucidated the mechanism by which 
inhibitory FcγRII reduces the arthritic 
response. Therefore, AIA was induced in 
mice lacking both activating FcγRI and III 
(FcγRI/III-/-) but not FcγRII and in mice 
lacking all three FcγRs (FcγRI/II/III-/-). 
In FcγRI/III-/- mice, arthritis could not 
be elicited, whereas in mice lacking all 
FcγRs, joint inﬂammation was tremen-
dously increased and ICs accumulation 
was found in the knee joint indicating im-
paired endocytosis. These results suggest 
that FcγRII reduces joint inﬂammation 
not only by inhibition of activating FcγRI 
and III, but also by promoting endocy-
tosis. Although joint inﬂammation was 
much higher in arthritic FcγRI/II/III-/- 
knee joints, severe cartilage destruction 
was completely prevented.  
 The role of FcγRs was further deter-
mined in the passively induced immune 
complex-mediated arthritis (ICA). In 
chapter 4, we investigated the role of 
FcγRs in joint inﬂammation, macrophage 
act ivat ion, and car t i lage destruct ion 
during arthritis solely provoked by ICs 
using selective FcγR deﬁcient mice.  
 The studies showed that FcγRI was 
critically involved in severe cartilage de-
struction in both AIA and ICA, as absence 
of FcγRI did not alter the inﬂammatory 
response, whereas severe cartilage destruc-
tion was signiﬁcantly inhibited. Interest-
ingly, in presence of T cells, irreversible 
cartilage destruction was more severe and 
completely dependent on FcγRI. This 
led us to speculate that T cells present in 
AIA might increase FcγRI expression by 
production of Th1 cytokines. In chapter 
5 and 6, we investigated whether local 
overexpression of the Th1 cytokine IFN-γ 
deteriorates cartilage damage, and to what 
extent this process was mediated by ac-
tivating FcγRs. An adenovirus encoding 
IFN-γ was injected into knee joints before 
ICA onset, and this resulted in increased 
severity of cartilage degradation. This 
effect of IFN-γ was only found in the 
presence of ICs, as IFN-γ overexpression 
during IC-independent zymosan arthritis 
did not induce severe cartilage destruction. 
These results implied a crucial role for ICs 
and FcγRs and this was further studied 
using FcγRI-/- and FcγRIII-/- mice (chap-
ter 5 and 6 respectively). It was found 
that in IFN-γ-stimulated ICA, chondro-
cyte death was speciﬁcally FcγRI-depend-
ent, whereas both activating FcγRI and 
III were able to induce MMP-mediated 
VDIPEN expression indicating the pres-
ence of active MMPs. 
 As the Th1 cytokine IFN-γ aggravated 
the arthritic response by up-regulation of 
activating FcγRs, overexpression of a Th2 
cytokine might negatively regulate arthri-
tis as these cytokines are able to decrease 
expression of activating FcγRs. Overex-
pression of the Th2 cytokine IL-13 has 
protective actions regarding inﬂamma-
tion and bone destruction in experimen-
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tal arthritis. However, in these studies 
cartilage destruction was not investi-
gated in detail. In chapter 7, the effect 
of IL-13 on severe cartilage damage was 
investigated. Local IL-13 overexpression 
during ICA enhanced joint inﬂamma-
tion. Nevertheless, chondrocyte death 
and MMP-mediated cartilage destruc-
tion were signiﬁcantly reduced by IL-13, 
and were accompanied by decreased 
FcγRI mRNA levels in synovium.
 These previous studies indicated that 
FcγRs are of crucial importance in the 
development of irreversible cartilage de-
struction. Moreover, a prominent role for 
FcγRI was found mediating chondrocyte 
death. 
Stimulation of FcγRI leads to production 
of oxygen radicals via the NADPH-oxi-
dase complex, which may induce apopto-
sis of cells. Furthermore, oxygen radicals 
have the potential to activate MMPs or 
inhibit their natural inhibitors. In chap-
ter 8, the contribution of NADPH-oxi-
dase driven oxygen radical production to 
cartilage destruction was investigated in 
mice lacking P47 (P47phox-/-), which is 
necessary for a functional NADPH-oxi-
dase complex. When IFN-γ-stimulated 
ICA was elicited in P47phox-/- mice, 
chondrocyte death and MMP-mediated 
proteoglycan damage were markedly di-
minished. Furthermore, it was found that 
FcγRI mRNA level was downregulated, 
whereas FcγRII and III were upregulat-
ed in synovium of P47phox-/- mice. This 
study showed that oxygen radicals pro-
duced via the NADPH-oxidase-pathway 
are critically involved in induction of ir-
reversible cartilage damage. 
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IgG-containing immune complexes, which are found in most RA joints, com-
municate with hematopoietic cells using three classes of Fc receptors (FcγRI, 
-II, -III). In a previous study we found that if a chronic T cell-mediated antigen-
induced arthritis (AIA) was elicited in knee joints of FcR γ-chain-deﬁcient mice 
that lack functional FcγRI and FcγRIII, joint inﬂammation was comparable but 
severe cartilage destruction was absent. We now examined the individual role 
of the stimulatory FcγRI and FcγRIII and inhibitory FcγRII in inﬂammation 
and functional cartilage damage in knee joints with AIA using FcγRI-, FcγRII-, 
and FcγRIII-deﬁcient mice. Three weeks after immunization with the antigen 
methylated bovine serum albumin (mBSA), cellular (T cell responses as meas-
ured by lymphocyte proliferation) immunity raised against mBSA was compara-
ble in all groups examined. Humoral (total IgG, IgG1, IgG2a, and IgG2b levels) 
immunity against mBSA was comparable in FcγRI-/- and FcγRIII-/- but higher 
in FcγRII-/- if compared to controls. Joint swelling as measured by 99mTc uptake 
at days 1, 3, and 7 was similar in FcγRI-/- and FcγRIII-/- mice and signiﬁcantly 
higher in FcγRII-/-. Chronic inﬂammation and cartilage damage (depletion of 
proteoglycans, metalloproteinase (MMP)-induced neoepitopes, and matrix ero-
sion) was studied histologically in total knee joint sections stained with hema-
toxylin or safranin-O. Histologically, at day 7 after AIA induction, exudate and 
inﬁltrate in the knee joint was similar in FcγRI-/- and FcγRIII-/- and signiﬁcant-
ly higher (230% and 340%) in FcγRII-/- mice if compared to controls. Aggrecan 
breakdown in cartilage caused by MMPs, which is related to severe irreversible 
cartilage erosion, was further studied by immunolocalization of MMP-mediated 
neoepitopes (VDIPEN) and image analysis. MMP-induced neoepitopes deter-
mined in various cartilage layers (tibia and femur) were primarily inhibited in 
FcγRI-/- (79 to 87% and 87 to 88%, respectively) and comparable in FcγRIII-/-. 
VDIPEN neoepitopes were much higher (82% to 122% and 200% to 250%, 
respectively) in FcγRII-/- mice. Initial depletion of proteoglycans was similar 
(60% to 100%) in all groups. In the chronic phase, cartilage matrix erosion in 
the lateral and medial tibia was signiﬁcantly elevated in FcγRII-/- (222% and 
186%, respectively) but not in FcγRI-/- or FcγRIII-/- mice. These results suggest 
that during T cell-mediated AIA, FcγRI and FcγRIII act in concert in acute and 
chronic inﬂammation whereas FcγRI is the dominant FcR involved in severe 
cartilage destruction. FcγRII is a crucial inhibiting factor in acute and chronic 
inﬂammation and cartilage erosion.
 Chronic inﬂammation and destruc-
tion of cartilage and bone are main char-
acteristics of rheumatoid arthritis (RA) 
[1]. IgG-containing immune complexes 
(ICs), present in large amounts in joints 
of most RA patients have been suggested 
to be major pathogenic factors in RA, re-
sponsible for initiation and persistence of 
the inﬂammatory cascade and its result-
ing destruction of the cartilage [2]. Apart 
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from ICs T cells have shown to be also 
important in ampliﬁcation of arthritis 
[3,4] and may enhance inﬂammatory re-
actions merely induced by ICs. 
 Immune complexes containing IgG, 
the dominant immunoglobulin in the cir-
culation, communicate with synovial cells 
via cellular receptors for IgG that belong 
to the IgG superfamily [5-7]. Murine 
phagocytic effector cells express three dif-
ferent classes of IgG receptors (FcγRI, -II, 
-III) [8,9]. FcγRI and FcγRIII are hetero-
oligomeric complexes in which ligand-
binding  chains are associated with the 
signal-transducing γ-chain. This γ-chain 
is required for their assembly and trigger-
ing of various effector functions includ-
ing phagocytosis [10], antigen-presenting 
function [11], antibody-dependent cyto-
toxicity [12], and the release of inﬂamma-
tory mediators [13]. These effector func-
tions are regulated by an immunoreceptor 
tyrosine-based activation motif within 
the γ-chain [14]. 
 The third receptor class for IgG, 
FcγRII is a single γ-chain receptor and 
contains an immunoreceptor tyrosine-
based inhibitory motif-containing cy-
toplasmic domain that by co-ligation of 
the immunoreceptor tyrosine-based ac-
tivation motif receptor inhibits cellular 
activation signals through the recruit-
ment of the inositol phosphatase SHIP 
[15]. FcγRII has been shown to be a 
negative regulator of FcγRIII in IgG-
IC-triggered inﬂammation [16]. 
 Recently we found that activating 
FcγR (FcγRI and FcγRIII) were crucial 
in severe cartilage destruction during 
antigen-induced arthritis (AIA) [17]. Ir-
reversible cartilage destruction within 
this model occurs through enzymatic 
cleavage by metalloproteinases (MMPs) 
of cartilage constituents. These Zn-de-
pendent endopeptidases are capable of 
cleaving aggrecan and collagen type 
II, the main components of cartilage, 
which leads to severe cartilage erosion 
[18-20]. Various MMPs (MMP-1, -2, -
3, -7, -8, -9, -13) have been found to 
cleave aggrecan between amino resi-
dues Asn341-Phe342 resulting in the 
neoepitope FVDIPEN that remains in 
the cartilage [21].
 AIA elicited in knee joints of FcR 
γ-chain-/- lacking functional FcγRI 
and FcγRIII showed similar synovial 
inﬂammation if compared to controls 
at day 7 after arthritis induction. Nev-
ertheless, severe cartilage destruction as 
MMP-mediated matrix destruction and 
erosion was fully absent in arthritic FcR 
γ-chain-/- knee joints. These results sug-
gest that FcγRI and/or FcγRIII are of 
crucial importance in severe cartilage 
destruction within this model. FcγRIII 
has been suggested as the most likely 
candidate in IC-mediated joint inﬂam-
mation [22]. 
 We now investigated the involvement 
of activating FcγRI and FcγRIII and the 
inhibitory FcγRII in severe cartilage de-
struction seen during AIA. Expression 
of MMP-induced aggrecan neoepitopes 
and erosion of the cartilage matrix was 
investigated in the knee joints of arthrit-
ic mice by histology and immunolocali-
zation. Our ﬁndings indicate that FcγRI 
and not FcγRIII is the dominant activa-
tory Fc receptor involved in severe car-
tilage destruction in a model in which 
T cells play a dominant role. In contrast, 
FcγRII is involved in inhibition of severe 
cartilage destruction within this model 
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and may be a new therapeutic target to 
combat severe cartilage destruction. 
Material and Methods
Animals     
 FcγRIII-/- mice were made deﬁ-
cient for the ligand-binding α-chain of 
FcγRIII (Dr. Verbeek) and were back-
crossed to the C57BL/6 background 
for 12 generations [23]. FcγRI-/- were 
made deﬁcient for the ligand-bind-
ing α-chain of FcγRI (Dr. Verbeek) 
and were backcrossed to BALB/c for 6 
generations [24]. FcγRII-/- were devel-
oped by Dr. Takai (Sendai, Japan) [25] 
in the 129 SV (H-2b) and C57BL6 (H-
2b) background. Control C57BL/6 and 
129SV/C57BL/6 hybrids were derived 
from Jackson Laboratories (Bar Harbor, 
ME) and bred in our own facilities. Ho-
mozygous mutants and their wild-type 
controls, 10 to 12 weeks old, were used 
in the experiments. 
Antibody determination in serum   
 Methylated BSA-speciﬁc antibod-
ies of various isotypes (total IgG, IgG1, 
IgG2a, IgG2b, IgG3) were measured in 
sera of individual mice with an enzyme-
linked immunosorbent assay (ELISA). 
Antigen was coated on microtiter plates 
(Greiner, Alphen a/d Rijn, The Nether-
lands) at a concentration of 100 µg/ml. 
Antibody titers were assessed by twofold 
serial dilution of the sera followed by de-
tection of bound mouse IgG with 1:500 
diluted peroxidase-conjugated rabbit 
anti-mouse IgG (Miles Laboratories 
Inc., Elkhart, IN, USA). O-Phenylene-
diamine (1 mg/ml; Sigma, Zwijndrecht, 
The Netherlands) was used as substrate 
for peroxidase, and the antibody titer was 
determined by using 50% of the maxi-
mal extinction as an end point. Sera of 
FcγRI-/-, FcγRII-/-, and FcγRIII-/- mice 
were compared to sera of their wild-type 
controls. In each group at least 10 mice 
were tested. 
T cell proliferation
 Mouse spleen cells were isolated and 
washed in RPMI supplemented with 
10% fetal calf serum, glutamine (2 mM), 
and pyruvate (1 mM). Erythrocytes 
were lysed by treatment of the cells with 
a 0.16 M NH
4
CL solution in 0.17 M Tris, 
pH 7.2, for 5 minutes. After two washes 
in RPMI, the cells were plated on plastic 
T ﬂasks (75 mm2) from Falcon Plastics, 
Oxnard, CA. After 60 minutes of incu-
bation at 37°C, the nonadherent cells 
were harvested by aspiration and two 4 
to 5 ml RPMI washes of the adherent 
cells. One hundred microliter of RPMI 
containing 1 x 105 T cell-enriched spleen 
cells were placed in each well of a sterile, 
U-bottomed polystyrene microculture 
plate (Costar, Cambridge, MA). Anti-
gens or mitogens were added in another 
100 µl to give a total volume of 200 µl, 
and ﬁnal concentrations of antigen of 
25, 12.5, and 6.25 µg/ml. Cultures were 
maintained at 37°C in a humidiﬁed at-
mosphere of 2% CO
2
 for 4 days. Sixteen 
hours before harvesting, 1 µCi of [3H]-
thymidine (6.7 µCi/mmol; New Eng-
land Nuclear, Boston, MA) was added in 
25 µl of RPMI. Cultures were harvested 
with a cell harvester (Tomtec) and [3H]-
thymidine incorporation was quantiﬁed 
using a Micro Beta-plate reader (Perkin-
Elmer, The Netherlands).
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Induction of experimental antigen-
induced arthritis
 Mice were immunized with 100 
µg of methylated BSA (mBSA, Sigma, 
Zwijndrecht, The Netherlands) emulsi-
ﬁed in 100 µl of Freund’s complete ad-
juvant (CFA). Injections were divided 
over both ﬂanks and footpath of the 
forelegs. Heat-killed Bordetella pertus-
sis (RIVM, Bilthoven, The Netherlands) 
was administered intraperitoneally as an 
additional adjuvant. Two subcutaneous 
booster injections with 50 µg of mBSA/
CFA were given in the neck region 1 
week after the initial immunization [26]. 
Two weeks after these injections, arthri-
tis was induced by intra-articular injec-
tion of either 15 µg (FcγRII-/-) or 60 µg 
(FcγRII-/-, FcγRI-/-, and FcγRIII-/-) of 
mBSA in 6 µl of saline into the right 
knee joint, resulting in chronic arthritis. 
The approval to induce arthritis in mice 
was given by the local ethical commit-
tee. 
99mTc Uptake measurements                      
 Joint inﬂammation was measured by 
99mTc pertechnetate uptake in the knee 
joint. This method has earlier been 
shown to correlate well with histo-
logical ﬁndings [27]. Brieﬂy, mice were 
injected intraperitoneally with 12 µCi 
of 99mTc and subsequently sedated with 
chloralhydrate. Thirty minutes there-
after, γ-radiation was assessed by use of 
a collimated Na-I-scintillation crystal 
and the knee in a ﬁxed position. Arthri-
tis was scored as the ratio of the 99mTc 
uptake in the right (R) and the left (L) 
knee joint. R:L ratios >1.1 were taken 
to indicate inﬂammation of the right 
knee joint. 
Histology                                                                                       
 Total knee joints were dissected, ﬁxed 
in phosphate-buffered formalin (pH 7.4), 
decalciﬁed in 5% buffered formic acid, 
and subsequently embedded in parafﬁn 
wax. Semiserial frontal whole knee joint 
sections (7 µm) were stained with hema-
toxylin and eosin (H&E) or safranin O 
and fastgreen. Histological parameters 
( joint inﬂammation, proteoglycan deple-
tion, and erosion) were scored by two in-
dependent observers in a blinded manner.
Determination of proteoglycan 
depletion                                                                                  
 Total knee joint sections were stained 
with safranin O and fastgreen. Loss of 
red staining from various cartilage layers 
(femur and tibia), which is related to loss 
of proteoglycans, was determined using 
an arbitrary scale ranging from 0 to 3. 
Normal cartilage and cartilage fully de-
pleted of proteoglycans was taken as a 0 
and 3 value, respectively. 
Immunolocalization of MMP-    
induced neoepitope          
 For immunohistochemical analysis, 
sections were deparafﬁnized, rehydrated, 
and digested with chondroitinase ABC 
(0.25 U/ml, 0.1 M Tris-HCL, pH 8.0; 
Sigma) for 1 hour at 37°C, to remove 
chondroitin sulfate from the proteogly-
cans. Sections were then treated with 1% 
H
2
O
2
 in methanol for 20 minutes and sub-
sequently 5 minutes with 0.1% (v/v) Triton 
X-100 in phosphate-buffered saline (PBS). 
After incubation with 1.5% (v/v) normal 
goat serum for 20 minutes, sections were 
incubated with afﬁnity-puriﬁed anti-
VDIPEN IgG overnight at 4°C. These 
antibodies were kindly provided by Irwin 
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Singer and Ellen Bayne (Merck Research 
Laboratories, Rahway, NJ) and have been 
extensively characterized before [28,29]. 
In addition, sections were incubated with 
biotinylated goat anti-rabbit IgG and 
binding was detected using avidin-per-
oxidase staining (Elite kit; Vector Labora-
tories, Inc., Burlingame, CA). Induction 
of the peroxidase product detected using 
nickel enhancement and counterstaining 
was performed with orange G (2%) for 5 
minutes. 
Immunolocalization of aggrecanase-
induced epitopes                 
 Non-decalciﬁed cryosections were 
digested with proteinase-free chondroiti-
nase ABC (0.25 U/ml Tris-HCl, pH 8.0) 
for 1 hour at 37°C to remove chondroitin 
sulfate from the PGs. Subsequently, sec-
tions were ﬁxed with periodate-lysine-
paraformaldehyde ﬁxative for 20 minutes. 
Sections were then treated with 1% H
2
O
2
 
for 20 minutes followed by 5 minutes in-
cubation with 0.1% Triton X-100 in PBS. 
After incubation with 1.5% normal goat 
serum for 20 minutes, sections were incu-
bated for 18 hours with the primary anti-
body recognizing the sequence NITEGE 
[30]. Then sections were incubated with 
biotinylated goat anti-rabbit IgG and 
were detected using avidin-peroxidase 
staining. Development of the peroxidase 
product was done using nickel enhance-
ment. Counterstaining was performed 
with orange G. 
Immunolocalization of IgG                   
 Parafﬁn-embedded total knee joint 
sections were pretreated with chondroiti-
nase ABC and additionally stained with 
goat anti-mouse IgG peroxidase overnight. 
Development of the peroxidase product 
was done using diaminobenzidine (0.5 
mg/ml). Sections were counterstained 
with H&E.
Measurement and characterization 
of cartilage erosion                                                      
 Erosion was determined in total knee 
joint sections stained with H&E. Erosion 
was detected as rufﬂing of the cartilage 
surface and was only mild at day 7 after 
AIA induction. Rufﬂing of the cartilage 
surface was determined using an arbitrary 
scale ranging from 0 to 3. Normal carti-
lage surface and maximal rufﬂing within 
this experiment was taken as a 0 and 3 
value, respectively. 
Results
Role of the activatory FcγRIII and 
inhibitory FcγRII in acute and 
chronic joint inﬂammation during 
AIA                     
 As the absence of a particular FcγR 
may alter the immunological response 
against methylated BSA during immuni-
zation, thereby impairing the onset and 
course of arthritis, we ﬁrst tested cellular 
and humoral immunity to mBSA, 3 weeks 
after immunization. Cellular immunity as 
measured by spleen lymphocyte prolifera-
tion against mBSA showed no signiﬁcant 
differences between knockouts and their 
controls (Figure 1B, D, and F). In addi-
tion, humoral immunity was measured by 
ELISA. Total IgG, IgG1, IgG2a, IgG2b, 
and IgG3 anti-mBSA levels were high but 
not signiﬁcantly different in immunized 
FcγRI-/- and FcγRIII-/- if compared to 
their controls (Figure 1, A and C). In sera 
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of FcγRII-/- immunized mice however, 
total IgG, IgG2a, and IgG3 anti-mBSA 
were fourfold higher and IgG1 was even 
eightfold higher. IgG2b anti-mBSA was 
not signiﬁcantly different (Figure 1E).  
 To investigate the role of a particular 
FcγR in joint inﬂammation, AIA was 
elicited by injection of 60 µg of mBSA 
directly into the knee joints of immu-
nized FcγRI-, FcγRIII-, and FcγRII-de-
ﬁcient mice and their wild-type controls. 
Because FcγRIII-/- has been described as 
a main regulator of IC diseases, we ex-
pected a down-regulation of swelling in 
FcγRIII-/- mice but knee swelling was not 
signiﬁcantly different from controls at all 
Figure 1.  
Humoral and cellular immunity in FcγRI-/-, FcγRIII-/-, and FcγRII-/- mice, and their wild-type controls was determined 7 days after induction of AIA. Humoral im-
munity was determined by measuring levels of various isotypes of antibodies (total IgG, IgG1, IgG2a, IgG2b) raised against mBSA using ELISA. Data of ELISA are 
the mean of the determination in sera of 10 mice. Mean is expressed as two-log values using 50% of the maximal extinction as an endpoint (A, C, and E). Cellular 
immunity was determined by measuring T cell proliferation in the presence of mBSA. 3H-Thymidine incorporation was measured in cpm of spleen T lymphocytes 
derived from arthritic mice that were stimulated with various concentrations of mBSA (25, 12.5, 6.25, 3.1, and 0 µg/ml) (B, D, and F). The results were expressed 
as stimulation indexes (ratio stimulation with and without antigen) and are the mean of 8 animals. Signiﬁcance was tested using the Wilcoxon rank test (*, P 
< 0.05).
37 Role of Fcγ receptors in AIA
time points measured (Figure 2B).
 The course of knee joint swelling in 
FcγRI-/- was also comparable (Figure 
2A) suggesting that FcγRI and FcγIII are 
redundant with respect to joint inﬂam-
mation. Subsequently, we investigated 
the role of FcγRII in joint inﬂamma-
tion. Because FcγRII-/- mice have been 
shown to be highly vulnerable to ICs, 
injection of 60 µg of mBSA into the knee 
joint may be too high and for that reason 
we also injected a lower (15 µg) mBSA 
dose. Injection of 15 µg of mBSA into 
knee joints of FcγRII-/- mice resulted in 
a signiﬁcantly higher knee joint swell-
ing if compared to controls (2.4 versus 
1.7) at day 1 but no difference was found 
anymore at day 4 or day 7 after AIA in-
duction (Figure 2C). Injection of 60 µg 
of mBSA led to a much higher swelling 
at day 1 (3.0 versus 2.0) and compared 
to controls was still signiﬁcantly higher 
at day 7 after AIA induction (2.0 versus 
1.1) (Figure 2D).
 In addition, cellular inﬁltration and 
exudate in the knee joint was studied by 
histology. At day 7 after induction of AIA, 
total knee joint sections were made and 
stained with hematoxylin and eosin. In 
FcγRI-/- and FcγRIII-/- arthritic knees, 
similar exudate and inﬁltrate was meas-
ured in all animals studied (Figure 3, A 
and B). In arthritic knees of FcγRII-de-
ﬁcient mice, both exudate and inﬁltrate 
were found to be signiﬁcantly elevated 
(180% and 242% in the 60-µg group, 
respectively) (Figure 3D). This reached 
signiﬁcance only in mice injected with 
the high dose of mBSA (Figure 3D, E, 
and F). As the total number of inﬂam-
matory cells present in the synovium 
at day 7 after AIA was not different in 
FcγRI-/- and FcγRIII-/- and higher in 
FcγRII-/- mice, we further investigated 
whether the absence of a particular Fc 
receptor might inﬂuence the type of 
inﬂammatory cell present in the joint. 
The polymorphonuclear leukocyte/
macrophage ratio was determined by 
immunolocalization using NIMP-R14 
that stains polymorphonuclear leuko-
cyte speciﬁcally. In arthritic knee joints 
of FcγRI-/-, FcγRIII-/-, and FcγRII-/- 
mice and their controls, no differences 
were found in the polymorphonuclear 
leukocyte/macrophage ratio that was 
40:60 in the exudate and 25:75 in the 
inﬁltrate (data not shown).   
Figure 2.  
R:L ratios of 99mTc uptake at various days (1, 4, and 7) after intra-articular in-
jection of mBSA in knee joints of mBSA-immunized FcγRI-/- (A), FcγRIII-/- (B), 
and FcγRII-/- (C and D) mice, and their wild-type controls. In knees of FcγRI-/- 
and FcγRIII-/- mice, 60 µg of mBSA was injected (A and B) and in knees of 
FcγRII-/- mice, 15 or 60 µg of mBSA (C and D) was injected. Values represent 
the mean ± SD of 10 mice. Data were evaluated using the Wilcoxon rank test 
(*, P < 0.05). Note the signiﬁcantly higher joint swelling in FcγRII-/- mice, 
after injection of 15 µg of mBSA at day 1(C) and after injection of 60 µg of 
mBSA at days 1, 4, and 7 (D).
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Figure 3.  
Frontal sections of whole knee joints 7 days after induction of AIA in FcγRI-/- (A), FcγRIII-/- (B), FcγRII-/- 15 µg (C), and FcγRII-/- 60 µg (D) mice, and their wild-type 
controls. The amount of cells present in the synovium (inﬁltrate) and in the joint cavity (exudate) was determined using an arbitrary scale from 0 to 3. 0, No 
cells; 1, minor; 2, moderate; 3, maximal. The amount of cells was determined by two blind observers. Data are the mean ± SD of 10 animals. Signiﬁcance was 
tested using the Wilcoxon rank test (*, P < 0.05). Original magniﬁcations, x100. F, Femur; T, tibia. Note the signiﬁcantly higher inﬁltrate and exudate at day 7 
after injection of 60 µg of mBSA in knee joints of FcγRII-/- (D and photographs F = FcγRII-/- versus E = wild-type control) and comparable cell mass in arthritic 
FcγRI-/- (A) and FcγRIII-/- (B) mice.
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 As Fc receptors have been shown to 
be involved in removal of ICs from vari-
ous body compartments, the presence of 
IgG ICs localized in the arthritic joints 
at day 7 AIA was determined using 
rabbit anti-murine IgG antibodies. No 
signiﬁcant differences in IC deposition 
were found in the knee joints of FcγRI-/, 
FcγRIII-/-, and FcγRII-/- mice and their 
controls (data not shown). 
Activatory FcγRI and FcγRIII and 
inhibitory FcγRII are not involved 
or redundant in loss of proteoglycans 
from cartilage layers in knee joints 
with AIA
 Subsequently, we studied the role of 
FcγRI, FcγRIII, and FcγRII in cartilage 
damage. The earliest cartilage damage 
seen during experimental arthritis is 
loss of proteoglycans from the cartilage 
matrix that is evident between 24 and 
48 hours after AIA induction. Prote-
oglycan breakdown was measured by 
determining the loss of red staining in 
safranin O-stained knee joint sections 
using an arbitrary scale from 0 to 3. At 
day 7 after induction of AIA, loss of red 
staining in the cartilage layers of femur 
and tibia in control mice injected with 
60 µg of mBSA reached almost maximal 
values (Figure 4 A, B, and D). In ar-
thritic knee joints of FcγRI-/-, FcγRIII-/-, 
and FcγRII-/- mice (Figure 4A, B, and 
D, respectively),  proteoglycan depletion 
was not signiﬁcantly different from their 
arthritic control groups. Injection of 
the 15 µg mBSA dose showed lower PG 
depletion (Figure 4C). Although prote-
oglycan depletion was slightly higher in 
the FcγRII-/- mice, this difference did 
not reach signiﬁcance. 
FcγRI activates, whereas FcγRII 
inhibits the induction of MMP 
cleavage site neoepitope VDIPEN 
during AIA. No effect of FcγRIII 
on VDIPEN expression       
 Within AIA, MMPs have been shown 
to be involved in degradation of aggre-
can [31,32] and collagen [33] leading to 
irreversible cartilage destruction. MMPs 
degrade aggrecan leaving the C-termi-
Figure 4.  
Loss of red staining from cartilage layers of total knee joint sections 7 days 
after induction of AIA in FcγRI-/- (A), FcγRIII-/- (B), FcγRII-/- 15 µg (C), and 
FcγRII-/- 60 µg (D) mice. Loss of red staining was scored in tibia and femur 
using an arbitrary scale from 0 to 3. Data are expressed as loss of red stain-
ing if compared to control cartilage layers and represent the mean ± SD of 
10 mice and were tested on signiﬁcance using the Wilcoxon rank test (*, P 
< 0.05). No signiﬁcant diﬀerence in PG loss was found between wild-type 
controls and FcγRI-/- (A), FcγRIII-/- (B), and FcγRII-/- (C and D) mice. MT, Medial 
tibia; MF, medial femur; LT, lateral tibia; LF, lateral femur; F, femur; T, tibia. 
Original magniﬁcations, x100.
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nal ending with the amino acid sequence 
VDIPEN that can be detected by speciﬁc 
antibodies around day 5 after induction 
of AIA [32]. For this reason, AIA day 7 
was taken to detect VDIPEN expression 
in the cartilage matrix.
 The amount of VDIPEN was measured 
by determining the area of cartilage ex-
pressing VDIPEN using automated image 
analysis. In all investigated knee joints 
of wild-type mice injected with 60 µg 
of mBSA, prominent VDIPEN staining 
was found in the cartilage layers of tibia 
and femur (Figure 5 A to D). Strikingly, 
Figure 5.  
Expression of VDIPEN staining in knee joints of FcγRI-/- (A), FcγRIII-/- (B), FcγRII-/- 15 µg (C), and FcγRII-/- 60 µg (D) mice, and their wild-type controls 7 days after 
AIA induction. Positive VDIPEN staining was determined in various cartilage layers at an original magniﬁcation of x100 (MT, medial tibia; MF, medial femur; LT, 
lateral tibia; LF, lateral femur; F, femur; T, tibia) using automated image analysis and expressed in VDIPEN staining per µm2 cartilage. VDIPEN expression was 
signiﬁcantly lower in cartilage layers of arthritic knee joints of FcγRI-/- (A and micrographs F = FcγRI-/- versus wild-type control = E) but not in FcγRIII-/- mice if 
compared to wild-type controls (B). VDIPEN expression was elevated in arthritic knee joints of FcγRII-/- (C and D). Diﬀerence reached signiﬁcance in the lateral and 
medial tibia after injection of 15 µg of mBSA (C) and in the lateral and medial tibia and medial femur after injection of 60 µg of mBSA (D and photographs H = 
FcγRII-/- versus wild-type control = G). Data represent the mean ± SD of 10 mice. Original magniﬁcations, x250.
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in arthritic knees of FcγRI-/-, VDIPEN 
expression was signiﬁcantly lower in 
medial and lateral femur (88% and 87%, 
respectively) and in medial and lateral 
tibia (79% and 87%, respectively) (Figure 
5A and micrographs in Figure 5, E and F). 
In arthritic knees of FcγRIII-/-, VDIPEN 
expression was comparable to controls 
(Figure 5B). In contrast, in FcγRII-/- ar-
thritic joints, VDIPEN was signiﬁcantly 
higher in lateral and medial femur and lat-
eral tibia (250%, 200%, and 122% higher, 
respectively), indicating that FcγRII is 
involved in MMP-mediated cartilage de-
struction (Figure 5, C and D and micro-
graphs in Figure 5, G and H). VDIPEN 
expression was much lower (between 56 
to 76%) when 15 µg of mBSA was injected 
if compared to the 60 µg group but still 
signiﬁcantly higher in lateral and medial 
tibia of FcγRII-/- if compared to their wild-
type controls (Figure 5C). 
FcγRII is involved in inhibition of 
erosion of the cartilage matrix                  
 To examine the role of FcγRI, FcγRIII, 
and FcγRII in severe irreversible cartilage 
destruction, we also analyzed erosion of 
the cartilage matrix in parafﬁn sections. 
Erosion of the cartilage matrix that is only 
mild at day 7 after AIA was determined as 
rufﬂing of the cartilage surface. No sig-
Figure 6.  
Erosion in cartilage layers (LF, lateral femur; LT, lateral tibia; MF, medial femur; MT, medial tibia) of arthritic knee joints at day 7 after AIA induction in FcγRI-/-, 
FcγRIII-/-, and FcγRII-/- mice, and their wild-type controls. Erosion of the cartilage surface was deﬁned as ruﬄing of the cartilage surfaces using an arbitrary scale 
from 0 to 3. In FcγRI-/- and FcγRIII-/- mice, erosion was mild and comparable to wild-type controls. Erosion was found in 8 of 10 animals in both groups (A and B). 
Injecting 60 µg of mBSA in knees of FcγRII-/- resulted in elevated erosion in all cartilage layers that reached signiﬁcance in the lateral and medial tibia (D and F: 
FcγRII-/- and their wild-type control, E). After injection of 15 µg of mBSA in knee joints of FcγRII-/-, erosion was higher but did not reach signiﬁcance (C). Original 
magniﬁcations, x100.
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nificant differences in matrix erosion were 
found in knees of FcγRI-/- and FcγRIII-/- 
mice if compared to their wild-type con-
trols (Figure 6, A and B). In contrast, in 
knee joints of FcγRII-/- mice, erosion was 
enhanced in the 60 µg mBSA group and 
this difference reached signiﬁcance in the 
lateral and medial tibia (222% and 186% 
higher, respectively) (Figure 6D and mi-
crographs in Figure 6, E and F). In the 
15 µg mBSA group, although erosion was 
somewhat higher, differences did not reach 
signiﬁcance (Figure 6C). 
Discussion
 In a previous study, we found that ab-
sence of functional FcγRI and FcγRIII is 
related to acute and sustained inﬂamma-
tion and is also a major determinant of 
severe destruction of cartilage in AIA. In 
the present study we show that both FcγRI 
and FcγRIII are important in synovial in-
ﬂammation, whereas FcγRI is the domi-
nant activatory receptor involved in severe 
cartilage destruction within this model. 
In contrast, FcγRII is crucial in negative 
regulation of both acute and chronic in-
ﬂammation and late severe cartilage de-
struction.                                
 Because the absence of a particular FcγR 
may impair the T and B cell-mediated im-
munological response against the arthri-
togen mBSA, cellular and humoral immu-
nity against mBSA was determined. T cell 
responses against mBSA were however not 
different in immunized FcγRI-/-, FcγRIII-/, 
and FcγRII-/- mice and their controls and is 
in line with earlier studies showing that loss 
of functional FcγRI and FcγRIII did not 
perturb T-cell maturation [34]. FcγRIII is 
also expressed on mast cells, and FcγRIII-
deﬁcient mice lack IgG-mediated mast 
cell degranulation [35]. However, earlier 
studies by our laboratory showed that the 
course of AIA elicited in knee joints of 
mast cell-deﬁcient (WBB6F1-W/Wv) 
mice was not signiﬁcantly different from 
control littermates, suggesting that mast 
cells do not play an important role in joint 
inﬂammation within this model [36]. 
 Measuring humoral immunity, iso-
type-speciﬁc antibody responses against 
mBSA were not different in FcγRI-/- and 
FcγRIII-/-, which is in line with ear-
lier studies [37]. In immunized FcγRII-/- 
however, all anti-mBSA isotype antibody 
titers (with the exception of IgG2b) were 
four-fold to eight-fold elevated if com-
pared to controls. In the present study, we 
investigated FcγRII-/- on a hybrid SV129/
C57BL6 background, because this back-
ground does not display abnormalities in 
the immunological status. FcγRII-/- mice 
on other backgrounds (eg, C57BL/6) 
develop autoantibodies of multiple IgG 
subclasses [38] that might enhance the 
arthritis induced by mBSA immunization. 
Differences in autoimmune development 
however suggest that FcγRII in combina-
tion with genetic loci may be important 
in breaking the tolerance not only against 
an autoantigen such as collagen type IV 
[39] but also against an exogenous antigen 
such as mBSA. FcγRII may function to 
maintain tolerance in the periphery and 
together with genetic loci, gate B cell ac-
tivation against various antigens.                              
 As the adaptive immunity in FcγRI-/- 
and FcγRIII-/- is not altered, local expres-
sion of both activating FcγR in the joint 
may drive synovial inﬂammation and 
cartilage destruction. Immune complex-
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mediated activation is predominantly regu-
lated by synovial macrophages that have 
been shown to drive onset [40,41], elonga-
tion [42], and ﬂare-up [43] during AIA. In 
a previous study we found that mice that 
express nonfunctional FcγRI and FcγRIII 
and developing comparable adaptive im-
munity with controls showed a signiﬁcant-
ly lower knee joint swelling. In this study, 
both FcγRI-/- and FcγRIII-/- mice showed 
however comparable swelling with con-
trols. These results suggest that FcγRI and 
FcγRIII present on macrophages act in con-
cert with respect to swelling. In the absence 
of one receptor its function may be fully 
compensated by the other FcγR. These re-
ceptors that are expressed on mononuclear 
cells [44] are involved in the respiratory 
burst on cross-linking by IgG-ICs. As a 
result these cells release vasoactive prod-
ucts such as oxygen and nitrogen radicals 
and histamine that are highly involved in 
vascular leakage leading to enhanced 99mTc 
uptake in the joint.                             
 In humans, FcγRIIIA has been sug-
gested to play a role in the pathogenesis 
of RA and a close correlation was found 
between FcγRIIIA expression and the 
location of both synovitis and extracellu-
lar features [45]. A recent study suggests 
a dominant role for FcγRIIIA in the in-
duction of both TNF-α and IL-1α pro-
duction by human macrophages in RA 
after receptor ligation by small ICs [46]. 
Furthermore many animal studies have 
shown that FcγRIII is crucial in IC-de-
pendent diseases raised in skin [47], kidney 
[48], or lung [49]. A reverse passive arthus 
reaction is inhibited within FcγRIII-/- 
mice [23]. Recently, we also found that 
arthritis elicited by ICs only is also very 
strongly FcγRIII-dependent (Nabbe K, 
Van Lent P, Blom AB, Holthuysen A, 
Verbeek S, Van den Berg W, manuscript 
in preparation). The reason why FcγRIII 
does not play an important role within 
AIA may be that apart from ICs T cells 
also play an important role in chronicity 
within this model. During AIA, mBSA-
speciﬁc Th1 cells accumulate in the ar-
thritic joint thereby releasing interferon 
(IFN)-γ. IFN-γ is one of the most potent 
cytokines involved in up-regulation 
of FcγRI on macrophages [50]. Local 
IFN-γ production may cause a shift in 
FcγR expression from FcγRIII to FcγRI 
and may explain the redundancy found 
within this study.  
 The inhibiting FcγRII seems to be of 
utmost importance in both the acute and 
chronic phase of synovial inﬂammation 
and absence leads to signiﬁcantly higher 
inﬂammation. FcγRII is expressed on 
various hematopoietic cells and is a nega-
tive regulator of FcγRIII receptor on B 
cells and macrophages [51] and probably 
also of FcγRI [52]. FcγRII may act as 
a negative regulator of antibody produc-
tion and/or local IC-triggered activation. 
As most of the anti-mBSA isotype titers 
were elevated, this may be responsible for 
a higher IC load within the knee joint.      
 Although we did not ﬁnd differenc-
es in the IC load in the knee joints of 
FcγRII-/- and controls at day 7 after AIA 
using immunolocalization, differences 
may have been present at earlier time 
points of this arthritis. Local IC-trig-
gered activation in the joint may further 
be different. Absence of the FcγRII on 
macrophages has been shown to enhance 
the release of inﬂammatory mediators 
such as IL-1 and TNF-α [53] that are 
highly involved in synovial inﬂamma-
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tion. Comparing two doses of mBSA we 
found that only the high dose (60 µg) 
of mBSA was FcγRII-dependent during 
the complete 7-day course of arthritis. 
Immune complexes drive inﬂammation 
by both activating Fc receptors and com-
plement and the two systems seemed to 
be co-dominant in the early arthus reac-
tion [54]. Our results suggest that after the 
arthus, in the developing phase of chro-
nicity of experimental arthritis, higher 
IC doses may be more FcγR-dependent if 
compared with lower IC doses. 
 Previous studies have shown that mac-
rophages are crucial in cartilage destruc-
tion seen during AIA [38-41]. Macro-
phages may function either indirectly by 
attracting inﬂammatory cells or directly 
as important producers of cytokines [55] 
and enzymes [56], and in RA activation 
of macrophages may be T cell-depend-
ent [57,58]. During AIA, two phases of 
cartilage destruction are observed. The 
ﬁrst early phase, which is characterized by 
proteoglycan loss, is mediated by aggreca-
nase, a member of the ADAMS (a desin-
tegrin and metalloproteinase) family. The 
second phase that starts at approximately 
day 5 after AIA induction, is characterized 
by MMP-mediated matrix destruction 
resulting in irreversible cartilage erosion 
[32]. Because no difference was found in 
PG breakdown nor NITEGE staining in 
cartilage surfaces of arthritic knee joints 
of FcγR-, FcγRIII-, or FcγRII-deﬁcient 
mice and their wild-type controls (data 
not shown), this suggests that these recep-
tors are not important or redundant in ag-
grecanase-induced cartilage damage. 
 In contrast, MMP-mediated cartilage 
destruction as measured by VDIPEN 
staining was signiﬁcantly lower in FcγRI-/- 
but not in FcγRIII-/- arthritic knee joints. 
The latter indicates that FcγRI rather than 
FcγRIII is involved in late severe cartilage 
destruction. This type of cartilage destruc-
tion only occurs in experimental models, 
containing an IC component [32]. Other 
arthritis models induced by bacterial or 
yeast cell walls never resulted in severe 
cartilage destruction and also expression 
of VDIPEN neoepitopes was fully absent 
[32]. As we showed earlier, the activatory 
FcγR are probably involved in activation 
of latent MMPs present in the cartilage 
matrix of arthritic knees, binding of 
FcγRI may lead to activation of synovial 
macrophages leading to selective pro-
duction of pro-MMP-activating factors. 
Although erosion was still mild at day 7 
after AIA induction, there was a tendency 
that erosion was lower in cartilage layers 
of arthritic knees of FcγRI-/- mice. Dif-
ferences may diverge more at later time 
points when erosion becomes more severe 
within this model.                 
 In contrast, in the absence of FcγRII 
signiﬁcantly higher MMP-mediated de-
struction was found within the cartilage 
layers of the arthritic joints. First, this 
may be because of an elevated load of 
IC within the joint as a result of higher 
anti-mBSA titers and may explain the 
higher VDIPEN expression in the 60 µg 
mBSA group. Furthermore, macrophages 
deﬁcient for FcγRII produce higher IL-1 
concentrations on activation with ICs [39]. 
As interleukin-1 is the dominant cytokine 
involved in VDIPEN expression during 
AIA [59] this also may contribute to the 
higher VDIPEN expression in the car-
tilage. Moreover, the absence of FcγRII 
may elevate mechanisms involved in ac-
tivation of pro-MMPs into their active 
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form. A higher concentration of enzymes 
released by macrophages and/or polymor-
phonuclear leukocytes such as elastase may 
be responsible for more efﬁcient activa-
tion of pro-MMPs [60]. Whether FcγRII 
contributes to higher joint inﬂammation 
and severe cartilage destruction either by 
elevation of anti-mBSA antibodies and 
subsequent raise of ICs and/or by eleva-
tion of local hypersensitivity of macro-
phages to ICs is momentarily under inves-
tigation by blocking FcγRII at the onset 
of AIA using anti-FcγRII antibodies. 
The above results suggest that expression 
of the activatory FcγRI on the surface of 
local cells present in the knee joint during 
T cell-dependent AIA is the dominant 
activatory Fc receptor involved in carti-
lage destruction, whereas the inhibiting 
FcγRII-/- may be an important regulating 
receptor of severe cartilage destruction. 
During late phases of human arthritis, 
monocytes/macrophages are the domi-
nant hematopoietic cells present in the RA 
joint and a strong correlation between the 
number of macrophages and erosion of 
the cartilage matrix was found during RA 
[61]. Disturbance in the balance between 
activating FcγRI and FcγRIII receptors 
and the inhibiting FcγRII receptor on 
synovial macrophages may have impor-
tant implications for cartilage destruction 
during arthritis and the inhibiting FcγRII 
may form a new target for therapeutic in-
tervention of cartilage destruction within 
this destructive disease. 
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Studies in FcγRII-/- mice identiﬁed the inhibitory function of this receptor in joint 
inﬂammation and cartilage destruction induced with immune complexes (ICs). 
To extend our insight in the role of FcγRII in arthritis, we explored the role of 
FcγRII in the absence of activating receptors I and III using FcγRI/III-/- as well as 
FcγRI/II/III-/- mice. When antigen-induced arthritis (AIA) was elicited , which is 
a mixture of T cell and IC-driven inﬂammation, arthritis was almost absent at day 
7 in FcγRI/III-/- mice. Remarkably, in FcγRI/II/III-/- mice, this model induced a 
tremendously increased arthritis as compared to wild-type controls. This implies 
that FcγRII regulates joint inﬂammation also in the abscence of activating FcγRI 
and III. To conﬁrm the IC speciﬁcity of this ﬁnding, similar studies were done with 
ICs or zymosan as arthritogenic stimuli. Strongly elevated inﬂammation was found 
in FcγRI/II/III-/- mice with IC but not with zymosan. Clearance studies identiﬁed 
accumulation of IgG in the knee joint in the absence of FcγRII. Moreover, macro-
phages expressing only FcγRII showed prominent endocytosis of  preformed soluble 
ICs not different from controls. In total absence of FcγR (FcγRI/II/III-/-), macro-
phages completely failed to endocytose ICs. Although joint inﬂammation was much 
higher in AIA arthritic knee joints of FcγRI/II/III-/- and the inﬂammatory cells still 
expressed an inﬂammatory phenotype,  severe cartilage destruction (MMP-medi-
ated neoepitopes in the matrix  and chondrocyte death) was completely prevented in 
contrast to the marked destruction which was observed in the wild-type. Our study 
indicates that  FcγRII reduces joint inﬂammation in the absence of activating FcγR 
by promoting endocytosis and clearance of ICs from the joint. Inﬁltrating cells, 
which fail to express activating FcγR although they still become stimulated are no 
longer capable of  inducing severe cartilage destruction. 
 Rheumatoid arthritis (RA) is a heter-
ogenous chronic joint disease character-
ised by invasion of leucocytes and local 
synovium activation, which leads to severe 
destruction of cartilage and bone [1]. The 
most prominent leucocyte present within 
the inﬂamed synovium is the macrophage. 
A strong correlation was found between 
the number of activated macrophages 
and severe cartilage destruction [2]. In a 
normal joint, macrophages are comprised 
within the intima layer which covers 
the surface of the synovium [3]. In RA, 
synovial macrophages become activated, 
resulting in the release of chemokines, 
cytokines, and enzymes involved in regu-
lation of joint inﬂammation and cartilage/
bone destruction [4, 5].
 The mechanism by which synovial 
intima macrophages become activated 
during RA is not known. One of the 
potential candidates are IgG-containing 
immune complexes (ICs). They are abun-
dantly found in RA synovial ﬂuid, syn-
ovium, and surface layers of the cartilage 
[6]. In previous studies we have found that 
lining macrophages are of utmost impor-
tance in both  onset and prolongation of 
experimental murine arthritis. When syn-
ovial intima macrophages were selectively 
depleted from the knee joint either before 
induction or during immune complex 
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(IC)-mediated  arthritides like collagen 
type II (CIA) or antigen-induced arthritis 
(AIA), onset and course of arthritis was 
largely reduced [7-9]. 
 IgG-containing ICs communicate with 
lining macrophages using Fcγ receptors 
(FcγRs) [10]. In the mouse, three classes 
of FcγR have been described. FcγRI and 
III are activating receptors and lead to 
elevation of intracellular signaling after 
binding of ICs [11-12]. The third class is 
FcγRII, which can co-ligate with either 
FcγRI or FcγRIII, resulting in inhibition 
of intracellular signaling [13]. Coordinate 
expression of activating and inhibiting 
FcγR on synovial lining cells has been 
shown to regulate both joint inﬂamma-
tion and severe cartilage destruction [10]. 
The inhibiting FcγRII exists as two iso-
forms, FcγRIIb1 and FcγRIIb2, differing 
by a 47-amino acid insertion in the intra-
cytoplasmatic domain of FcγRII encoded 
by the ﬁrst exon of the FcγRII gene [14]. 
The in vivo role of FcγRII was extensive-
ly studied using FcγRII-deﬁcient mice 
and it is generally agreed that inhibition 
occurs only when FcγRII is co-clustered 
with ITAM-bearing receptors [15,16]. 
The inhibitory function is mediated by 
the inositol phosphatase SHIP which as-
sociates with the phosphorylated ITIM of 
FcγRII via the SHIP SH2 domain [17]. 
However, in vitro studies also suggested 
other biological functions for FcγRII. By 
transferring cDNA of both FcγRII iso-
forms into ﬁbroblastic cell lines which 
do not express FcγR, it was found that 
FcγRIIb2 is involved in endocytosis and 
enhancement of antigen presentation [18-
20]. FcγRIIb1, which is preferentially ex-
pressed in B lymphocytes, lacks immune 
internalization properties, yet it inhibits 
B-cell activation and subsequent antibody 
production when cross-linked to mem-
brane Ig. This suggests that FcγRII, apart 
from inhibiting activating FcγR, may also 
have other important functions in vivo.
 In the present study, we investigated 
the in vivo role of FcγRII, uncoupled 
from its function as inhibitor of activat-
ing FcγR, in regulating joint inﬂamma-
tion and severe cartilage destruction in 
models of IC-mediated arthritis using 
mice which were made deﬁcient for either 
both activating FcγR (FcγRI/III-/-) or all 
three FcγR (FcγRI/II/III-/-). We found 
that FcγRII is a major regulator of joint 
inﬂammation by promoting clearance of 
ICs by synovial lining cells. Furthermore 
activating FcγR on inﬂammatory cells 
appeared to be prerequisites for severe ir-
reversible cartilage destruction.
Material and Methods
Animals
 FcγRI and FcγRIII-/- were made de-
ﬁcient for the ligand-binding α-chain of 
FcγRI [21]  and FcγRIII [22], respec-
tively. FcγRIII-/- were back-crossed to 
the C57BL/6 background for 12 gen-
erations.  FcγRIIb-/-  were developed  by 
Dr.Takai [15] in the 129Ola (H-2b) and 
C57BL6 (H-2b) background. FcγRI-/- 
was made in the 129Ola/C57Bl/6 back-
ground. FcγRII/III-/- and their controls 
(control 1) were developed in the 129Ola/
C57Bl/6 background. Intercrossing led to 
FcγRI/II/III-/- in the 129Ola/C57Bl/6/
balb/c (enriched for C57Bl/6), as were 
their triple controls (control 2). Control 
C57Bl/6 and 129Ola/C57Bl/6 were 
derived from Jackson laboratories (Bar 
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Harbor, ME) and bred in our own facili-
ties. Homozygous mutants and their wild-
type (WT) controls, aged 10 to 12 weeks, 
were used in the experiments. 
Humoral immunity against mBSA 
 Antibodies of various isotypes (IgG, 
IgG1, IgG2a, IgG2b, IgG3) directed 
against methylated bovine serum albu-
min (mBSA) were measured in sera of 
individual mice with an enzyme-linked 
immunosorbent assay (ELISA). Antigen 
was coated on microtiter plates (Greiner, 
Alphen a/d Rijn, The Netherlands) at a 
concentration of 100 µg/ml. Antibody 
titers were assessed by two-fold serial di-
lution of the sera followed by detection 
of bound mouse Ig with 1:500 diluted 
peroxidase-conjugated rabbit anti-mouse 
Ig (Miles Laboratories Inc., Elkhart, IN). 
O-Phenylenediamine (1 mg/ml; Sigma, 
St. Louis, MO) was used as substrate for 
peroxidase, and the antibody titer was de-
termined by using 50% of the maximal 
extinction as an end-point. 
Cellular immunity against mBSA
 Mouse spleen cells were isolated and 
washed in RPMI supplemented with 10% 
fetal calf serum, glutamin (2 mM) and 
pyruvate (1 mM). Erythrocytes were 
lysed  by treatment of the cells with an 
0.16 M NH
4
CL solution in 0.17 M Tris, 
pH 7.2, for 5 minutes. After two washes 
in RPMI, the cells were plated on plastic 
T ﬂasks (75 mm2) from Falcon Plastics 
(Oxnard, CA). After 60 minutes of  in-
cubation at 37oC, the nonadherent cells, 
were harvested by aspiration and two 4- to 
5-ml RPMI washes of the adherent cells. 
Hundred microliter of RPMI containing 
1 x 105 T-cell-enriched spleen cells were 
placed in each well of a sterile, U-bot-
tomed polystyrene microculture plate 
(Costar, Cambridge, MA). Antigens or 
mitogens were added in another 100 µl 
to give a total volume of 200 µl, and 
ﬁnal concentrations of antigen of 50, 
25, 12, 6, and 3 µg/ml. Cultures were 
maintained at 37 °C in a humiﬁed at-
mosphere of 2% CO
2
 for 4 days. Sixteen 
hours before harvesting, 1 µCi of [3H]-
thymidine (6.7 µCi/mmole from New 
England Nuclear, Boston, MA) was 
added in 25 µl of RPMI. Cultures were 
harvested with a cell harvester and [3H]-
thymidine incorporation was quantiﬁed 
using a Micro Beta-plate reader (Perkin, 
The Netherlands).
Induction of experimental arthritis
 AIA was induced by injecting 60 µg 
of mBSA in 6 µl PBS directly into the 
knee joints of mice that were previously 
immunized with that antigen. Mice 
were immunized with 100 µg of mBSA 
(Sigma, Zwijndrecht, The Netherlands), 
emulsiﬁed in 100 µl Freunds com-
plete adjuvant (CFA). Injections were 
divided over both ﬂanks and footpath 
of the forelegs. Heat-killed Bordetella 
pertussis was administered intraperito-
neally as an additional adjuvant. Two 
subcutaneous booster injections with 
50 µg mBSA/CFA were given in the 
neck region one week after the initial 
immunization. Two weeks after these 
injections, arthritis was induced into 
the right knee joint, resulting in chronic 
arthritis.
 Immune complex arthritis (ICA) was 
passively induced in knee joints of  mice 
[23].  Three microgram of lysozyme in 
6 µl were injected directly into the knee 
 54 Chapter 3
joint of mice that previously were given 
anti-lysosyme antibodies intravenously. 
An acute arthritis develops, which became 
maximal at day 3 and waned thereafter.   
 A non-IC-mediated zymosan-induced 
arthritis (ZIA) was induced by injecting 
180 µg sterilized zymosan in 6 µl PBS 
into the knee joint.
99mTc Uptake measurements
 Joint inﬂammation was measured by 
99mTc pertechnetate uptake in the knee 
joint. This method was shown earlier to 
correlate well with histological ﬁndings 
[24].  Brieﬂy, mice were injected intra-
peritoneally with 12 µCi 99mTc and sub-
sequently  sedated with chloralhydrate. 
Thirty minutes thereafter, gamma radia-
tion was assessed by use of  a collimated 
Na-I-scintillation crystal with the knee 
in a ﬁxed position. Arthritis was scored as 
the ratio of the 99mTc uptake in the right 
(R) and the left (L) knee joint. R:L ratios 
> 1.1 were taken to indicate inﬂamma-
tion of the right knee joint.
Histology
 Total knee joints were dissected, ﬁxed 
in phosphate buffered formalin (pH 7.4), 
decalciﬁed in 5% buffered formic acid, 
and subsequently embedded in parafﬁn 
wax. Semiserial frontal whole knee joint 
sections (7 µm) were stained with he-
matoxylin and eosin (H&E) or safranin 
O and fast green. The severity of joint 
inﬂammation was determined using an 
arbitrary score (0 to 3). Inﬁltrate and 
exudate were scored separately. Scoring 
was performed in a blinded manner by 
two independent observers: 0, no cells; 1, 
mild cellularity; 2, moderate cellularity; 
3, maximal cellularity.  
Endocytosis and clearance of IgG 
immune complexes 
 Endocytosis and clearance of IgG ICs 
were studied both in vivo and in vitro. The 
clearance of IgG-containing ICs from ar-
thritic knee joints of FcγRI/II/III-/- and 
FcγRI/III-/- mice was studied using anti-
IgG immunolocalization. In one group, 
AIA was induced whereas in a second group 
knee joints were injected with 6 µg of 
heat-aggregated IgG. The latter was made 
by heating rabbit-IgG during 30 minutes 
at 61oC. Knee joints were isolated 7 days 
after AIA induction or 8 hours after injec-
tion of aggregated IgG. Parafﬁn-embedded 
total knee joint sections were pretreated 
with hyaluronidase ABC and additionally 
stained with either goat anti-mouse per-
oxidase or goat anti-rabbit peroxidase over-
night. Induction of the peroxidase product 
was detected using diaminobenzidine (0.5 
mg/ml). Sections were counterstained with 
H&E.   
Isolation of peritoneal macrophages 
from mice previously injected with 
thioglycolate
 ICs were preformed by incubating 
soluble ﬂuorescein isothiocyanate (FITC)-
labeled OVA (Molecular Probes, Leiden, 
The Netherlands) with 25 µg/ml polyclo-
nal OVA-speciﬁc rabbit IgG (rIgG OVA; 
Sigma-Aldrich, Zwijndrecht, The Nether-
lands) for 30 minutes at 37ºC in propylene 
tubes. Fifty thousand peritoneal macro-
phages were added to FACS tubes contain-
ing OVA-ICs or soluble OVA and incu-
bated for 15 minutes at 37ºC. Cells were 
washed twice and resuspended in presence 
of 0.4% (w/v) trypan blue (Sigma-Aldrich), 
which quenches extracellular, but not in-
tracellular, ﬂuorescence. Flow cytometry 
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was performed with FACScan. The mean 
ﬂuorescence value of six measurements is 
shown. 
Immunohistochemical staining of 
myeloid related proteins (MRP)8 
and 14 
 Rabbit anti-sera against recombinant 
murine MRP8 (α-MRP8) and MRP14 
(α-MRP14) were produced as described 
earlier [25]. Monospeciﬁcity of antibod-
ies was analyzed by immunoreactivity 
against recombinant MRP8 and MRP14 
and Western blot analysis of lysates of 
granulocytes [25]. Formalin-ﬁxed sec-
tions of knee joints were stained using a 
ﬁnal antibody concentration of 1 µg/ml. 
Primary antibodies were detected using 
peroxidase-conjugated second-stage anti-
bodies against rabbit IgG (Dianova, Ham-
burg, Germany). Finally, sections were 
counterstained with Mayer’s hematoxylin 
(Merck, Darmstadt, Germany). MRP8- 
and MRP14-positive cells present in the 
joint cavity and synovial lining were 
determined and expressed as percentage 
of the total cell population, using an ar-
bitrary score (0:0%, 1:1 to 30%, 2:31 to 
70%, 3:71 to 100%). 
Immunolocalization of MMP-    
induced neoepitope (VDIPEN)
 For immunohistochemical analysis, 
sections were deparafﬁnized, rehydrated 
and digested with chondroitinase ABC 
(Sigma, 0.25 U/ml, 0.1 M Tris-HCL, 
pH 8.0) for 1 hour at 37ºC, to remove 
chondroitine sulphate from the prote-
oglycans. Sections were then treated with 
1% H
2
O
2
 in methanol for 20 minutes and 
subsequently for 5 minutes with 0.1% 
(v/v) triton X-100 in PBS. After incuba-
tion with 1.5% (v/v) normal goat serum 
for 20 minutes, sections were incubated 
with af f inity-purif ied anti-VDIPEN 
IgG overnight at 4oC. These antibodies 
were kindly provided by Irwin Singer 
and Ellen Bayne (Merck Research 
Laboratories,Rahway,NJ) and  have been 
extensively characterized before [26,27]. 
In addition, sections were incubated with 
biotinylated goat anti-rabbit IgG and 
binding was detected using avidin-perox-
idase staining (Elite kit, Vector Laborato-
ries, Inc., Burlingham, CA). Induction of 
the peroxidase product was detected using 
nickel enhancement and counterstaining 
was performed with orange G (2%) for 5 
minutes.
Measurement and characterization 
of chondrocyte death
 Chondrocyte death was determined 
at day 7 after AIA induction in total 
knee joint sections stained with H&E. 
Chondrocyte death was determined as 
percentage of the area of the cartilage 
containing empty lacunae in relation to 
the total area. 
Results
Role of the inhibitory FcγRII in the 
absence of activating FcγR during 
antigen-induced arthritis
 To investigate the role of FcγRII in the 
absence of activating FcγR, we induced 
AIA in knee joints of  FcγRI/III-/- and 
FcγRI/II/III-/- mice. As the absence of 
FcγR may alter the immunological re-
sponse against methylated BSA during 
immunization of these mice, thereby 
impairing the onset and course of arthri-
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tis, we ﬁrst tested cellular and humoral 
immunity to mBSA, 3 weeks  after im-
munization. Cellular immunity as meas-
ured by spleen lymphocyte stimulation 
(LST) against various concentrations of 
mBSA showed no signiﬁcant differences 
between the knockout (KO) and  their 
controls (Table 1). In addition, humoral 
immunity was measured by ELISA. Total 
IgG, IgG1, IgG2a, and IgG3 anti-mBSA 
levels were two to four times higher, 
whereas IgG2b levels were not different 
in sera of both immunized FcγRI/III-/- 
and FcγRI/II/III-/- when compared  to 
their WT controls (Table 1).
 Subsequently, AIA was induced and 
knee joint swelling was determined at 
various time-points after induction. We 
found that inﬂammation in arthritic 
knee joints of FcγRI/III-/- was sig-
niﬁcantly lower both at day 3 and day 
7 when compared to arthritic controls 
(Figure 1A). Interestingly, inﬂammation 
in arthritic knee joints of FcγRI/II/III-/- 
was not different from that seen in con-
trol knee joints both at day 3 and 7 after 
AIA induction (Figure 1B). 
 To further verify these observations, 
histology of total arthritic knee joints 
was investigated. At day 7 after AIA 
induction, FcγRI/III-/- mice showed 
that although IgG2a antibody titers 
were much higher, exudate and inﬁl-
trate was signiﬁcantly lower (90% and 
87%, respectively) when compared to 
WT controls (Figure 2, A and D, versus 
WT control, Figure 2E). In contrast, 
at day 7 after AIA induction in knees 
Table 1 Cellular and humoral immunity four weeks after immunization with mBSA/CFA  
        
            Cellular Immunity (SI)  Humoral  Immunity (titer)
    50       25       12        6        3          IgG     IgG1   IgG2a   IgG2b   IgG3
WT control 3(1)     5(1)     6(2)    7(1)    5(1)          13(2)   11(1)   12(2)    11(1)     10(1)       
FcγRI/III-/- 5(2)     7(1)     8(1)    8(0)   5(0)          14(2)   13(1)   13(1)     11(1)    11(0)
WT control 1(1)     2(1)     5(0)    6(1)    4(1)          17(1)   14(2)   13(1)     14(0)    10(1)
FcγRI/II/III-/- 1(0)     4(2)     6(1)    7(1)    5(0)         18(1)   16(2)   15(1)     14(1)    11(2)
  
Cellular immunity was measured by spleen lymphocyte proliferation and expressed as stimulation index (ratio of T cells stimulated with various concentrations 
of mBSA (50, 25, 12, 6, 3 µg/ml) and T cells not stimulated). Values represent the mean ± SD of three groups of 2 mice each. Humoral immunity was measured as 
antibody production against mBSA and various isotypes were determined using ELISA. Note that IgG1, IgG2a and IgG3 levels were elevated (2-4 times), whereas 
IgG2b was not elevated in both FcγRI/III-/- and FcγRI/II/III-/- when compared to controls.
Figure 1
Inﬂammation of the knee joint, expressing cellular activation, was deter-
mined as R:L ratios of 99mTc uptake at various days (3 and 7) after injection 
of 60µg mBSA in the right knee joints of mBSA-immunized FcγRI/III-/- (A) 
and FcγRI/II/III-/- mice(B). In the left knee joints PBS was injected. Values 
represent the mean ± SD of 7 mice. Data were evaluated using the Wilcoxon 
rank test (*, P< 0.05). Note that swelling was almost absent in knee joints of 
arthritic FcγRI/III-/-, whereas similar joint inﬂammation was found in arthritic 
FcγRI/II/III-/-.
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of FcγRI/II/III-/-, joint inﬂammation 
appeared to be markedly higher when 
compared to their controls (exudate and 
inﬁltrate were respectively 200% and 
120% higher (Figure 2, B and F versus 
WT control, Figure 2E)), suggesting 
that FcγRII is an important regulator 
of joint inﬂammation in the absence of 
activating FcγR. 
FcγRII regulation of joint inﬂam-
mation is speciﬁc for immune 
complexes
 To further investigate whether FcγRII 
regulation of joint inﬂammation in the 
absence of activating FcγR is speciﬁc for 
ICs (and not, for example, by T cells also 
involved in AIA), we induced arthritis 
solely by ICs. ICA was passively induced 
by injecting lysozyme in knee joints of 
mice that were previously given anti-lys-
ozyme antibodies. Histology taken at day 
3 after arthritis induction showed that 
joint inﬂammation was almost completely 
prevented in FcγRI/III-/-, whereas sub-
stantial arthritis was found in their WT 
controls (Figure 3A). When ICA was 
induced in knee joints of FcγRI/II/III-/-, 
the inﬂammatory cell mass as measured 
at day 1 and 3 was in line with that found 
in AIA, again signiﬁcantly higher when 
compared to WT controls. At day 1, exu-
dates and inﬁltrate were 310% and 60%, 
respectively (Figure 3B), and at day 3, 
2200% and 270% higher (Figure 3C).
 To further substantiate the speciﬁcity 
for ICs, we additionally injected zymosan 
in the knee joints of FcγRI/II/III-/-. The 
inﬂammatory cell mass measured at day 
3 after ZIA induction was not different 
from controls, suggesting that knee joints 
of these mice develop a normal inﬂam-
matory response after injection with zy-
mosan (Figure 3D).
FcγRII is involved in efﬁcient    
endocytosis and clearance of ICs
 One of the reasons why joint inﬂam-
mation is elevated in FcγRI/II/III-/- mice 
may be an impaired endocytosis and clear-
ance of ICs from the joint. 
 To investigate whether FcγRII is in-
Figure 2 
Frontal sections of knee joints 7 days after induction of AIA in FcγRI/III-/- (A), 
FcγRI/II/III-/- (B) and their wild-type controls 1 and 2. The amount of cells 
present in the synovium (inﬁltrate) and in the knee joint cavity (exudate) 
was determined using an arbitrary scale from 0 to 3: 0, no cells; 1, minor; 2, 
moderate; 3, maximal. The amount of cells was determined independently by 
two blinded observers. Data are the mean of 7 mice. Signiﬁcance was tested 
using the Wilcoxon rank test (*, P<0.05). Original magniﬁcation of the photo-
graphs is 100X.F, femur; P, patella. Note the signiﬁcantly lower inﬂammatory 
cell mass in knee joints of FcγRI/III-/- (A and D versus WT control C) and the 
signiﬁcantly higher cell mass  in FcγRI/II/III-/- knee joints (B and F versus WT 
control E) when compared to WT controls.
 58 Chapter 3
volved in endocytosis of IgG containing 
ICs, we ﬁrst investigated the presence of 
murine IgG, localized within the arthritic 
joints at day 7 after AIA induction using 
immunolocalization. No signiﬁcant dif-
ferences in IgG deposition was found in 
the knee joints of FcγRI/III-/- mice and 
their WT controls, suggesting an effective 
clearance of IgG containing ICs in the 
presence of only FcγRII (Figure 4B versus 
WT control, Figure 4A). In contrast, ar-
thritic knee joints of FcγRI/II/III-/- con-
tained large amounts of IgG, suggesting 
that removal of ICs is retarded (Figure 
4D versus WT controls, Figure 4C). To 
conﬁrm this ﬁnding, heat-aggregated 
IgG was injected in the knee joints of 
FcγRI/III-/- and FcγRI/II/III-/- mice and 
their WT controls. Immunolocalization 
of IgG showed that 8 hours after injec-
tion signiﬁcantly more IgG was detected 
in FcγRI/II/III-/- knee joints which was 
mainly bound to the synovial lining layer 
(Figure 5D versus WT control, Figure 
5E). Similar intensity of staining was 
found when aggregated IgG was injected 
in knee joints of FcγRI/III-/- and their 
controls (Figure 5B versus WT control, 
Figure 5A).
 To further analyze FcγRII function 
on macrophages, thioglycollate-induced 
peritoneal macrophages were isolated. 
When macrophages expressing only 
FcγRII (FcγRI/III-/-) were pre-incubated 
with pre-formed FITC-labeled OVA-IgG 
ICs, prominent endocytosis was found 
Figure 3
Inﬂammatory cell mass in knee 
joints, 3 days after induction of ICA in 
FcγRI/III-/- (A), 1 and 3 days after ICA in 
FcγRI/II/III-/- (B and C) or 3 days after 
induction of zymosan-induced arthri-
tis (D) in FcγRI/II/III-/- and their WT 
controls 1 and 2. Data are the mean of 
7 mice. Signiﬁcance was tested using 
the Wilcoxon rank test (*, P<0.05). 
Original magniﬁcation of the photo-
graphs is X 100.F, femur; P, patella. 
Note the signiﬁcantly lower inﬂam-
matory cell mass after ICA induction 
in knee joints of FcγRI/III-/- (A) and the 
signiﬁcantly higher cell mass at day 
1 and 3 in FcγRI/II/III-/- knee joints (B 
and C) and the comparable cell mass at 
day 3 after ZIA (D) when compared to 
WT controls.
Figure 4
Presence of  IgG-containing ICs, detected by immunolocalization, in knee 
joints of various KO mice, 7 days after induction of antigen-induced arthritis. 
Note that IgG is present in large amounts in arthritic FcγRI/II/III-/- knee joints 
when compared to their WT controls (D versus WT control C). No diﬀerence 
in amounts of IgG was found in arthritic knee joints of FcγRI/III-/- when com-
pared to their controls (B versus WT control A). Original magniﬁcation, X 100. 
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not different from control macrophages 
(Figure 6B versus control, Figure 6A). In-
terestingly when FcγRII was also absent 
(FcγRI/II/III-/-), endocytosis of ICs was 
completely prevented (Figure 6C versus 
control, Figure 6A).    
Type and activation state of inﬂam-
matory cells in arthritic knee joints 
of FcγRI/II/III-/- mice
 To further analyze the composition of 
the inﬂammatory cell mass within the ar-
thritic FcγRI/II/III-/- knee joint, we next 
investigated the type and activation state of 
the inﬂammatory cells using immunolocal-
ization. PMN and monocyte/macrophage 
ratios were determined by immunolo-
calization using NIMP-R14, which stains 
PMN speciﬁcally. At day 7 after AIA in-
duction in FcγRI/II/III-/- knee joints, the 
majority of inﬂammatory cells appeared 
to be monocytes (ratio monocytes/PMN 
60-40) and no differences were found 
between KO and their controls. In addi-
tion, we determined the pro-inﬂamma-
tory phenotype of the inﬁltrated cells. In 
FcγRI/II/III-/- mice, the inﬁltrated cells 
in the arthritic joint displayed an activated 
phenotype, according to high expression 
of MRP8 and 14 (respectively 47% and 
92%: Figure 7, A and C versus WT con-
trol, Figure 7B), whereas inﬁltrated cells 
in the joints of FcγRI/III-/- mice failed to 
express these activation markers (data not 
shown). In fact this implies that FcγRII 
can prevent cellular activation even in the 
absence of FcγRI/III. 
Activated inﬂammatory cells in the 
absence of activation FcγR fail to 
induce severe cartilage destruction 
 As the majority of the inﬁltrated cells 
in the FcγRI/II/III-/- knee joints were 
activated, we additionally investigated 
Figure 5
Presence of heat-aggregated IgG detected by immunolocalization, 8 hours 
after injection in knee joints of various KO mice. Heat-aggregated rabbit IgG 
is less eﬃciently cleared (arrow) when injected in FcγRI/II/III-/- knee joints in 
comparison to WT controls 2 (D versus WT control C). No diﬀerences are found 
between knee joints of FcγRI/III-/- and their WT controls (B versus WT control 
A). Original magniﬁcation, X 100.
Figure 6
Endocytosis of soluble ﬂuorescent ovalbumin–IgG ICs by peritoneal macro-
phages derived from FcγRI/III-/- and FcγRI/II/III-/-. Note that ICs are eﬃciently 
endocytosed by macrophages expressing only FcγRII (FcγRI/III-/-) not dif-
ferent from controls (B versus WT control A). When macrophages missing 
all FcγR (FcγRI/II/III-/-) were used, endocytosis of ICs was blocked (C versus 
WT control A). Peritoneal macrophages of WT littermates of FcγRI/III-/- and 
FcγRI/II/III-/- were used as controls. As uptake of IC by both control cells was 
similar, only control cells of FcγRI/II/III-/- are shown. MFI, mean ﬂuorescent 
intensity.  Data are the mean of three diﬀerent experiments. Signiﬁcance was 
tested using the Wilcoxon rank test (*, P<0.05). 
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whether these cells were capable of induc-
ing severe cartilage destruction like met-
alloproteinase (MMP)-induced damage 
and chondrocyte death. MMPs are crucial 
in degradation of aggrecan and collagen, 
leading to irreversible cartilage destruc-
tion. MMPs degrade aggrecan leaving the 
C-terminal  ending with the amino acid 
sequence VDIPEN which can be detected 
by speciﬁc antibodies around day 5 after 
induction of AIA [27]. For this reason, 
AIA day 7 was taken to detect VDIPEN 
expression in the cartilage matrix.
 The amount of VDIPEN was meas-
ured by determining the percentage of 
the area of cartilage expressing VDIPEN. 
In most investigated knee joints of WT 
mice injected with 60 µg of mBSA, 
VDIPEN staining was found particularly 
in the cartilage layers of tibia and femur 
(Figure 8, A, C, and E).  In arthritic knees 
of FcγRI/III-/-, VDIPEN expression was 
completely absent when compared to 
WT controls (Figure 8, A and D, versus 
WT control, Figure 8C). Interestingly, in 
FcγRI/II/III-/- arthritic joints, although 
much more joint inﬂammation was found 
which abundantly expressed the activation 
markers MRP8 and 14, VDIPEN was vir-
tually absent when compared to arthritic 
controls (Figure 8, B and F, versus WT 
control, Figure 8E). This conﬁrms again 
that only activating FcγR mediate severe 
cartilage destruction and that this prereq-
uisite also holds in condition of abundant 
inﬂammatory cell inﬂux showing an acti-
vated phenotype. 
 In addition, chondrocyte death was 
measured by determining the percentage 
of the area of cartilage with empty lacunae. 
Chondrocyte death varied between 5% to 
40% in various cartilage layers of the WT 
arthritic knee joints (Figure 9, A, C, and 
E). Chondrocyte death was  absent in ar-
thritic FcγRI/III-/- knee joints (Figure 9, 
A and D, versus WT control, Figure 9C). 
Again in arthritic FcγRI/II/III-/-, despite 
its high joint inﬂammation, chondrocyte 
death was completely absent (Figure 9, B 
and F,  versus WT control, Figure 9E).
Discussion
 The in vivo role of FcγRII has been 
extensively studied using FcγRII-deﬁ-
cient mice. Induction of IC-mediated 
inﬂammation within these mice caused a 
signiﬁcantly elevated inﬂammation when 
compared to controls. In general, the 
function of FcγRII as a  major inhibitor of 
the activatory FcγR is highlighted. In the 
present study, we demonstrate that in the 
absence of activating FcγR, the inhibit-
ing FcγRII still functions as an important 
Figure 7
Expression of activation markers MRP8 and 14 in synovial lining and joint 
cavity in FcγRI/II/III-/- and their WT controls at day 7 after AIA induction. Note 
the signiﬁcantly higher expression of both MRP8 (A and C versus WT control 
B) and MRP14 (A). Data are the mean of 7 mice. Signiﬁcance was tested using 
the Wilcoxon rank test (*, P<0.05). Original magniﬁcation, X 400.  
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down-regulator of synovial inﬂammation, 
which might be related to IC clearance 
and complement activation. 
 FcγRII, in the abscence of activating 
FcγR signiﬁcantly reduced joint inﬂam-
mation during T cell-mediated AIA. 
One of the explanations may be an al-
tered T cell response. FcγR are expressed 
on precursors of T cells [28] and the ab-
sence of these receptors may have had 
an impact on the development of T cell 
reactivity and may explain the markedly 
elevated anti-mBSA IgG2a antibody re-
sponses in both immunized FcγRI/III-/- 
as FcγRI/II/III-/-. However anti-mBSA 
T cell responses were found not to be sig-
niﬁcantly different and this may indicate 
that FcγRII present on resident synovial 
lining macrophages may be more impor-
tant in regulating joint inﬂammation.
 To further substantiate the involve-
ment of FcγRII on synovial macrophages, 
arthritis was induced by local deposition 
of IC within the joint. In that model, ar-
thritis is regulated by lining macrophages 
and not by T cells [23]. Comparable to 
Figure 8
Expression of  VDIPEN neoepitopes  in knee joints of FcγRI/III-/- (A), 
FcγRI/II/III-/- (B) and their WT controls 1 and 2, 7 days after AIA induction. 
VDIPEN staining was determined in various cartilage layers of the knee 
joint (P, patella; MF, medial femur; MT, medial tibia; LF, lateral femur; LT, 
lateral tibia). VDIPEN was expressed as percent positive staining of the 
total cartilage area. VDIPEN staining was almost absent in arthritic knee 
joints of both FcγRI/III-/- (A and D versus WT control C)  as in FcγRI/II/III-/- 
(B and F versus WT control E). Data represent the mean ± SD of 7 mice and 
were statistically evaluated using the Wilcoxon rank test. * P<0.05.
Figure 9
Measurement of chondrocyte death in cartilage layers of knee joints of 
FcγRI/III-/- (A), FcγRI/II/III-/- (B) and their WT controls 1 and 2, 7 days after 
AIA induction. Chondrocyte death was determined in various cartilage 
layers of the knee joint ( MF, medial femur; MT, medial tibia; LF, lateral 
femur; LT, lateral tibia). Chondrocyte was expressed as percent empty la-
cunae (arrows in C and E) of the total cartilage area. Note that chondrocyte 
death was signiﬁcantly lower in both FcγRI/III-/- (A and D versus WT control 
C)  as in FcγRI/II/III-/- (B and F versus WT control E). Data represent the mean 
± SD of 7 mice and were statistically evaluated using the Mann-Whitney 
U-test. * P<0.05.
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that seen in AIA, FcγRII, in the absence 
of activating FcγR, again strongly reduced 
joint inﬂammation. The FcγRII depend-
ency appeared to be IC-speciﬁc since in-
jection of zymosan directly into the knee 
joint of FcγRI/II/III-/- caused similar 
joint inﬂammation than when injected in 
WT and thus indicates that the joints of 
these mice develop a normal inﬂamma-
tory response on non-IC triggers.
 The most plausible function of FcγRII 
in joint inﬂammation in the abscence of 
activating FcγR is its role in clearance of 
IgG-ICs from the joint. Clearance of ICs 
is largely regulated by synovial lining cells 
and its efﬁciency is highly correlated to 
development of arthritis [29]. IgG-con-
taining ICs activate complement. In the 
mouse IgG2a and IgG3  mediate com-
plement via the classical pathway [30], 
whereas IgG1, when attached to cartilage 
layers uses the alternative pathway [31]. 
Co-dominance between complement 
and FcγR has previously been described 
[32].  Efﬁcient removal of these ICs from 
the joint may lower the amount and 
course of complement activation within 
the joint, thereby lowering onset and/or 
prolongation of arthritis. This is in line 
with studies that show that complement is 
especially important in the onset, whereas 
at later time-points inﬂammation is more 
FcγR-mediated [33]. 
 Within the joint, macrophages are cru-
cial in clearance and endocytosis of ICs. In 
earlier in vitro studies using cDNA trans-
fection, it was found that FcγRII mediates 
internalization and lysosomal degradation 
of IgG-antigen complexes [34,35]. In 
line with that, we now ﬁnd that perito-
neal macrophages from KO mice, which 
only express FcγRII and no activating 
FcγR, are still able to endocytose soluble 
ovalbumin-IgG complexes not different 
from controls, whereas in the absence of 
all FcγR, endocytosis is almost completely 
blocked. Moreover, when ICs were inject-
ed directly into the joint, clearance and 
endocytosis by lining cells were strongly 
retarded in the FcγRI/II/III-/-. This sug-
gests that in vivo FcγRII is a major recep-
tor for endocytosis. In vivo studies using 
FcγRII-deﬁcient mice have shown that 
FcγRII inhibited phagocytosis and clear-
ance, and this was explained by inhibit-
ing activating FcγR [36]. We now clearly 
demonstrate for the ﬁrst time that in vivo, 
FcγRII also reduces inﬂammation by ac-
celerating IC clearance and endocytosis. 
In contrast to our study, Mathis et al [31] 
found no involvement of FcγRII in the K/
BXN serum transfer arthritis model. One 
explanation may be that arthritis within 
this model is regulated by anti-GPI an-
tibodies of only the IgG1 isotype. These 
antibodies preferentially bind to FcγRIII 
which may largely be responsible for IC-
removal within this model.
 Removal of ICs from the joint is a 
combined action of leakage through the 
pores of the lining layer into the draining 
lymph vessels and lymph nodes, and bind-
ing and endocytosis by synovial lining 
cells. Synovial intima macrophages ﬁrst 
meet these ICs and have been shown to be 
crucial in both onset as well as propaga-
tion of synovial inﬂammation [8,37]. This 
in contrast to synovial intima ﬁbroblasts 
which fail to express FcγR. Activation of 
lining cells forms one of the crucial events 
in arthritis development. Transfer of early 
activated lining cells appeared to be suf-
ﬁcient to induce arthritis in normal rats 
[38].
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 It is generally accepted that FcγRII 
acts by coligating with activatory FcγRIII 
and probably also with FcγRI eventu-
ally leading to inactivation of synovial 
macrophages and reduced production of 
cytokines and chemokines [16]. In the 
present study we ﬁnd that in the absence 
of all FcγR, IgG-ICs when injected into 
the joint still bind to intimal synovial 
cells. Moreover these cells express abun-
dant MRP8/14 indicating that they still 
become activated and likely produce sufﬁ-
cient pro-inﬂammatory factors leading to 
pronounced joint inﬂammation. As FcγR 
are absent, ICs may bind to other recep-
tors. A good candidate may be the promis-
cuous complement receptor 3 (CR3) [39]. 
The complement splitting product C3bi 
tightly binds to various antibody isotypes 
involved in IC formation [40]. C3bi may 
form the link between ICs and binding 
to the CR3 receptor on macropages not 
expressing FcγR and may mediate intra-
cellular signaling leading to activation of 
the intimal macrophage. 
 The amount of inﬂammatory cell mass 
within an inﬂamed  joint is often related 
to severe cartilage destruction. In the 
present study, we found a remarkable un-
coupling between joint inﬂammation and 
severe cartilage destruction like MMP-
mediated damage and chondrocyte death. 
Severe cartilage destruction seen during 
IC-mediated arthritides is mediated by 
metalloproteinases, which are released by 
chondrocytes in a latent pro-form within 
the cartilage matrix. Interleukin-1 ap-
peared to be the master cytokine regulat-
ing MMP production by the chondrocyte 
[41]. Large amounts of inactive MMPs 
accumulate within the cartilage matrix 
and on activation lead to destruction of 
the collagen type II network and the pro-
teoglycans embedded within this matrix 
[42]. The factors needed for this activa-
tion step are still unknown. 
 As inﬂammatory cells are capable of 
mediating activation of latent MMPs 
inside the cartilage matrix [43], the way in 
which these cells become activated within 
the joint seems crucial and recent studies 
by our lab suggest that activating FcγR 
are of utmost importance [10,21,44].
 Binding of IC to activating FcγR (es-
pecially FcγRI) on macrophages may lead 
either to a higher production of MMP-
activating factors or promote generation 
of mediators which inhibit these factors. 
MMP-activating factors may be other 
MMP [45], enzymes like plasmin [46], 
EMPRINN [47], or oxygen radicals [48], 
which all have been shown to possess 
the capacity of activating latent MMPs. 
Oxygen radicals have been shown to be 
abundantly  released by macrophages after 
IC binding to FcγRI [49] and may explain 
the clear chondrocyte death seen during 
IC-mediated arthritis. In the absence of 
FcγRI, chondrocyte death was completely 
absent [10, 44] at day 7 after AIA induc-
tion. In contrast, FcγR binding may also 
lead to a rise in inhibitors like TIMPs, 
which may efﬁciently reduce MMP-me-
diated cartilage destruction.
 When inﬁltrating cells are activated by 
bacterial or yeast cell walls when injected 
into the knee joint of mice, although a 
pronounced inﬂammation developed, 
MMP-mediated cartilage destruction nor 
chondrocyte death was detected [27]. Al-
though these cells express an inﬂamma-
tory phenotype, the released factors were 
incapable of activating latent MMP which 
were found in large amounts within the 
 64 Chapter 3
cartilage layers of the joint [27]. In line 
with this we now ﬁnd that in knee joints of 
arthritic triple KO, despite abundant joint 
inﬂammation, no VDIPEN epitopes nor 
chondrocyte death was observed. Like in 
the non-IC arthritis, the inﬁltrated cells 
despite expressing an inﬂammatory phe-
notype were incapable to activate MMPs. 
This again conﬁrms that FcγR activation 
is a prerequisite for inducing irreversible 
cartilage destruction.
 The present study underlines that ac-
tivating FcγR are crucial in induction 
of severe cartilage destruction and that 
FcγRII is an important inhibiting recep-
tor which regulates both chronic joint 
inﬂammation as well as cartilage destruc-
tion  during arthritis. FcγRII may be a 
powerful inhibitor to prevent both syno-
vial inﬂammation and  cartilage destruc-
tion  and its overexpression may form a 
new therapeutic tool to combat the severe 
pathogenicity of ICs involved in RA.  
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Objective: To study the role of the activating Fcγ receptor types I and III (FcγRI 
and FcγRIII, respectively), and the inhibiting Fcγ receptor (FcγRII) in inﬂamma-
tion and in various aspects of cartilage destruction during arthritis that is solely 
induced by immune complexes.
Methods: Immune complex-mediated arthritis (ICA) was passively induced by lys-
ozyme-antilysozyme complexes in FcγRI-, FcγRIII-, and FcγRII-knockout mice 
and their wild-type controls. Total knee joint sections were isolated to study 
inﬂammation and cartilage destruction (loss of proteoglycans (PG), chondro-
cyte death, matrix metalloproteinase (MMP)-mediated neoepitope expression 
(VDIPEN), and erosion). The presence of an active phenotype of macrophag-
es was studied by detection of myeloid-related proteins 8 and 14 (MRP8 and 
MRP14, respectively).  
Results: Inﬂux and activation of inﬂammatory cells (MRP expression) during ICA 
was decreased in FcγRIII-deﬁcient mice and enhanced in mice lacking FcγRII. 
Mild cartilage destruction reﬂected by loss of proteoglycans was consistent with 
the degree of inﬂammation. Mice lacking FcγRIII showed almost no PG deple-
tion, whereas in FcγRII-/- mice, PG depletion was increased 3-7- fold in various 
cartilage areas. Initiation of erosive cartilage destruction, as reﬂected by MMP-
mediated VDIPEN expression was reduced in FcγRIII-/- and FcγRI-/- mice, di-
recting the two different critical steps of cellular inﬂux and subsequent activation. 
These aspects were enhanced in FcγRII-/- mice. In FcγRI-/- and FcγRIII-/- mice, 
VDIPEN expression was 90 – 99% lower, whereas in FcγRII-/- mice, VDIPEN ex-
pression was increased 4-fold. Chondrocyte death was reduced in FcγRIII-/- mice 
(68% lower) and enhanced in FcγRII-/- mice (6-12-fold higher). Progression of 
arthritis and erosion of the cartilage surface were markedly elevated in FcγRII-/- 
arthritic joints.  
Conclusion: During ICA, FcγRIII is the dominant activating receptor mediating 
joint inﬂammation, whereas both FcγRI and FcγRIII are involved in cartilage 
destruction. FcγRII inhibits both joint inﬂammation and severe cartilage destruc-
tion during IC-mediated arthritis.
 IgG-containing immune complexes 
(ICs) are found in the serum and joint 
tissue of most patients with rheuma-
toid arthritis (RA) [1,2] but the role of 
these complexes in the pathogenicity 
of this disease is still a matter of debate. 
ICs can communicate via Fcγ receptors 
(FcγRs). These receptors are expressed 
on macrophages residing within the 
intima layer, which covers the inside of 
normal diarthrodial joints. Furthermore, 
they are present on other hematopoietic 
cells, which inﬁltrate into the synovium 
during arthritis [3-5]. In mice, FcγRs are 
divided into three classes: the high-afﬁn-
ity activating FcγRI (CD64), the low-af-
ﬁnity inhibitory FcγRII (CD32) and the 
low-afﬁnity activating FcγRIII (CD16) 
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[6]. FcγRI and FcγRIII are multimeric 
receptors containing both a ligand-bind-
ing α-subunit and the associated signaling 
subunit, the immunoreceptor tyrosine-
based activation motif (ITAM)-contain-
ing γ-chain. FcγRII is a single subunit 
receptor containing the immunoreceptor 
tyrosine-based inhibitory motif (ITIM) 
[7]. The latter suppresses B cell, mast cell, 
neutrophil, and macrophage activation 
triggered by cross-linking B cell receptor 
(BCR) or activating FcγRs [8]. 
 During experimental arthritis passive-
ly induced by lysozyme-antil-ysozyme 
ICs (immune complex-mediated arthritis 
(ICA)), a prominent inﬂammatory cell 
mass in the synovial layer and joint cavity 
and severe cartilage destruction are found 
[9]. Cartilage destruction starts with pro-
teoglycan (PG) depletion, which is a re-
versible process, followed by irreversible 
collagen ﬁber degradation. The matrix 
metalloproteinases (MMPs) stromelysin 
and collagenase, which generate speciﬁc 
cleavage sites within the matrix molecules, 
are involved in this process [10-12], and 
blocking of interleukin-1 (IL-1) prevents 
erosive damage [13]. MMPs are secreted 
in an inactive form by IL-1-stimulated 
chondrocytes and stored within the car-
tilage matrix, and become active after 
further cleavage [14]. This process is still 
poorly understood, but MMP activation is 
primarily found in those arthritis models 
in which ICs are present and in which 
synovial lining macrophages are crucial 
in cartilage pathology [15-17]. The lining 
macrophages meet ICs formed in the joint 
cavity and their depletion prevents arthri-
tis. It suggests that the Fcγ receptor bal-
ance on the membrane of these cells may 
determine the severity of inﬂammation 
and destruction.  
 Recently, we found that activating 
FcγRs play an important role in ICA. After 
induction of arthritis in the knee joints of 
FcR γ-chain-deﬁcient mice (which fail to 
express functional activating FcγR), in-
ﬂammation and cartilage destruction were 
completely absent [18].  FcγR dependency 
in IC-mediated inﬂammation varies in 
different body compartments. FcγRIII is 
the dominant FcγR involved in inﬂam-
mation in the kidney [19] and in the skin 
[20], whereas FcγRI is dominant in peri-
tonitis [21]. Type II collagen-induced 
arthritis (CIA) was absent in FcR γ-chain-
deﬁcient mice [22]. Although the γ-chain 
is not only present in activatory FcγR but 
also in FcεR, this study strongly indicates 
that FcγRI and/or III are involved during 
CIA [22]. Intriguingly, we found in a T 
cell mediated antigen-induced arthritis 
model that FcγRI was involved in carti-
lage destruction but not in joint inﬂam-
mation [23,24]. 
 To evaluate a distinct role of FcγRI 
and FcγRIII in joint inﬂammation and 
cartilage destruction during arthritis 
solely induced by ICs, we elicited ICA in 
the recently generated, selective FcγRI-, 
FcγRIII-, and FcγRII-deﬁcient mice and 
their wild-type controls. Joint inﬂamma-
tion and cartilage destruction were inves-
tigated by histologic analysis of total knee 
joints. Macrophages were studied by the 
expression of myeloid-related proteins 8 
and 14 (MRP8 and MRP14, respectively), 
which are two calcium-binding proteins 
that characterize a proinﬂammatory cell 
population [25,26]. Cartilage destruction 
was measured by expression of MMP-in-
duced aggrecan neoepitopes (VDIPEN), 
chondrocyte death, and erosion of the car-
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tilage matrix. It was found that  FcγRIII 
determines the inﬂammation in ICA, 
whereas both FcγRI and FcγRIII are in-
volved in irreversible cartilage destruction. 
Moreover, FcγRII inhibits both the sever-
ity of inﬂammation and the destruction 
of cartilage, suggesting that therapeutic 
overexpression of FcγRII during arthritis 
can be protective against development of 
inﬂammation and cartilage damage.
Material and Methods
Animals
 FcγRI-/- mice, which were lacking the 
α-chain of FcγRI, were generated (by SV) 
and were backcrossed to the BALB/c back-
ground for 6 generations [27]. FcγRIII-/- 
mice, which lack the α-chain of FcγRIII 
(generated by SV), were backcrossed to 
the C57Bl/6 background for 12 genera-
tions [28]. FcγRII-/- mice were developed 
by Dr. Toshiyuki Takai [29] in the 129 SV 
(H-2b) and C57Bl/6 (H-2b) background. 
Control C57Bl/6 and 129SV / C57Bl/6 
hybrids were derived from Jackson labo-
ratories (Bar Harbor, ME, USA) and bred 
in our own facilities. BALB/c mice were 
obtained from Charles River Institute 
(Sulzfeld, Germany). Homozygous mu-
tants and their wild-type controls (10-12 
weeks old) were used in the experiments. 
Mice were fed a standard laboratory diet 
and tapwater ad libitum. Ethical approval 
was obtained from the local research ethics 
committee.
Induction of ICA
 ICA was passively induced by inject-
ing 3 µg of a cationic antigen (lysozyme 
coupled to poly-L-lysine) in 6 µl pyrogen-
free saline in the knee joints of mice 
that had previously (16 hours earlier) 
received, intravenously, polyclonal anti-
bodies directed against lysozyme. The 
latter antibodies had been raised in rab-
bits. A moderate arthritis developed 
in the mice, which was characterized 
by inﬂux of polymorphonuclear cells, 
apparent joint swelling, and cartilage 
destruction as demonstrated by PG de-
pletion and MMP-mediated cartilage 
damage [9].
Histology of arthritic knee joints
 Total knee joints of mice were iso-
lated at days 1, 3, and/or 7 after induc-
tion of arthritis. For standard histology, 
tissue was ﬁxed in 4% formaldehyde, de-
calciﬁed in formic acid and subsequently 
dehydrated and embedded in parafﬁn. 
Parafﬁn sections (7 µm thick) were 
mounted on SuperFrost slides (Menzel-
Gläser, Braunschweig, Germany). 
 Hematoxylin and eosin staining was 
performed to study joint inﬂammation. 
Inﬁltrate and exudate were scored sepa-
rately. The severity of inﬂammation in 
the knee joints was determined using an 
arbitrary score (0-3). Scoring was per-
formed in a blinded manner by two in-
dependent observers (0: no cells, 1: mild 
cellularity, 2: moderate cellularity, and 
3: maximal cellularity). 
 To study PG depletion from the car-
tilage matrix, sections were stained with 
safranin O followed by counterstaining 
with fast green. Depletion of PG (loss 
of red staining) from various cartilage 
layers (patella and femur) was deter-
mined using an arbitrary scale from 0-3. 
Normal cartilage was scored 0, whereas 
cartilage fully depleted of proteoglycans 
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was scored the maximum value of 3.
 Chondrocyte death was examined by 
determining the amount of empty lacunae 
in the cartilage, and results were expressed 
as a percentage of the total amount of cells 
(empty lacunae and viable chondrocytes). 
 Erosion was deﬁned as rufﬂing of the 
cartilage surface and expressed as the 
percentage of impaired cartilage surface 
of the total cartilage. In all experiments, 
these variables were scored separately 
and independently.
Immunohistochemical staining for 
MRP8 and MRP14
 Formalin-ﬁxed sections of knee joints 
were prepared as described above. Rabbit 
antisera against recombinant murine 
MRP8 (anti-MRP8) and MRP14 (anti-
MRP14) were produced as described 
previously [30]. The monospeciﬁcity of 
the antibodies was analyzed by immu-
noreactivity against recombinant MRP8 
and recombinant MRP14 and Western 
blot analysis of lysates of granulocytes 
[30]. Sections were stained as described 
previously [30], using a ﬁnal antibody 
concentration of 1 µg/ml. Primary an-
tibodies were detected using peroxidase-
conjugated second-stage antibodies 
against rabbit IgG (Dianova, Hamburg, 
Germany). Isotype-matched antibodies 
without relevant speciﬁcity were used 
as negative controls (Dianova, Ham-
burg, Germany). Finally, sections were 
counterstained with Mayer’s hematoxy-
lin (Merck, Darmstadt, Germany). The 
presence of MRP8- and MRP14-posi-
tive cells present in the joint cavity and 
synovial lining was determined and ex-
pressed as a percentage of the total cell 
population, using an arbitrary score (1: 
1 – 30%, 2: 31 – 70%, 3: 71 – 100%).
Immunohistochemical VDIPEN 
staining
 Sections were digested with protei-
nase-free chondroitinase ABC (0.25 
units/ml in 0.1 M Tris HCl, pH 8.0; 
Sigma, Zwijndrecht, The Netherlands) 
for 2 hours at 37ºC to degrade hyaluro-
nan and remove chondroitin sulfate 
from the PGs. Subsequently, sections 
were treated with 1% H
2
O
2
 in methanol 
for 20 minutes and with 0.1 % Triton 
X-100 in phosphate buffered saline for 
5 minutes. After being incubated with 
1.5 % normal goat serum for 20 minutes, 
the sections were incubated overnight 
at room temperature with afﬁnity-pu-
riﬁed rabbit anti-VDIPEN IgG. This 
antibody has been extensively charac-
terised [31-33]. The anti-VDIPEN an-
tiserum detects the VDIPEN C-termi-
nal neoepitope of aggrecan generated by 
MMPs. As a control, afﬁnity-puriﬁed 
rabbit IgG was used. In addition, sec-
tions were incubated with biotinylated 
goat anti-rabbit IgG, the binding of 
which was detected with biotin-strepta-
vidin-peroxidase staining (Elite kit; 
Vector, Burlingame, CA). Induction of 
the peroxidase staining was detected 
using nickel enhancement. Counter-
staining was performed with orange G 
(2%). Areas of immunostaining were 
expressed as a percentage of the total 
cartilage surface.
Statistical analysis
 Signiﬁcance was tested using the 
Wilcoxon rank test. P values less than 
0.05 were considered signiﬁcant. Re-
sults are expressed as the mean ± SD.
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Figure 1 
Cellular inﬁltration (arbitrarily scored 0 – 3, with 3 being maximal cellularity) in frontal sections of whole knee joints in Fcγ receptor I-, II-, and III-deﬁcient 
(FcγRI-/-, FcγRII-/-, and FcγRIII-/-, respectively) mice and their wild-type (WT) controls at various days after immune complex-mediated arthritis (ICA) induction. 
Bars show the mean and SD of 10 animals for FcγRI-/- at day 3 (A), FcγRIII-/- at day 1 (B) and at day 3 (C), and FcγRII-/- at day 3 (D) and day 7 (E). Note the signiﬁcantly 
lower inﬁltrate and exudate in FcγRIII-/- both at day 1 (B) and at day 3 (C) versus WT controls (also in I versus H), whereas comparable cell mass was found in 
FcγRI-/- and WT controls at day 3 after ICA induction (A and in G  versus F). Signiﬁcantly higher inﬁltrate and exudate were found in FcγRII-/- versus WT controls at 
day 3 (D and in K versus J) and at day 7 (E) after ICA induction. * = P < 0.05 versus WT controls, using the Wilcoxon rank test. P = patella; F = femur, S = synovial 
lining, JS = joint space. (Original magniﬁcation x 100 in F-K).
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Results
Determination of joint inﬂammation 
of ICA by FcγRIII
 Recently, we found that mice lack-
ing both of the functional activating 
receptors FcγRI and FcγRIII failed to 
develop synovial inﬂammation after 
induction of the passively induced ICA 
[18]. To investigate the relative role of 
the two activating receptors, ICA was 
induced in knee joints of recently gen-
erated, selective FcγRI-/- or FcγRIII-/- 
mice, and their wild-type controls. 
 Total knee joint sections obtained 3 
days after ICA induction showed mild 
inﬂammation (both inﬁltrate in the syn-
ovium and exudate in the joint cavity) 
in FcγRI-/- mice, which did not differ 
from that in their wild-type controls 
(Figure 1A, 1F, and 1G). 
 Interestingly, when ICA was induced 
in knee joints of FcγRIII-/- mice, mark-
edly less cell inﬂux was evident at day 
3 in the synovial layer and joint cavity 
compared with that in their wild-type 
controls (Figure 1C, 1H, and 1I). This 
difference was already apparent at day 
1 (Figure 1B), suggesting that, in addi-
tion to the role of complement, FcγRIII 
plays a crucial role not only in the sus-
tained inﬂammatory response, but also 
in the early onset of ICA. 
 In addition to cellular inﬁltration, 
joint swelling was measured as the 
extent of cellular activation, using 99mTc 
uptake. A signiﬁcant reduction in joint 
swelling was evident in FcγRIII-/- ar-
thritic joints, both at day 1 (mean ± SD 
ratio of right paw to left paw measure-
ments (R/L), wild-type controls 1.27 ± 
0.01 versus FcγRIII-/- mice 1.17 ± 0.03) and 
at day 3 (R/L ratio wild-type controls 
1.20 ± 0.04 versus FcγRIII-/- mice 1.05 
± 0.01).  
Enhancement of ICA by FcγRII 
deﬁciency
 Earlier studies revealed that cross-
linking of the inhibiting FcγRII to the 
activating FcγRs inhibits the intracel-
lular signaling, thereby inhibiting cell 
activation [7].  Our results show, for the 
ﬁrst time, that this inhibition also occurs 
in vivo in passive ICA. In wild-type 
controls, a moderate joint inﬂammation 
was observed at day 3 (Figure 1D and 1J), 
which waned rapidly, and at day 7, hardly 
any inﬂammatory cells were found 
(Figure 1E). In contrast, FcγRII-/- mice 
showed a signiﬁcantly enhanced joint 
inﬂammation at day 3, with 300% more 
inﬁltrated cells than their wild-type con-
trols (Figure 1D and 1K). Moreover, in-
ﬂammation did not wane and remained 
as severe until day 7 (Figure 1E). 
Control studies
 A complicating observation was the 
large variability in severity of ICA in the 
various wild-type controls, which un-
fortunately were not in a fully identical 
genetic background. Earlier work iden-
tiﬁed major differences in the levels of 
FcγR expression in closely related mouse 
strains, which probably underlie these 
variations. Although the ﬁndings in the 
various knockout were all relative to their 
genetically identical wild-type controls, 
it was reassuring to note that we did not 
ﬁnd any differences in arthritis between 
the knockout mice and controls when 
zymosan was injected in the joint as a 
general inﬂammatory trigger (data not 
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shown).  This underlines the speciﬁcity 
of the differences noted for ICA. 
Differentiation of macrophages to 
an active inﬂammatory phenotype 
antagonistically modulated by    
FcγRIII and FcγRII
 Apart from the amount of inﬁltrating 
cells in the synovial tissue, the activation 
of inﬁltrating and resident cells and release 
of mediators will determine the net effect 
on joint tissues. To investigate the activa-
tion state of the resident intima macro-
phages and the inﬁltrated cells, we used 
MRP8 and MRP14 as markers [25,26,30]. 
MRP8- and MRP14-expressing macro-
phages are generally found at inﬂamed 
sites, and the markers are associated with 
production of IL-1 and oxidative radicals 
[34,35].  
 First, we focused on the synovial lining. 
Intima cells of FcγRI-/- mice showed ex-
pression of MRP8 comparable with that in 
their controls (Figure 2A and 2B). How-
Figure 2 
Localization of myeloid-related protein 8 (MRP8) in the synovial lining and joint cavity at day 3 after ICA induction in FcγRI-/- (B), FcγRIII-/- (D), and FcγRII-/- (F) 
mice versus their wildtype controls (A, C, and E, respectively). Note the signiﬁcantly lower MRP8 expression in FcγRIII-/- in the synovial lining (D versus C) and in 
the joint cavity (H) compared with WT controls, whereas similar expression was found in FcγRI-/- and controls (B versus A, and in G). Signiﬁcantly higher MRP8 
expression was found in FcγRII-/- versus controls both in the synovial lining (F versus E) and joint cavity (I). Bars show the mean and SD of 10 mice. * = P < 0.05, 
using the Wilcoxon rank test. I = intima lining (see Figure 1 for other deﬁnitions). (Original magniﬁcation x 400 in A-F). 
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ever, the intima layer of FcγRIII-/- and 
FcγRII-/- mice showed a much lower 
(Figure 2C and 2D, respectively, for Fc-
γRIII-/-) and higher (Figure 2E and 2F, 
respectively, for FcγRII-/-) number of 
MRP8-positive intima lining cells com-
pared with their wild-type controls.   
 In addition, we investigated whether 
the inﬁltrated cells exhibited a proin-
ﬂammatory phenotype. FcγRI-/- mice 
and wild-type controls showed a compa-
rable expression of MRP8 (Figure 2G), 
whereas the percentage of inﬁltrated cells 
found in FcγRIII-/- knee joints express-
ing MRP8 was 2 times lower compared 
with that in their wild-type controls 
(Figure 2H). In mice that lacked FcγRII, 
inﬁltrated cells showed a 5 times higher 
expression of MRP8 compared with that 
in their wild-type controls (Figure 2I). 
MRP14 expression on cells in the syno-
vial lining and joint tissue was identical 
with MRP8 expression and followed the 
same pattern as described above in the 
various knockout mice (data not shown).
Involvement of FcγRII and FcγRIII 
in early PG breakdown during ICA
 Breakdown of PGs from the carti-
lage layer characterizes the early phase 
of cartilage destruction in ICA. Loss of 
red staining, reﬂecting PG depletion, was 
found to be similar in arthritic knee joints 
of FcγRI-/- mice and their wild-type con-
Table 1 Fcγ receptors (FcγRs) and loss of proteoglycans (PG) during ICA        
    ICA day 1     ICA day 3            ICA day 7
         Patella      Femur       Patella      Femur          Patella        Femur
FcγRI-/-            ND             ND          1.3 ± 0.3     2.1 ± 0.3         ND               ND
WT control           ND             ND          0.9 ± 0.2     1.8 ± 0.3         ND               ND
FcγRIII-/-              0.3 ± 0.1*   0.5 ± 0.1*     0.3 ± 0.1*   0.4 ± 0.2*           ND              ND     
WT control       0.9 ± 0.1     1.6 ± 0.4       1.8 ± 0.2    2.5 ± 0.2             ND              ND
FcγRII-/-            ND            ND          2.0 ± 0.4*   2.4 ± 0.4*     1.7 ± 0.3*      2.6 ± 0.4*
WT control           ND            ND                0    0     0.3 ± 0.2        0.7 ± 0.3
Values are the mean ± SD of 10 mice. Loss of red staining, which is a measure of PG depletion, was determined in knee joints at day 1, day 3, and day 7 after induc-
tion of immune complex-mediated arthritis (ICA) in FcγRI-/-, FcγRIII-/-, and FcγRII-/- mice, and in wild-type (WT) control mice. Loss of red staining was scored by 
two blinded and independent observers, using an arbitrary scale of 0-3. (0 = no staining, 1 = minor, 2 = moderate, 3 = maximal). ND = not determined. 
* P < 0.05 versus controls, by Wilcoxon rank test. 
Table 2 Fc γ receptors and matrix metalloproteinase  
   activity in the lateral femur during ICA
  VDIPEN expression 
            (% of cartilage surface)
FcγRI-/-     0.6 ± 0.4*
WT control    6.1 ± 2.7
FcγRIII-/-   0.2 ± 0.2*
WT control  20.0 ± 8.1
FcγRII-/-   51.3 ± 4.9*
WT control  12.6 ± 6.3
Values are the mean ± SD percentage of the total cartilage surface of 10 mice, 
determined as VDIPEN expression in the femoral cartilage surface 3 days after 
ICA induction in FcγRI-/-, FcγRIII-/-, and FcγRII-/- mice, and in WT control mice. 
The percentage of immunostained cartilage surface was determined by two 
blinded and independent observers.  * P < 0.05, by Wilcoxon rank test.
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trols (Table 1). In contrast, PG loss was 
signiﬁcantly lower both at day 1 and day 
3 after ICA induction in FcγRIII-/- mice 
compared with their wild-type controls 
(Table 1). Nearly maximal loss of red 
staining was found in FcγRII-/- mice 
at day 3, whereas their wild-type con-
trols showed only limited PG depletion 
(Table 1). Almost maximal PG depletion 
was still present at day 7 after ICA induc-
tion in these mice (Table 1), consistent 
with the prolonged presence of active 
inﬂammation. 
Effect of FcγRI, -II, and -III on 
MMP-mediated cartilage damage, 
chondrocyte death, and cartilage 
erosion
 Shortly after the initial PG loss, MMPs 
become involved in further degradation of 
aggrecan and type II collagen, eventually 
leading to irreversible cartilage destruction 
[11]. Degradation of aggrecan by MMPs 
leaves a speciﬁc neoepitope in the carti-
lage that ends on the amino acid sequence 
VDIPEN, which can be detected by spe-
ciﬁc antibodies. 
 In arthritic knee joints of wild-type 
control mice, VDIPEN neoepitopes were 
induced mainly at the margins of the 
femoral-tibial region. VDIPEN was most 
prominently present in the lateral femur, 
which is the cartilage surface we focused on. 
Of extreme interest, although PG loss did 
not differ between FcγRI-/- mice and their 
controls, these mice showed a 90% decrease 
in VDIPEN expression (Table 2, Figure 3A 
and 3B). VDIPEN expression was also re-
duced by 99% in FcγRIII-/- mice (Table 2, 
Figure 3C and 3D), whereas FcγRII-/- mice 
showed a 4-fold increase in MMP mediated 
breakdown compared with their wild-type 
controls (Table 2, Figure 3E and 3F). 
 As a result of MMP activation, irrevers-
Figure 3 
VDIPEN expression in the femoral region of 
FcγRI-/- (B), FcγRIII-/-(D), and FcγRII-/-(F) mice 
versus their WT controls (A, C, and E, respec-
tively). VDIPEN expression was signiﬁcantly 
lower in FcγRI-/- and FcγRIII-/-, and much higher 
in FcγRII-/- mice, compared to their wildtype 
controls. See Figure 1 for deﬁnitions. (Original 
magniﬁcation x 250).
Figure 4 
Erosion and chondrocyte death in the femoral region of FcγRII-/- mice (B) and 
their WT controls (A). Note the ruﬄed surface of the cartilage (arrows) and 
large amounts of empty lacunae representing chondrocyte death. See Figure 
1 for deﬁnitions. (Original magniﬁcation x 250).
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ible cartilage destruction (chondrocyte 
death and matrix erosion) may develop. 
The percentage of chondrocyte death was 
evaluated in patellar and femural cartilage 
surface of arthritic knee joints. Chondro-
cyte death was almost absent both in the 
FcγRI-/- mice and in their wild-type 
controls, thus not providing a sufﬁcient 
window for evaluation. Chondrocyte death 
in FcγRIII-/- mice was low and comparable 
with that in their controls 1 day after ICA 
induction. Three days after ICA induction, 
the percentage chondrocyte death was 3 
times lower in the cartilage surface of the 
femur of FcγRIII-/- mice compared with 
their controls (FcγRIII-/- 7 ± 1.6 versus 
wild-type controls 22 ± 4.5), whereas no 
signiﬁcant difference was found in the 
patellar cartilage surface (FcγRIII-/- 5 ± 
1.8 versus wild-type controls 8 ± 1.1). In 
contrast, in the patella and femur carti-
lage layers of FcγRII-/- mice, chondrocyte 
death was 6 times higher in the femoral 
region at day 3 (33 ± 7.5 versus 5 ± 2.8 in 
controls) and even 12 times higher at day 
7 after ICA induction (50 ± 9.3 versus 4 ± 
1.6 in controls) (Figure 4A and 4B). 
 In addition, cartilage erosion, which 
reﬂects the ultimate step to irreversible 
cartilage destruction, was evaluated. As 
expected at this early time point, no signif-
icant erosion could be detected in the car-
tilage layers of FcγRI-/- or FcγRIII-/- mice 
and their wild-type controls. However, in 
arthritic FcγRII-/- knee joints, signiﬁcant 
erosion was observed at day 3 (patella 3 ± 
1.2 and femur 5 ± 1.6) and day 7 (patella 4 
± 1.5 and femur 9 ± 2.8) of ICA, whereas 
erosion was absent in cartilage surfaces of 
wild-type control mice (Figure 4A and 
4B). This identiﬁes FcγRII as a suppressive 
regulator of severe cartilage destruction.
Discussion
 In the present study, we ﬁnd that ICA 
induced within the murine knee joint 
is predominantly mediated by FcγRIII, 
whereas erosive cartilage damage is medi-
ated by both FcγRI and FcγRIII. We also 
ﬁnd that FcγRII is an efﬁcient inhibitor 
of both acute inﬂammation and cartilage 
destruction. 
 In this study, we used an arthritis 
model mediated solely by ICs. The onset 
of inﬂammation is determined by intima 
macrophages residing in the synovial 
lining of the joint. Removal of these mac-
rophages prior to induction of ICA largely 
prevents the onset of inﬂammation [17]. 
The severity of this model is inﬂuenced by 
the genetic background of the mice [18], 
which explains the observed differences 
in arthritis found among the various wild-
type controls of the knockout mice.
 We demonstrated that inﬂammation 
after induction of ICA is determined by 
the activating FcγRIII. This important 
role for FcγRIII in IC-mediated inﬂam-
mation was also found in the kidney [19], 
the lung [36] and the skin [20]. Because 
macrophages are involved in the onset of 
inﬂammation, activation of macrophages 
was studied using MRP8 and MRP14, 
which are markers for a proinﬂammatory 
phenotype of macrophages. These two 
calcium-binding proteins of the S100-
family are generally expressed by macro-
phages in various inﬂammatory reactions 
but not by resting-tissue macrophages 
[26,30,37]. Our results show that FcγRIII 
regulates induction of these molecules in 
macrophages. 
 Published data indicate a potential 
role for these molecules in inﬂammation. 
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MRP8- and MRP14-expressing macro-
phages have been shown to be the major 
source of TNF-α, IL-1, and respiratory 
burst under inﬂammatory conditions in 
vivo [34,35]. Recent data indicate that 
MRP8 and MRP14 are expressed in high 
amounts in synovia of human rheumatoid 
arthritis and are released at the site of in-
ﬂammation [38]. They propagate adher-
ence of leukocytes to endothelial cells and 
exhibit chemotactic activity in vitro. Ab-
sence of MRP8 and MRP14 both in the 
lining cells and in the inﬂammatory cells 
in FcγRIII-/- joints suggests that activa-
tion of macrophages is clearly mediated by 
FcγRIII. Increased expression of MRP8 
and MRP14 in FcγRII-/- joints indicates 
that FcγRII inhibits this activation.
 An explanation for the FcγRIII de-
pendency found during ICA could be that 
FcγRIII is highly expressed on macro-
phages in normal joints, whereas FcγRI 
expression remains low. FcγR expression 
within the joint may be altered by local 
production of cytokines. In human mono-
cytes, FcγRI is up-regulated by interferon-
γ (IFN-γ) [39], granulocyte colony-stim-
ulating factor (G-CSF) [40], and IL-10 
[41], whereas transforming growth factor 
β (TGFβ) is potent in up-regulation of 
FcγRIII [42]. Moreover, other cytokines, 
such as IL-4 and IL-13, down-regulate 
activating FcγR [39]. Alteration of the 
FcγRIII dependency occurs during T cell-
mediated antigen-induced arthritis, which 
is not blocked in FcγRIII-/- mice[23,24]. 
This might be explained by the fact that 
T cell-derived cytokines, such as IFN-γ 
produced by activated T cells, induce up-
regulation of FcγRI, resulting in a shift of 
the involvement of FcγRIII toward FcγRI 
[43,44].               
 Apart from FcγRs, complement also 
plays a major role in IC-mediated in-
ﬂammation, and a codominance between 
these two factors has been suggested [45]. 
In our model, complement activation is 
regulated by the classical complement 
pathway, and in earlier studies we found 
that eliminating C5a, using cobra venom 
factor, completely abrogated ICA [9], 
indicating an important role for comple-
ment. The FcγRIII and complement C5a 
dependency was also found in the novel 
glucose-6-phosphate isomerase (GPI) 
ICA model [46,47]. In this model, arthri-
tis is induced by transfer of K/BxN anti-
bodies directed against the enzyme GPI. 
However, in contrast to our model, the 
K/BxN model is mediated by IgG1 iso-
type antibodies, which do not bind C1q, 
resulting in activation of complement by 
the alternative pathway [47]. Both models 
show that FcγRIII and C5a, elicited by 
either the classical or the alternative path-
way, need to cooperate to elicit optimal 
joint inﬂammation. 
 Absence of FcγRII aggravates joint 
inﬂammation after induction of ICA. 
Stimulation of FcγRII and co-crosslink-
ing with an ITAM-bearing receptor lead 
to phosphorylation of the tyrosine resi-
due in the ITIM motif. Phosphorylation 
of this residue leads to the recruitment 
of SH2-containing phosphatases, which 
are responsible for dephosphorylation 
of speciﬁc protein tyrosine kinases [48], 
resulting in deactivation of the cell. In-
terestingly, in the K/BxN model FcγRII 
was not involved in inﬂammation [49]. 
A clear explanation for this difference in 
FcγR dependency is not available yet, but 
subtle differences in mouse strains housed 
at various sites are often noted. Of interest, 
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mouse strains sensitive to CIA develop a 
severe and chronic arthritis after induc-
tion of ICA, whereas the same amounts 
of IC injected into nonsusceptible strains 
induce only mild arthritis, which wanes 
after 4 days. This susceptibility is due to 
differences in the FcγR balance in these 
mice [50]. Another explanation for the 
difference in FcγR dependency may be 
that IgG1 ICs, which are dominant in the 
GPI model, are less able to cross-link be-
tween FcγRIII and II, which is needed for 
inhibition of FcγRIII by FcγRII. Moreo-
ver, our IC model is macrophage medi-
ated, whereas the K/BxN model seems to 
be dependent on polymorph nuclear cells 
[46]. 
  During ICA, activated inﬂammatory 
cells that migrate into the knee joint are 
crucial in the destruction of cartilage 
[51,52]. This destruction can be divided 
into two phases. The early phase, char-
acterized by breakdown of PGs, is me-
diated by aggrecanase, a member of the 
ADAMS (a desintegrin and metalloprotei-
nase) family [11,53]. The second phase is 
characterized by MMP-mediated matrix 
destruction, which results in irreversible 
cartilage erosion [11,12]. PG depletion 
was lower in FcγRIII-/- mice and higher 
in FcγRII-/- mice, compared with their 
wild-type controls, which implies a role 
for these receptors in reversible cartilage 
damage and release of aggrecanase. More-
over, FcγRIII and FcγRII modulate the 
expression of MRP8 and MRP14. MRP8- 
and MRP14-expressing macrophages are 
found to be the major producers of IL-1 
and oxygen radicals [34;35]. These results 
suggest that the balance between FcγRIII 
and FcγRII on inﬂammatory cells deter-
mines their activation state and thereby 
the release of cytokines and enzymes in-
volved in PG depletion.
 Irreversible cartilage destruction is 
mediated by MMPs, which are released 
in the cartilage matrix in an inactive 
form, and major involvement of MMP-3 
(stromelysin) and MMP-13 (collagenase) 
was demonstrated [10-13]. Regulation 
of these MMPs is complex and is most 
likely mediated by activated macrophages. 
Three levels of regulation can be deﬁned: 
production and secretion of latent MMPs, 
activation of latent MMPs, and inhibition 
of activated MMPs. IL-1 has been shown 
to be the dominant cytokine regulat-
ing production of latent MMPs by the 
chondrocyte [54]. VDIPEN expression 
was completely prevented after blockage 
of IL-1 with either anti-IL-1 antibodies 
[55] or with IL-1 receptor antagonist [13]. 
Because macrophages are the dominant 
IL-1-producing cells, FcγR expression 
on these cells may determine the amount 
of cytokine released during ICA. Mac-
rophages deﬁcient in either FcγRIII and 
FcγRII, produced lower and higher levels 
of IL-1, respectively, after IC stimulation 
[8].
 Formation of active MMP in the carti-
lage matrix by splitting the signal peptide 
of latent MMPs is probably regulated by 
enzymes released from activated phago-
cytes. The present data and recent work in 
antigen-induced arthritis [23,24] suggest 
that activation of macrophages through 
FcγRI, and not FcγRIII, is crucial in 
this process. In FcγRI-/- mice, VDIPEN 
staining was signiﬁcantly decreased, 
whereas no differences were found in 
inﬂammation and PG loss. Investiga-
tions that should identify the distinct 
enzymes released after FcγRI triggering 
81 Fcγ receptors in immune complex arthritis
are in progress. 
 The third regulation level is inhibition 
of MMPs by tissue inhibitors of MMPs 
(TIMPs). Oxygen radicals are able to 
dysregulate TIMPs [56]. Activation of 
FcγR on macrophages induces oxidative 
burst [57], which results in inhibition of 
TIMPs [11]. Overkill of the oxydative 
burst is mediated by FcγRI, which can 
result in either inhibition of TIMPs or 
oxygen radicals-mediated chondrocyte 
death [58]. Activation of FcγRI, there-
fore, eventually results in irreversible 
cartilage destruction.
 The present study clearly demon-
strates that the balance between activato-
ry and inhibitory FcγR determines both 
the inﬂux and the activation of inﬂam-
matory cells and the destruction within 
a joint, stimulated solely by ICs. During 
ICA, FcγRIII is dominant in the devel-
opment of inﬂammation. Both FcγRI 
and FcγRIII are important in irrevers-
ible cartilage destruction, and the latter 
receptor acts indirectly by enhancing 
cell inﬂux and ampliﬁcation of activated 
cell mass. The inhibitory FcγRII is the 
regulating receptor of both inﬂamma-
tion and cartilage destruction and there-
fore may be an important therapeutic 
target for ameliorating both processes in 
the arthritic joint. 
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Using various FcγR-deﬁcient mice, we have obtained suggestive evidence that 
FcγRI on macrophages is responsible for severe cartilage destruction during arthri-
tis mediated by immune complexes (ICs). This role of FcγRI is pronounced in the 
presence of activated Th1 cells and a likely Th1 cell-derived cytokine mediating 
up-regulation of FcγRI expression is interferon (IFN)-γ.  
We now investigated whether local overexpression of IFN-γ using an adenoviral 
vector is able to elevate cartilage destruction during experimental immune com-
plex-mediated arthritis (ICA) and to what extent this process is FcγRI-mediated. 
IFN-γ overexpression during ICA had no signiﬁcant effect on the total cell mass 
inﬁltrating the knee joint. However, a higher percentage macrophages express-
ing markers for a proinﬂammatory phenotype was found and these macrophages 
were situated in close proximity of the cartilage surface. Interestingly, cartilage 
destruction as studied by matrix metalloproteinase (MMP)-mediated proteoglycan 
damage (VDIPEN expression), chondrocyte death, and erosion was signiﬁcantly 
increased. This effect of IFN-γ was only found in presence of ICs, as IFN-γ over-
expression during zymosan-induced arthritis, which is not IC-dependent, did not 
lead to severe cartilage destruction. These results imply a crucial role for ICs and 
the IgG-binding receptors in the aggravation of cartilage damage by IFN-γ. 
Local overexpression of IFN-γ induced increased FcγRI mRNA levels in syn-
ovium. To study whether this up-regulation of FcγRI mediates aggravation of car-
tilage destruction, ICA was raised in FcγRI-/- and their wild-type controls. IFN-γ 
resulted in elevated VDIPEN expression, which was still present in FcγRI-/-. Of 
great interest, chondrocyte death remained low in FcγRI-/-.  
These results indicate that IFN-γ overexpression deteriorates cartilage destruction 
in the presence of ICs and that FcγRI is crucial in the development of chondrocyte 
death.
 Rheumatoid arthritis is charactarized 
by chronic inﬂammation and cartilage 
destruction. Macrophages play a key role 
in the onset and progression of rheuma-
toid arthritis. Elegant studies performed 
by Breshnihan and colleagues [1,2] have 
shown that the abundance and activation 
of macrophages in the inﬂamed synovial 
membrane and pannus correlates closely 
with the severity of cartilage destruction 
in rheumatoid arthritis.    
 Macrophages are present in the syno-
vial intimal layer, which covers the inside 
of diarthrodial joints. Experimental stud-
ies in our laboratory have shown that 
synovial lining macrophages are involved 
in onset, propagation, and exacerbation 
of experimental arthritis mediated by 
immune complexes (ICs) [3-5].
 IgG-containing ICs are abundantly 
found in rheumatoid arthritis synovium 
[6] and are thought to be involved in 
activation of inﬁltrated and resident he-
matopoietic cells. ICs can activate macro-
phages by binding to Fc receptors for IgG 
(FcγRs) [7,8]. Three classes have been 
described in the mouse: the high-afﬁn-
ity receptor FcγRI, and the two low-af-
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ﬁnity receptors FcγRII and FcγRIII [9]. 
FcγRI and FcγRIII trigger cell activation 
through a common γ-chain that contains 
an immunoreceptor tyrosine-based acti-
vation motif [10-12]. In contrast, FcγRII 
contains an immunoreceptor tyrosine-
based inhibitory motif that inhibits via co-
cross-linking activation signals through 
immunoreceptor tyrosine-based activa-
tion motif-containing receptors [13,14]. 
Murine macrophages express all three 
classes of FcγRs.  
 Recently, we have found that FcγRI is 
involved in cartilage destruction during 
experimental arthritis mediated by ICs 
[15] and this role seemed to be even more 
pronounced when T cells are also in-
volved, as in the chronic antigen-induced 
arthritis [16]. The T cell subsets mediating 
antigen-induced arthritis are not exactly 
deﬁned yet. However, this model shows 
similarities with the collagen type II-in-
duced arthritis [17-19], in which Th1 cells 
are of importance. One of the most char-
acteristic mediators primarely released by 
Th1 cells is interferon (IFN)-γ. IFN-γ has 
a wide variety of proinﬂammatory ac-
tions such as activation of macrophages 
to produce inﬂammatory mediators and 
promoting the killing of intracellular or-
ganisms [20-22]. IFN-γ is also known to 
induce a marked up-regulation of FcγRI 
expression [23-25]. 
 In the present study we investigated 
whether local overexpression of IFN-γ 
using an adenoviral vector aggravates car-
tilage destruction in a FcγRI-dependent 
manner. Local overexpression of IFN-γ 
induced only deterioration of cartilage 
destruction during immune complex-me-
diated arthritis (ICA), whereas no effects 
were found when IFN-γ was overex-
pressed during zymosan-induced arthritis 
(ZIA), which is an IC-independent model. 
As IFN-γ is able to up-regulate FcγRI, 
FcγRI mRNA levels were detected in 
synovium. An increase of FcγRI mRNA 
levels was found and to deﬁne the role of 
FcγRI in the deterioration of cartilage de-
struction when IFN-γ was overexpressed, 
we used selective FcγRI-deﬁcient mice. 
Our ﬁndings indicate that local overex-
pression of IFN-γ aggravates cartilage 
destruction only in presence of ICs, and 
that chondrocyte death is mediated by 
FcγRI-dependent processes.
Material and Methods
Animals
 C57Bl/6 mice were purchased from 
Charles River Lab (Sulzfeld, Germany). 
FcγRI-/- mice (Dr Verbeek) were back-
crossed to the BALB/c background for 6 
generations [26]. Homozygous mutants 
and their wild-type controls (10-12 weeks 
old) were used in the experiments. Mice 
were fed a standard diet and tapwater ad 
libitum.
Overexpression of IFN-γ in vivo 
using an adenovirus
 The recombinant adenovirus-encod-
ing murine IFN-γ (AdIFN-γ) was gener-
ated as described before [27]. As control 
adenovirus AdeGFP, encoding green 
ﬂuorescent protein, was used. Knee joints 
of naive mice were intra-articularly in-
jected with 6 µl phosphate-buffered saline 
(PBS) or with 6 µl of either AdIFN-γ or 
AdeGFP (1.107 pfu). At different time 
points, patellae with adjacent synovium 
were dissected in a standardized manner 
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[28] and synovium biopsies were taken 
using a biopsy punch with a diameter of 
3 mm. Total RNA was extracted in 1 ml 
TRIzol reagent [29] (Invitrogen, Carlsbad, 
CA) and used for quantitative polymerase 
chain reaction (PCR) as described below. 
PBS, AdIFN-γ, or AdeGFP were intra-ar-
ticularly injected one day before arthritis 
induction.  
Induction of immune complex-
mediated and zymosan-mediated 
arthritis
 Polyclonal antibodies directed against 
lysozyme were intravenously injected into 
mice. These antibodies were raised in rab-
bits. ICA was then induced by injecting 3 
µg of PLL-lysozym in 6 µl pyrogen-free 
saline into the right knee joint. Zymosan 
arthritis was induced by injecting 180 µg 
sterilized zymosan into the right knee 
joint.
Joint swelling
 Joint swelling was determined by 99mTc 
uptake measurements of the knee joint at 
days 1 and 3 after arthritis induction [30]. 
Brieﬂy, mice were injected with 12 µCi 
of 99mTc and sedated with 4.5% chloral 
hydrate. After 30 minutes, the amount of 
radioactivity was determined by external 
gamma counting. Arthritis was scored 
as the ratio of 99mTc uptake in the right 
(R) and the left (L) knee joint. R/L ratios 
> 1.1 were taken to indicate signiﬁcant 
swelling of the right knee.
Histology of arthritic knee joints
 Total knee joints of mice were isolated 
at day 3 after induction of arthritis. For 
standard histology, joints were decalciﬁed, 
dehydrated, and embedded in parafﬁn. 
Sections of 7 µm thick were made and 
stained with hematoxylin and eosin. Serial 
sections were scored by two observers on 
decoded slides. Inﬂammation was graded 
on a scale from 0 ( no inﬂammation) to 
3 (severe inﬂamed joint) as inﬂux of in-
ﬂammatory cells in synovium and joint 
cavity. Chondrocyte death was scored as 
the amount of empty lacunae expressed as 
percentage of total amount of cells within 
the cartilage layers. Cartilage erosion 
was scored by expressing the amount of 
eroded cartilage as percentage of the total 
cartilage surface. Chondrocyte death and 
erosion were determined using cartilage 
surfaces of the lateral femur-tibia, and 
medial femur-tibia and data shown are the 
mean chondrocyte death and erosion ex-
pression present in these cartilage layers.
Immunohistochemical staining of 
polymorphonuclear cells (PMNs)
 Sections were stained as described ear-
lier using NIMP-R14, a speciﬁc rat anti-
mouse PMN monoclonal (diluted 1:50) 
[3]. Primary antibodies were detected 
using rabbit anti-rat peroxidase. Finally, 
sections were counterstained with hema-
toxylin. The percentage of PMNs was de-
termined in two representative locations 
of the synovial lining and joint cavity. A 
total of 100 cells was counted and the 
amount of brown-stained cells was ex-
pressed as percentage PMNs of the total 
cell population. 
Immunohistochemical staining of 
Myeloid-Related Proteins (MRP)8 
and 14
 Sections were stained as described ear-
lier using a ﬁnal antibody concentration 
of 1 µg/ml [31-33]. Primary antibodies 
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were detected using peroxidase-conjugat-
ed second-stage antibodies against rabbit 
IgG (Dianova, Hamburg, Germany). Fi-
nally, sections were counterstained with 
Mayer’s hematoxylin (Merck, Germany). 
The percentage of MRP8- and MRP14-
positive cells was determined in two rep-
resentative locations of the synovial lining 
and joint cavity. A total of 100 cells was 
counted and the amount of red-stained 
cells was expressed as percentage activated 
macrophages of the total cell population.
Immunohistochemical VDIPEN 
staining
 Sections were digested with protein-
ase-free chondroitinase ABC (0.25 units/
ml in 0.1 M Tris HCl, pH 8.0; Sigma, 
Zwijndrecht, The Netherlands) to remove 
the side chains of PGs. Subsequently, sec-
tions were treated with 1% H
2
O
2
, 1.5% 
normal goat serum, and afﬁnity-puri-
ﬁed rabbit anti-VDIPEN IgG [34-36]. 
Thereafter, sections were incubated with 
biotinylated goat anti-rabbit IgG, and 
avidin-streptravidin-peroxidase (Elite kit; 
Vector, Burlingame, CA). Development 
of the peroxidase staining was performed. 
Counterstaining was done with orange 
G (2%). Areas of immunostaining were 
expressed as percentage of the total car-
tilage surface. The cartilage layers of the 
lateral femur-tibia and medial femur-tibia 
were used to determine the percentage 
VDIPEN expression and data shown are 
the mean of these cartilage surfaces.
Measurement of IFN-γ by Enzyme-
Linked Immunosorbent Assay
 To determine the levels of IFN-γ in 
washouts, patellae with adjacent synovi-
um were isolated in a standard manner 
and incubated in RPMI 1640 medium 
(GIBCO BRL, Breda, The Netherlands) 
for 1 hour at room temperature. IFN-γ 
levels in the supernatants were measured 
using a speciﬁc sandwich enzyme-linked 
immunosorbent assay. The capture anti-
body, monoclonal rat anti-mouse IFN-γ 
(Pharmingen, San Diego, CA), was coated 
overnight in a 96-well plate. After incu-
bating with the supernatants, wells were 
washed three times and incubated using 
a biotinylated antibody, rat anti-mouse 
IFN-γ. The second antibody was detected 
using poly-horseradish peroxidase and 
subsequently developed using 3, 3, 5, 5 
– tetramethylbenzidine/ureum peroxidase 
solution. Absorbance was measured at 492 
nm. The cytokine concentration in the 
samples was calculated as pg/ml using re-
combinant murine IFN-γ as standard in 
the calibration curve.
Determination of MIP-1α and KC 
levels
 To determine levels of KC and MIP-
1α in patellae washouts, patellae were 
isolated in a standard manner and incu-
bated in RPMI 1640 medium (GIBCO 
BRL, Breda, The Netherlands) for 1 hour 
at room temperature. Chemokine levels 
were determined using the BioPlex system 
from BioRad (Hercules, CA) in combina-
tion with multiplex cytokine and chem-
okine kits for the Luminex multianalyte 
system.
Quantitative detection of FcγRI 
mRNA using Reverse Transcriptase-
PCR
 Speciﬁc mRNA level for FcγRI was 
quantiﬁed using the ABI/PRISM 7000 
Sequence Detection System (ABI/PE, 
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Foster City, CA). Brieﬂy, 1 µg of synovial 
RNA was used for reverse transcriptase-
PCR. mRNA was reverse-transcribed to 
cDNA using oligodT primers and 1/20 of 
the cDNA was used in one PCR ampli-
ﬁcation. PCR was performed in SYBR 
Green Master Mix using the follow-
ing ampliﬁcation protocol: 2 minutes at 
50°C followed by 40 cycles of 15 seconds 
at 95°C and 1 minute at 60°C with data 
collection in the last 30 seconds. Message 
for murine GAPDH and FcγRI was am-
pliﬁed using speciﬁc primers (Biolegio, 
Malden, The Netherlands) for GAPDH 
and FcγRI (Table 1) at a ﬁnal concentra-
tion of 300 nmol/L. Relative quantiﬁca-
tion of the PCR signals was performed 
by comparing the cycle threshold value 
(Ct) of the FcγRI gene in the different 
samples after correction of the GAPDH 
content for each individual sample to rule 
out confounding by variation of the RNA 
puriﬁcation and reverse transcriptase step. 
Statistical analysis
 Differences between experimental 
groups were tested for signiﬁcance using 
the Mann-Whitney U-test with the statis-
tic program GraphPad Prism 3.0. P values 
less than 0.05 were considered signiﬁcant.
Results
Kinetics of IFN-γ overexpression 
in naive knee joints
 AdIFN-γ was injected into the right 
knee joint of naive mice and subsequently 
IFN-γ levels were measured in washouts 
from synovium specimen taken at 6, 24, 
48, and 72 hours after injection. IFN-γ 
was already detected at 6 hours (1230 
pg/ml), reached its maximum at 24 hours 
(2870 pg/ml), and waned thereafter. After 
48 hours, IFN-γ was below detection 
level. Control eGFP adenoviral vector did 
not induce IFN-γ production.
 Because IFN-γ is a proinﬂammatory 
cytokine, this short-lasting IFN-γ pro-
duction within the joint may on itself lead 
to inﬂammation. Using 99mTc uptake, no 
swelling was measured in knee joints that 
received AdIFN-γ or AdeGFP (data not 
shown). Histology of total knee joint sec-
tions showed no inﬂammatory cell mass 
in the joint cavity and only a mild activa-
tion of the synovial lining was induced by 
both adenoviruses (Figure 1).
IFN-γ overexpression has no effect 
on the amount of inﬁltrating cells, 
but increases the population of 
activated macrophages in the joint 
cavity
 To investigate whether local IFN-γ 
production, in the presence of ICs, leads 
to enhanced joint inﬂammation, we in-
jected PBS, AdeGFP, and AdIFN-γ, 1 
day before induction of ICA. Injection of 
either AdIFN-γ or AdeGFP resulted in a 
30% decrease in joint swelling, compared 
to mice that had received PBS (Table 2). 
Three days after ICA induction, swelling 
in the AdIFN-γ group and PBS group was 
Table 1. Primers for detection of murine FcγRI mRNA.
      Primer Sequence (5’ - 3’)  
 
GAPDH 
Up    GGCAAATTCAACGGCACA 
Low   GTTAGTGGGGTCTCGCTCCTG
FcγRI  
Up   ACACAATGGTTTATCAACGGAACA 
Low   TGGCCTCTGGGATGCTATAACT
Primer sequences for quantitative PCR on synovium samples. 
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comparable (Table 2).  The inﬂammatory 
cell mass in joint cavity (exudate) and syn-
ovium (inﬁltrate) at day 3, was similar in 
the PBS, AdeGFP, and AdIFN-γ groups 
(Table 2).   
 To study whether IFN-γ overexpres-
sion altered the composition of the cell 
mass, PMNs were stained (Figure 2A). 
The percentage of PMNs inﬁltrated in the 
synovium was similar in the PBS, AdeGFP, 
and AdIFN-γ group (± 45-50%). Interest-
ingly, in the joint cavity the percentage of 
inﬁltrated PMNs was signiﬁcantly lower 
in the AdIFN-γ group (50%) compared 
to the PBS and AdeGFP groups (70%), in-
dicating that macrophages are more abun-
dantly present in the AdIFN-γ group. 
 As stimulation of macrophages with 
IFN-γ modulates chemokine production 
[37, 38], we measured macrophage inﬂam-
matory protein (MIP)-1α, which attracts 
monocytes [39] and KC, a neutrophil 
attractant [39]. IFN-γ overexpression in 
naive joints resulted in 220 pg/ml MIP-1α 
levels after 3 days, injection of AdeGFP 
induced only 25 pg/ml. KC levels were 
not up-regulated by IFN-γ (30 pg/ml), 
and were similar as found after AdeGFP 
injection (20 pg/ml). These enhanced 
MIP-1α levels might explain the increase 
of inﬁltrating macrophages found. 
 Furthermore, we studied the activation 
state of macrophages using MRP8 and 14 
as markers. These S100 proteins are as-
sociated with an activated phenotype of 
macrophages present in inﬂammatory 
sites. In the synovial layer, the percentage 
of macrophages expressing MRP8 was 
Figure 1 
Histology of naive knee joints 24 
hours after injection of AdeGFP (A) 
or AdIFN-γ (B) (1 .107 pfu). Injec-
tion of both AdeGFP and AdIFN-γ 
resulted in a mild thickening  of the 
synovial lining (S), whereas no in-
ﬂammatory cell mass was found in 
the joint cavity (J). Original magni-
ﬁcation, x100 (A,B), x 200 (insert).
Table 2 Inﬂammatory response 1 and 3 days after ICA induction.
            Joint Swelling   Inﬂammatory cell mass
    Day 1   Day 3          Joint cavity          Synovium
ICA + PBS 1.3 ± 0.1   1.3 ± 0.1             1.4 ± 0.1            1.6 ± 0.1
ICA + AdeGFP 1.2 ± 0.1  1.2 ± 0.1             1.4 ± 0.1            1.5 ± 0.1
ICA + AdIFN-γ 1.2 ± 0.1  1.3 ± 0.1             1.6 ± 0.2            1.6 ± 0.2
Inﬂammation was determined using joint swelling and inﬂammatory cell mass in the joint cavity and synovium. Joint swelling of the right inﬂamed knee joint 
was quantiﬁed using the right/left ratio of 99mTc uptake in both knee joints. The amount of inﬂammatory cells in the joint cavity (exudate) and in the synovial layer 
(inﬁltrate) were scored in a blinded fashion by two independent observers using an arbitrary scale from 0-3 (0, no; 1, minor; 2, moderate; 3, maximal). Note that 
both joint swelling and inﬂammatory cell mass were not signiﬁcantly diﬀerent between the PBS, AdeGFP, and AdIFN-γ group. Data are the mean ± SEM of 12 mice 
and signiﬁcance was evaluated using the Mann-Whitney U test (*, P< 0.05). 
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similar in all groups (40-45%) (Figure 2B). 
However, in the joint cavity the percentage 
MRP8-positive macrophages was some-
what, although signiﬁcantly, increased in 
the AdIFN-γ group (50% versus 35-40% 
in controls) (Figure 2B). Intriguingly, 
these MRP8-expressing macrophages 
were clustered in the proximity of the car-
tilage surface. MRP14 expression on cells 
in the synovial lining and joint tissue was 
identical with MRP8 expression and fol-
lowed the same pattern as described above 
in all groups (data not shown).   
Local overexpression of IFN-γ 
during ICA results in aggravation 
of severe cartilage destruction
 In addition, we studied the impact 
of IFN-γ on cartilage destruction in 
ICA. MMP-mediated cartilage damage 
(VDIPEN immunostaining), chondrocyte 
death, and surface erosion were used as his-
tological parameters. Strikingly, injection of 
AdIFN-γ and subsequent induction of ICA 
resulted in a two- to three-fold increase in 
VDIPEN expression in the cartilage matrix, 
when compared to both control groups 
(Figure 3, A and D (AdIFN-γ) versus B and 
C (controls)).  Furthermore, chondrocyte 
death as measured by the percentage of 
empty lacunae within the cartilage layers 
was two times higher in presence of IFN-γ, 
compared to the PBS group (Figure 3, A 
and G (AdIFN-γ) versus E (PBS)) and even 
four times elevated when compared to the 
AdeGFP-injected group (Figure 3, A, G 
(AdIFN-γ) and F (AdeGFP)). Figure 2 
The percentage of PMNs (A) and MRP8-expressing macrophages (B) in the 
joint cavity (exudate) and synovial lining (inﬁltrate) 3 days after ICA induction 
in the PBS, AdeGFP, and AdIFN-γ groups. Note the signiﬁcantly lower percent-
age of PMNs and the signiﬁcant increase of MRP8-expressing macrophages 
in the exudate of the AdIFN-γ group.Values represent the mean ± SEM of 12 
mice. Data were evaluated using the Mann-Whitney U test (*, P < 0.05). 
Figure 3 
Cartilage destruction, measured as VDIPEN expression (A-D), chondrocyte 
death, and erosion of the cartilage matrix (A, E-G), in the PBS, AdeGFP, and 
AdIFN-γ group 3 days after ICA induction. IFN-γ overexpression resulted in a 
signiﬁcant increase in VDIPEN expression (A and D versus control B and C), 
chondrocyte death (A and G versus control E and F), and erosion (A and G 
(arrows) versus control E and F). Values represent the mean ± SEM of 12 mice. 
Data were evaluated using the Mann-Whitney U test (**,  P< 0.0001). Orginal 
magniﬁcation, x 200.
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 Matrix erosion was determined using 
the cartilage surfaces of the lateral and 
medial femur-tibia plateau. Erosion was 
almost absent in the PBS and AdeGFP 
group, in line with the early time point 
chosen (Figure 3, A, E, and F). In contrast, 
local overexpression of IFN-γ induced 
erosion, which was found on all cartilage 
surfaces (Figure 3, A and G). Our results 
indicate that during an arthritis mediated 
by ICs, IFN-γ overexpression signiﬁcantly 
aggravates irreversible cartilage destruc-
tion.
Aggravation of cartilage destruction 
by IFN-γ is IC-dependent
 To further investigate whether the 
aggravating effect of IFN-γ on cartilage 
destruction is speciﬁc for ICs, we also 
induced zymosan arthritis (ZIA). Twenty-
four hours before ZIA induction, mice 
were injected with either PBS, AdeGFP 
or AdIFN-γ. IFN-γ resulted in increased 
number of inﬂammatory cells in the joint 
cavity (exudate) at day 3, whereas the 
inﬁltrate in the synovium was compara-
ble with both control groups (Table 3). 
VDIPEN expression, chondrocyte death, 
and erosion were completely absent in all 
groups (Figure 4, A to F). These results 
show that local overexpression of IFN-γ 
in the knee joint during a non-IC-de-
pendent model, does not elicit irreversible 
cartilage destruction. 
Up-regulation of FcγRI in synovium 
by IFN-γ
 Because we recently found an important 
role for FcγRI in mediating cartilage de-
struction, we focused on the expression of 
this receptor. After injection of AdIFN-γ 
in knee joints, synovial specimens were 
Table 3 Inﬂammatory response 3 days after zymosan  
   arthritis induction.
  Inﬂammatory cell mass
            Joint Cavity       Synovium
ZIA + PBS 0.9 ± 0.1          1.0 ± 0.1
ZIA + AdeGFP 1.3 ± 0.2          1.2 ± 0.2
ZIA + AdIFN-γ 1.7 ± 0.1*          0.8 ± 0.2 
The amount of inﬂammatory cells in the joint cavity (exudate) and in the 
synovium (inﬁltrate) were scored in a blinded fashion by two independent 
observers using an arbitrary scale from 0-3 (0, no; 1, minor; 2, moderate; 3, 
maximal). Note that the inﬂammatory cell mass is signiﬁcantly increased in 
the AdIFN-γ group, when compared to the PBS and AdeGFP group. Data are 
the mean ± SEM of 8 mice and signiﬁcance was evaluated using the Mann-
Whitney U test (*, P< 0.05). 
Figure 4 
Cartilage destruction after zymosan arthritis. Cartilage destruction, meas-
ured as VDIPEN expression (A-C), chondrocyte death, and erosion of the car-
tilage matrix (D-F), in the PBS, AdeGFP, and AdIFN-γ group, respectively, 3 
days after ZIA induction. No VDIPEN expression (C versus control A and B), 
chondrocyte death and erosion (F versus control D and E) were found. Original 
magniﬁcation, x 200.
Figure 5 
Expression proﬁle of FcγRI mRNA levels after injection of PBS, AdeGFP, and 
AdIFN-γ in synovium specimens at diﬀerent time points (6 hrs, day 1, day 3, 
and day 7). The Ct value of FcγRI in synovium at 0 hours was substracted from 
the Ct values for FcγRI at diﬀerent time points after injection. Ct values were 
corrected for GAPDH content for each individual sample.
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isolated at different timepoints (6 hours, 1, 
3, and 7 days) and mRNA levels of FcγRI 
were detected. In naive knee joints FcγRI 
mRNA could not be detected, whereas 
6 hours after AdIFN-γ injection, FcγRI 
mRNA level was markedly increased 
(∆ Ct = 3.97). At day 1, maximal values 
were found, which remained high until 
day 7 after injection (Figure 5). Injection 
of PBS had no effect on FcγRI mRNA 
levels, whereas AdeGFP levels showed an 
increase at 6 hours (∆ Ct = 1.59), which 
was decreased at day 1 and completely 
absent after 3 days (Figure 5).  
IFN-γ-induced aggravation of 
chondrocyte death is FcγRI       
dependent
 As presence of IFN-γ induced an in-
crease of FcγRI mRNA, we further inves-
tigated whether this receptor contributed 
to the aggravation of cartilage destruction 
using FcγRI-deﬁcient mice and their re-
spective wild-type controls. The IFN-γ 
effect in these wild-type controls was 
primarily as expected. FcγRI-/- and wild-
type controls received PBS, AdeGFP, or 
AdIFN-γ, 24 hours before ICA induction. 
Joint inﬂammation was similar in both 
wild-type controls and FcγRI-/- (Table 4). 
Unexpectedly, IFN-γ enhanced VDIPEN 
expression was still present in FcγRI-/- 
(Figure 6A). In the FcγRI-/- related wild-
type controls, IFN-γ greatly increased 
chondrocyte death, resulting in 35% 
empty lacunae. Of great interest, chondro-
cyte death remained low in FcγRI-/- (3%) 
(Figure 6B). Unfortunately, erosion of the 
cartilage surface could not be detected in 
these wild-type controls after IFN-γ over-
expression, hampering analysis of FcγRI 
involvement.
Table 4 Inﬂammatory response in FcγRI-/- compared  
   to wild-type controls after injection of PBS,  
   AdeGFP, or AdIFN-γ 3 days after ICA induction 
               Inﬂammatory cell mass
            Joint Cavity  Synovium 
 
PBS  
   WT control 0.7 ± 0.3      1.7 ± 0.3
   FcγRI-/-  1.1 ± 0.1       1.9 ± 0.3 
AdeGFP 
   WT control 0.9 ± 0.2      1.6 ± 0.3
   FcγRI-/-  0.7 ± 0.2      1.6 ± 0.2
AdIFN-γ 
   WT control 1.1 ± 0.2      1.7 ± 0.3 
   FcγRI-/-  1.1 ± 0.1      1.3 ± 0.2
The amount of inﬂammatory cells in the joint cavity (exudate) and in the 
synovium (inﬁltrate) were scored in a blinded fashion by two independent 
observers using an arbitrary scale from 0-3 (0, no; 1, minor; 2, moderate; 3, 
maximal). Note that the inﬂammatory cell mass is not signiﬁcantly diﬀerent 
between the PBS, AdeGFP, and AdIFN-γ group. Data are the mean ± SEM 
of 6 mice and signiﬁcance was evaluated using the Mann-Whitney U test 
(*, P< 0.05). 
Figure 6 
Cartilage destruction, measured as VDIPEN expression (A) and chondrocyte 
death (B) after injection of PBS, AdeGFP, and AdIFN-γ in FcγRI-/- and their 
wild-type controls 3 days after ICA induction. Note that IFN-γ resulted in 
increased VDIPEN expression in both wild-type controls and FcγRI-/-. IFN-γ-
enhanced chondrocyte death was not found in FcγRI-/-. Values represent the 
mean ± SEM of 6 mice.Data were evaluated using the Mann-Whitney U test 
(*, P< 0.05, **, P< 0.0001). 
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Discussion
In the present study we demonstrate that 
overexpression of IFN-γ results in in-
creased chondrocyte death by up-regula-
tion of FcγRI. We locally overexpressed 
IFN-γ in two different arthritis models 
using an adenoviral vector and found that 
only in presence of ICs cartilage damage 
was aggravated. Using FcγRI-deﬁcient 
mice, it was conﬁrmed that chondrocyte 
death is mediated by FcγRI and that up-
regulation of this receptor by IFN-γ di-
rects deterioration of chondrocyte death.
 Injection of AdIFN-γ in naive knee 
joints induced a short-lasting although 
high peak of IFN-γ. This might be ex-
plained by the ability of IFN-γ to shut 
off the CMV promotor of the adenovirus 
[40]. We found that 1 day after injection 
of AdIFN-γ only a very mild synovial in-
ﬂammation was induced, indicating that 
this concentration of IFN-γ was not able 
to attract large amounts of inﬂammatory 
cells. This is in line with a previous study 
in which recombinant mouse IFN-γ was 
injected in the peritoneal cavity, and no 
chemotactic activity for mouse macro-
phages or neutrophils was found [41]. 
When triggers such as ICs or zymosan 
were additionally injected into the joint, 
a large amount of inﬂammatory cells in-
ﬁltrated probably regulated by IL-1 [42] 
and chemotactic factors [43]. Surprisingly, 
IFN-γ did not alter the amount of inﬁl-
trated cells in ICA, whereas in ZIA the 
inﬂammatory cell mass in joint cavity was 
increased. A possible explanation for this 
discrepancy might be that IFN-γ elevates 
joint inﬂammation dependent on the 
trigger and receptors involved to induce 
arthritis. Although AdIFN-γ injection 
before ICA induction did not contribute 
to the amount of inﬁltrated cells, yet the 
type of inﬁltrated cells was markedly al-
tered. The percentage of macrophages was 
signiﬁcantly higher in the IFN-γ stimu-
lated joint. This is in line with our ﬁnding 
that IFN-γ elevated levels of MIP-1α, a 
potent chemokine of macrophages, but not 
of KC, which is dominant for attracting 
PMNs [39]. Macrophages in IC-mediated 
arthritis expressed MRP8 and 14, which 
are markers for a proinﬂammatory phe-
notype. MRP8- and MRP14-expressing 
macrophages have shown to be the major 
source of IL-1 and respiratory burst under 
inﬂammatory conditions in vivo [44,45]. 
Because the abundance and activation of 
macrophages is closely correlated to the 
severity of cartilage destruction [1,2], we 
further studied this parameter.
 IFN-γ may directly stimulate chondro-
cytes resulting in higher expression of latent 
stromelysin. Apart from that, expression 
of aggrecan and other core protein genes 
can decrease [46-48]. This eventually 
may lead to enhanced levels of pro-MMPs 
within the cartilage matrix and decreased 
proteoglycan synthesis. However, in the 
present study IFN-γ alone did not induce 
severe cartilage destruction directly, since 
injection of AdIFN-γ in naive knee joints 
failed to induce irreversible cartilage de-
struction (data not shown) and additional 
triggers are needed. 
 When AdIFN-γ was injected before 
zymosan-induced arthritis, although in-
creased inﬁltration of inﬂammatory cells 
was found, severe cartilage destruction 
was completely absent. In contrast, when 
in such an IFN-γ joint, IC-mediated ar-
thritis was induced, a strongly increased 
MMP-mediated proteoglycan damage, 
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chondrocyte death, and erosion were 
found. This suggests an important role 
for IgG-binding FcγR. In earlier studies 
using FcγRI-/-, we have found that FcγRI 
is highly involved in mediating severe 
cartilage destruction during IC-mediated 
arthritides [15,16]. In the present study, 
IFN-γ signiﬁcantly increased FcγRI 
mRNA levels in the synovium for 7 days 
which is in line with earlier studies de-
scribing up-regulation of FcγRI by IFN-γ 
[23-25]. This elevated FcγRI expression 
is exclusively present on the macrophage 
population, since murine PMNs do not 
express FcγRI [49]. Unfortunately, it was 
not possible to detect the murine FcγRI 
protein as a speciﬁc anti-FcγRI antibody 
is not available. Further proof that eleva-
tion of FcγRI induced by IFN-γ is respon-
sible for the observed cartilage destruction 
was obtained by IFN-γ overexpression in 
mice lacking FcγRI.
 Chondrocyte death appeared to be 
speciﬁcally mediated by FcγRI. Chondro-
cyte death may be mediated by oxygen 
radicals. Binding of IgG to FcγRI leads 
to an overkill of the oxidative burst re-
sulting in prominent oxygen radical pro-
duction [50]. Apart from that, IFN-γ also 
regulates the production of nitric-oxide 
by macrophages [51], which has been 
shown to induce apoptosis of chondro-
cytes [52]. The close interaction between 
macrophages and the cartilage surface 
we found makes the above mechanisms 
highly plausible, since oxygen and nitro-
gen radicals only produce tissue damage 
within a short distance. Furthermore, the 
ﬁnding that chondrocyte death is absent 
in FcγRI-/- also indicates that neutrophils 
are probably not involved, since these cells 
lack FcγRI [49].   
 Unexpectedly, we found that IFN-γ 
st i l l induced car t i lage proteoglycan 
damage mediated by MMPs (VDIPEN 
epitopes) when FcγRI was absent. One 
explanation may be that in FcγRI-deﬁ-
cient mice, the other activating FcγRIII 
is still present and becomes up-regulated 
after IFN-γ stimulation. As VDIPEN ex-
pression was strongly diminished in ICA 
in both FcγRI-/- and FcγRIII-/- mice, this 
indicates that also FcγRIII when present 
in sufﬁcient amounts may signiﬁcantly 
contribute to MMP-mediated proteogly-
can damage [15].     
 Eventually, activation of MMPs leads 
to degradation of the collagen type II net-
work and erosion of the cartilage matrix. 
In contrast to marked erosion after ICA 
induction in mice with C57Bl/6 back-
ground, erosion was completely absent in 
the FcγRI-/- but also in their proper con-
trols. As the FcγRI-/- are generated in the 
Balb/c background and the severity of the 
ICA model is related to the genetic back-
ground of the mice [53], this explains the 
absence of erosion, but hampers evalua-
tion of this aspect at present.
 The present study demonstrates that 
IFN-γ aggravates irreversible cartilage de-
struction in the presence of ICs implicating 
an important role for FcγRI in mediating 
chondrocyte death. As ICs and macro-
phages are abundantly found within the 
synovia of rheumatoid arthritis patients, 
local production of IFN-γ within the syn-
ovium may induce elevated expression of 
FcγRI on the macrophage which appears 
to be a crucial receptor involved in medi-
ating severe cartilage destruction. FcγRI 
may form a new important therapeutic 
target in order to combat this crippling 
disease 
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105 Eﬀect of IFN-γ on cartilage damage in IC-arthritis
Introduction: Previously, it was shown that the onset and the degree of joint 
inﬂammation during immune complex (IC)-mediated arthritis (ICA) depend 
on FcγRIII. Local adenoviral overexpression of IFN-γ in the knee joint prior 
to ICA onset aggravated severe cartilage destruction. In FcγRI-/- mice how-
ever, chondrocyte death was not enhanced by IFN-γ, whereas metalloproteinase 
(MMP)-mediated aggrecan breakdown was markedly elevated suggesting a role 
for the activating FcγRIII in the latter process. 
Objective: To study the role of FcγRIII in joint inﬂammation and severe carti-
lage destruction in IFN-γ-stimulated ICA using FcγRIII-/- mice.  
Methods: FcγRIII-/- and wild-type mice were injected in the knee joint with 
AdIFN-γ or AdeGFP one day prior to ICA induction. Histology was taken three 
days after arthritis onset to study inﬂammation and cartilage damage. MMP-
mediated expression of the VDIPEN neoepitope was detected by immunolocali-
zation. Chemokine and FcγR expression levels were determined in respectively 
synovial washouts and synovium. 
Results: Injection of AdIFN-γ in naive knee joints markedly increased mRNA 
levels of all three FcγRs. Upon IFN-γ overexpression prior to ICA induction, 
joint inﬂammation was similar in FcγRIII-/- and WT mice. The percentage of 
macrophages in the knee joint was increased, which correlated with high con-
centrations of the macrophage-attractant MIP-1α. Furthermore, IFN-γ induced 
a 3-fold increase of chondrocyte death in WT controls, which was also present 
in FcγRIII-/- mice. Remarkably, VDIPEN expression remained also high in 
FcγRIII-/- mice.
Conclusion: IFN-γ bypasses FcγRIII dependency of the development of ICA. 
Furthermore, both FcγRI and III can mediate MMP-dependent cartilage matrix 
destruction. 
 Rheumatoid arthritis (RA) is a chronic 
inﬂammatory synovitis characterized by 
synovial hypertrophy and synovial pannus 
formation with accompanying destruc-
tion of juxta-articular cartilage and bone 
[1]. Macrophages play a major role in the 
arthritic process by releasing multiple fac-
tors such as pro-inﬂammatory cytokines 
and tissue-degrading enzymes and several 
studies have shown that the number of 
macrophages in the joints of RA patients 
correlates well with joint inﬂammation 
[2] and cartilage damage [3,4]. 
 IgG containing immune complexes 
are abundantly present in the synovium 
of most RA patients and play a dominant 
role in the activation of macrophages 
[5,6]. Fcγ receptors (FcγRs) on mac-
rophages interact with IgG-containing 
immune complexes [7,8]. These receptors 
for the Fc portion of the IgG molecule 
play a central role in immune-mediated 
tissue injury due to their ability to recruit 
effector immune cells [9]. Three classes 
of FcγRs are distinguished on hemat-
opoietic cells: the high afﬁnity receptor 
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FcγRI (CD64), and the low afﬁnity 
receptors FcγRII (CD32) and FcγRIII 
(CD16). FcγRI and FcγRIII are activat-
ing receptors, associated with a dimer 
of a signal transduction subunit the FcR 
γ-chain, which contains an immunore-
ceptor tyrosine-based activation motif 
(ITAM). The single chain FcγRII is an 
inhibitory receptor, containing an im-
munoreceptor tyrosine-based inhibitory 
motif (ITIM) in its cytoplasmic domain 
[10].
 In a recent study using FcγRI-/- and 
FcγRIII-/- mice, we found that during 
IC-mediated arthritis FcγRIII mainly 
regulates the inﬂammatory response, 
whereas FcγRI is more prominently 
involved in chondrocyte death and car-
tilage matrix erosion via activation of 
matrix metalloproteinases [11,12]. 
 Cartilage damage starts with the 
reversible process of proteoglycan de-
pletion mediated by aggrecanases. If 
cartilage destruction continues, ir-
reversible collagen ﬁbre degradation 
occurs. Stromelysin and collagenase 
are the main matrix metalloproteinases 
(MMPs) involved in this process [13-15]. 
MMPs are secreted in an inactive form 
by chondrocytes, stored in the cartilage 
matrix and activated after further cleav-
age [16]. MMP activation is primarily 
found when experimental arthritis is 
elicited by ICs, which suggests an im-
portant role for the IC-binding FcγRs 
in this process. 
 Cartilage destruction is more pro-
nounced in T cell dependent arthritis 
models, indicating that Th1 cytokines 
might be of importance. One of the 
typical Th1 cytokines secreted by T 
cells is interferon (IFN)-γ. Local over-
expression of IFN-γ during immune 
complex mediated arthritis (ICA) re-
sulted in more severe cartilage destruc-
tion as found in enhanced MMP-me-
diated proteoglycan (PG) degradation, 
chondrocyte death, and erosion [17]. 
In FcγRI deﬁcient mice, chondrocyte 
death remained low even when IFN-γ 
was overexpressed, suggesting a crucial 
role for FcγRI [17]. However, MMP-
mediated cartilage destruction was 
enhanced by IFN-γ in arthritic knee 
joints of FcγRI-/- mice, indicating that 
FcγRIII compensates absence of FcγRI. 
 In the present study, we investigate 
the particulate role of FcγRIII in joint 
inﬂammation and cartilage destruction 
during IFN-γ-enhanced immune com-
plex arthritis. 
 This study shows that IFN-γ aggra-
vates MMP-mediated cartilage damage 
mediated by activating FcγRI and III. 
Furthermore, we show that both acti-
vating FcγRs are redundant in initiating 
MMP-mediated cartilage destruction, 
but we conﬁrm a speciﬁc role for FcγRI 
in mediating chondrocyte death. 
Material and Methods
Animals
 FcγRIII-/- mice, deﬁcient for the α-
chain of FcγRIII, were backcrossed to 
the C57Bl/6 background for 12 gen-
erations [18]. Homozygous mutants and 
their wild-type (WT) controls (10-12 
weeks old) were used in the experiments. 
Mice were fed a standard diet and tap-
water ad libitum. Ethical approval was 
obtained from the local research ethics 
committee.
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In vivo overexpression of IFN-γ 
using an adenovirus
 The recombinant adenovirus encod-
ing murine IFN-γ (AdIFN-γ) was gen-
erated as described before [19]. AdeGFP 
(green ﬂuorescent protein) was used as 
control virus. Knee joints of naive mice 
were intra-articularly injected with 6 µl 
PBS or with 6 µl of either AdIFN-γ or 
AdeGFP (1.107 pfu). At different time 
points, patellae with adjacent synovium 
were dissected in a standardized manner 
[20] and synovium biopsies were taken 
using a biopsy punch with a diameter of 
3 mm. Total RNA was extracted in 1 ml 
TRIzol reagent and used for quantitative 
PCR as described below. PBS, AdIFN-γ, 
or AdeGFP were intra-articularly injected 
one day prior to arthritis induction. 
Induction of immune complex-
mediated arthritis
 ICA was passively induced by inject-
ing 3 µg PLL-lysozyme in knee joints of 
mice that had previously (16 hours earlier) 
received, intravenously, polyclonal anti-
bodies directed against lysozyme. These 
antibodies were raised in rabbits. 
Histology of arthritic knee joints
 Total knee joints of mice were isolated 
3 days after arthritis onset. Joints were 
decalciﬁed, dehydrated, and embedded 
in parafﬁn. Tissue sections (7 µm) were 
stained with hematoxylin and eosin. His-
topathological changes were scored using 
the following parameters. Inﬂammation 
was graded on a scale from 0 (no inﬂam-
mation) to 3 (severe inﬂamed joint) as 
inﬂux of inﬂammatory cells in synovium 
and joint cavity. Chondrocyte death was 
scored as the amount of empty lacunae 
expressed as percentage of total amount of 
cells within the cartilage layers. 
Immunohistochemical detection of 
macrophage marker F4/80 
 F4/80, a murine macrophage mem-
brane antigen, was detected using a specif-
ic rat anti-mouse F4/80 IgG [21]. Primary 
antibodies were detected using rabbit anti-
rat IgG and avidin-horseradish peroxidase 
conjugate. Finally, sections were counter-
stained with haematoxylin. The percent-
age of macrophages was determined at 
two representative locations of both the 
synovial lining and joint cavity in 3 dif-
ferent sections of each knee joint. Using 
a magniﬁcation of 200x, the percentage 
F4/80-positive cells of the inﬂammatory 
cell mass present in the visual ﬁeld was 
determined using an arbitrary score from 
0-4 (0, 0%; 1, 1-25%; 2, 26-50%; 3, 51-
75%; 4, 76-100%).
Immunohistochemical staining of 
Myeloid Related Proteins (MRP)8 
and 14
 Sections were stained as described ear-
lier using a ﬁnal antibody concentration 
of 1 µg/ml [22]. Primary antibodies were 
detected using peroxidase-conjugated 
second-stage antibodies against rabbit IgG 
(Dianova, Hamburg, Germany). Finally, 
sections were counterstained with May-
er’s haematoxylin (Merck, Germany). 
Immunohistochemical VDIPEN 
staining
 Active MMPs can cleave PGs resulting 
in the neoepitope VDIPEN, which can be 
detected by speciﬁc monoclonal antibod-
ies. VDIPEN expression indicates pres-
ence of active MMPs, which also degrade 
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collagen ﬁbers resulting in severe cartilage 
damage. To detect VDIPEN, sections were 
digested with proteinase-free chondroiti-
nase ABC (0.25 units/ml in 0.1 M Tris 
HCl, pH 8.0; Sigma, Zwijndrecht, The 
Netherlands) to remove the side chains of 
PGs followed by incubation with afﬁnity-
puriﬁed rabbit anti-VDIPEN IgG [23]. 
The primary antibody was detected using 
biotinylated goat anti-rabbit IgG, and 
avidin-streptravidin-peroxidase (Elite kit; 
Vector, Burlingame, CA). Counterstain-
ing was done with orange G (2%). Areas 
of immunostaining were expressed as per-
centage of the total cartilage surface. 
Quantitative detection of FcγRs 
mRNA using RT-PCR
 Speciﬁc mRNA-level for FcγRI, II, 
and III was detected using the ABI/
PRISM 7000 Sequence Detection System 
(ABI/PE, Foster City, CA). Brieﬂy, one 
µg of synovial RNA was used for RT-
PCR. mRNA was reverse transcribed to 
cDNA using oligodT primers 1/100 of 
the cDNA was used in one PCR ampli-
ﬁcation. PCR was performed in SYBR 
Green Master Mix using the follow-
ing ampliﬁcation protocol: 2 minutes at 
50°C followed by 40 cycles of 15 seconds 
at 95°C and 1 minute at 60°C with data 
collection in the last 30 seconds. Mes-
sage for murine FcγRI, II, and III was 
ampliﬁed using the following primers 
(Biolegio, Malden, The Netherlands) at a 
ﬁnal concentration of 300 nmol/l: upper 
5’-ACA-CAA-TGG-TTT-ATC-AAC-
GGA-ACA-3’ and lower 5’-TGG-CCT-
CTG-GGA-TGC-TAT-AAC-T-3’ for 
FcγRI, upper 5’-GAC-AGC-CGT-GCT-
AAA-TCT-TGC-T-3’ and lower 5’-GTG-
TCA-CCG-TGT-CTT-CCT-TGA-G-3’ 
for FcγRII, upper 5’-GAC-AGG-CAG-
AGT-GCA-GCT-CTT-3’ and lower 
5’-TGT-CTT-CCT-TGA-GCA-CCT-
GGA-T-3’ for FcγRIII. Relative quantiﬁ-
cation of the PCR signals was performed 
by comparing the cycle threshold value 
(Ct) of the FcγR genes in the different 
samples after correction of the GAPDH 
content for each individual sample.
Determination of macrophage in-
ﬂammatory protein (MIP)-1α and 
KC levels
 To determine levels of KC (chemo-
tactic for PMNs) and MIP-1α (chemo-
tactic for macrophages) in patellae wash-
outs, synovial specimens were isolated 
in a standard manner, incubated in 200 
µl RPMI 1640 medium (GIBCO BRL, 
Breda, The Netherlands) for 1 hour at 
room temperature and weight hereafter. 
Chemokine levels were determined using 
the BioPlex system from BioRad (Her-
cules, CA, USA) for the Luminex multi-
analyte system. Chemokine levels were 
expressed as pg/mg synovium.
Statistical analysis
 Differences between experimental 
groups were tested for signiﬁcance using 
the Mann-Whitney U test. P values less 
than 0.05 were considered signiﬁcant.
Results
IFN-γ-induced up-regulation of all 
three FcγRs in the synovial lining
 As activating FcγRs expressed on 
synovial macrophages are important in 
the onset of ICA, the ability of IFN-γ 
to regulate FcγR expression in the syn-
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ovium was investigated ﬁrst. AdIFN-γ or 
the control AdeGFP virus was injected 
into naive knee joints of C57BL/6 mice 
and mRNA levels of the activating FcγRI 
and III and the inhibiting FcγRII were 
detected in synovial specimen. Injection 
of the control virus resulted in a slight in-
crease of mRNA levels of FcγRI but not 
FcγRIII, which was back to baseline 3 
days after injection (Table 1).
 When AdIFN-γ was injected, a high 
level of IFN-γ was found in synovial 
washouts at day 1 (2870 pg/ml), which 
was already undetectable at day 2. This 
high peak of IFN-γ resulted in a sig-
niﬁcant increase of FcγRI mRNA al-
ready after 6 hours (∆Ct = 4), and this 
remained high until day 7 (∆Ct = 3.7) 
(Table 1). In contrast, FcγRIII mRNA 
levels were not yet elevated at 6 hours, 
but increased signiﬁcantly thereafter. 
Moderate levels of FcγRIII were found 
both at 24 hours and 7 days after injec-
tion (∆Ct = 2.6 and ∆Ct = 1.9 respec-
tively), but these were evidently lower 
compared to levels of FcγRI. IFN-γ also 
induced up-regulation of inhibitory 
FcγRII mRNA at day 1 and 3 (respec-
tively ∆Ct=1.3 and ∆Ct=1.6).  
IFN-γ bypasses IC-mediated joint 
inﬂammation in FcγRIII-/- mice, 
resulting in inﬂammatory cell 
mass similar to that found in WT 
controls
 In a previous study, we found that 
FcγRIII is the dominant activating recep-
tor involved in the onset of ICA as cell 
inﬂux was largely blocked in FcγRIII-/ 
Table 1 FcγR mRNA levels in naive knee joints injected  
   with  AdeGFP or AdIFN-γ at diﬀerent time  
   points
         Days
FcγR     Treatment   6 hr    1       3      7
FcγRI      AdeGFP   1.6         0.5      0    0
               AdIFN-γ   4.0         6.2      6.5    3.7
FcγRII      AdeGFP   0.3         0.5      0       0
 AdIFN-γ   0.1         1.3      1.6     0.5
FcγRIII AdeGFP   0.6         0.5      0       0 
 AdIFN-γ   0.1         2.6      2.8    1.9
  
Expression proﬁle of FcγRI, II, and III mRNA levels after injection of AdeGFP 
or AdIFN-γ in synovium samples isolated at diﬀerent time points (6 hours, 
day 1, day 3, and day 7). Synovium samples from 4 knee joints were pooled 
in each experiment and mRNA was isolated. The Ct values of FcγRI, II, and III 
in naive knee joints were subtracted from the Ct values for FcγRs at diﬀerent 
time points after injection. Ct values were corrected for GAPDH content for 
each individual sample. Data are the mean of 2 experiments.
Figure 1 
Joint inﬂammation in WT control and FcγRIII-/- arthritic knee joints deter-
mined as the amount of inﬂammatory cells in the synovium (A) and in the 
joint cavity (B) using an arbitrary scale from 0-3 (0, no; 1, minor; 2, mod-
erate; 3, maximal). The inﬂammatory cell mass was signiﬁcantly increased 
in FcγRIII-/- mice after injection with AdIFN-γ. Data are the mean ± SEM of 
6 mice and signiﬁcance was evaluated using the Mann-Whitney U test (*, 
P<0.05).
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knee joints [11]. Injection of AdIFN-γ in 
FcγRIII-/- knee joints followed by ICA 
induction led to an elevation of 100% of 
the inﬂammatory cell mass at day 3, to a 
level comparable with that found in WT 
controls. In contrast, joint inﬂammation 
in PBS or control AdeGFP virus injected 
FcγRIII-/- arthritic knee joints remained 
signiﬁcantly inhibited compared to WT 
controls (Figure 1). These results indi-
cate that IFN-γ bypasses inhibition of 
joint inﬂammation. 
 In addition, we determined wheth-
er the inﬂammatory cell mass was of 
similar composition. Macrophages, the 
dominant cell type involved in carti-
lage destruction within this arthritis 
model, were detected using an antibody 
directed against F4/80. The activation 
state of the inﬁltrating inﬂammatory 
cells was determined using MRP8 and 
14 as markers, which are associated with 
an activated phenotype of cells present 
in inﬂammatory sites. Using an arbi-
trary scale from 0-4, we found that the 
amount of macrophages in FcγRIII-/- ar-
thritic knee joints injected with PBS or 
AdeGFP was low both in joint cavity and 
synovium compared with the amount 
of macrophages found in arthritic knee 
joints of WT mice. However, in IFN-γ-
accelerated arthritis in FcγRIII-/- and 
WT control arthritic knee joints the 
percentage macrophages was similar 
(Figure 2A and B). Furthermore, it was 
Figure 2 
Macrophages in the synovial lining (A, in-
ﬁltrate) and in the joint cavity (B, exudate) 
and myeloid-related protein 8 (MRP8) in 
WT controls (C) and FcγRIII-/- mice (D), 3 
days after ICA induction. Macrophages 
were detected using an antibody against 
F4/80. Note that after injection of AdIFN-γ, 
the percentage of macrophages was com-
parable in WT controls and FcγRIII-/- mice, 
whereas injection of PBS or AdeGFP re-
sulted in signiﬁcantly less macrophages in 
FcγRIII-/- mice. Values represent the mean 
± SEM of 6 mice. Representative sections 
showing MRP8 localization which was 
comparable in arthritic knee joints of WT 
control (C) and FcγRIII-/- (D) mice. (Original 
magniﬁcation x 200.) * = P<0.05, Mann-
Whitney U test.
Figure 3 
KC and MIP-1α levels measured in patella washouts from arthritic knee joints 
of WT controls and FcγRIII-/- mice injected with AdeGFP or AdIFN-γ. Note that 
IFN-γ induced a signiﬁcant up-regulation of MIP-1α both in WT control and 
FcγRIII-/- mice. Values are expressed as mean ± SEM of 5 mice. * P<0.05, 
Mann-Whitney U-test. 
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found that the amount of MRP8 and 14 
positive cells both in synovium and joint 
cavity was comparable in FcγRIII-/- mice 
and their WT controls after injection of 
AdIFN-γ (Figure 2C and D). MRP14 ex-
pression on cells in the synovial lining and 
in the joint cavity was identical to MRP8 
expression (data not shown).
Complete restoration of chemok-
ine production in FcγRIII-/- mice 
during IFN-γ-driven IC-mediated 
arthritis
 In the presence of IFN-γ, the amount 
of inﬂammatory cells found in WT con-
trol and FcγRIII-/- arthritic knee joints 
was comparable. IFN-γ overexpression 
increased the inﬂux of macrophages. 
Macrophage and neutrophil chemokine 
production in the arthritic knee joints was 
additionally investigated. MIP-1α (which 
is chemotactic for macrophages) and KC 
(which is chemotactic for PMNs) protein 
levels were determined in synovial wash-
outs using the BioPlex method. Knee joints 
injected with AdIFN-γ showed a signiﬁ-
cant up-regulation of MIP-1α  (from 1,5 
to 4,5 pg/mg synovium), whereas levels 
of KC remained low (<1 pg/mg synovial 
tissue) which may explain the elevated 
macrophage inﬂux (Figure 3). No sig-
niﬁcant differences were found between 
FcγRIII-/- and WT control synovial wash-
outs (FcγRIII-/- and WT; 4.3 and 4.5 pg/
mg synovial tissue, respectively). 
Lack of involvement of FcγRIII 
in regulating chondrocyte death 
in IFN-γ-stimulated IC-mediated 
arthritis  
 As in the presence of IFN-γ, the 
amount and activation state of macro-
phages in early-phase ICA is similar in 
FcγRIII-/- mice and WT controls, we 
further investigated whether IFN-γ 
also bypasses FcγRIII in late-phase car-
tilage destruction. Chondrocyte death 
is a characteristic feature in late-phase 
IC-mediated arthritis and is one of the 
causes of irreversible cartilage destruc-
tion. Chondrocyte death was determined 
in knee joints by measuring empty lacu-
nae as a percentage of the total amount of 
chondrocytes in various cartilage layers. 
Injection of AdIFN-γ signiﬁcantly ele-
vated chondrocyte death (by up to 50%) 
in cartilage layers of WT controls and 
FcγRIII-/- mice (Figure 4).
Figure 4 
Chondrocyte death after injection of PBS, AdeGFP, or AdIFN-γ in WT controls 
and FcγRIII-/- mice (A), 3 days after arthritis onset. Note that chondrocyte 
death was signiﬁcantly enhanced by IFN-γ both in FcγRIII-/- mice and WT 
controls. Bars show the mean ± SEM of 6 mice. Representative sections dem-
onstrating chondrocyte death in cartilage layer of AdIFN-γ injected arthritic 
knee joints of WT controls (B) and FcγRIII-/- mice (C). (Original magniﬁcation x 
400.) * = P<0.05, Mann-Whitney U test.
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Enhancement of MMP-mediated 
cartilage destruction by IFN-γ in 
arthritic knee joints of FcγRIII-/- 
mice  
 In addition, we determined carti-
lage breakdown mediated by MMPs, 
which previously has been shown to 
be responsible for induction of severe 
irreversible breakdown of the carti-
lage matrix. MMP-mediated cartilage 
damage in arthritic knee joints was de-
termined using immunolocalization of 
neoepitopes in proteoglycans (VDIPEN 
expression) and was scored in various 
cartilage layers within the knee joint. 
 Local overexpression of IFN-γ re-
sulted in marked VDIPEN expression 
both in WT control and FcγRIII-/- knee 
joints  (45% and 35%, respectively, in 
the total cartilage surface)(Figure 5) 
compared with knee joints that had re-
ceived PBS and AdeGFP before onset of 
IC-mediated arthritis. 
Discussion
 In the present study, we demonstrated 
that the FcγRIII dependency of joint 
inﬂammation during ICA can be by-
passed by local overexpression of IFN-γ. 
Furthermore, we showed that both acti-
vating FcγRI and III are able to initiate 
MMP-mediated cartilage damage, and 
we thereby conﬁrmed the speciﬁc link-
age between activation of FcγRI and 
chondrocyte death.
 In a previous study using FcγRIII-/- 
mice, we found that the onset of ICA is 
highly FcγRIII-dependent, whereas ICA 
was not inhibited in FcγRI-/- mice [11]. 
Here we show that local IFN-γ expression 
in the knee joint can bypass this FcγRIII 
dependency. Synovial lining macrophages, 
which determine the onset of IC medi-
ated arthritis [24-26], express low levels of 
FcγRIII whereas FcγRI is not expressed. 
IFN-γ induces strong up-regulation of 
activating FcγRI on macrophages and to 
a lesser extent, FcγRIII [27]. In accord-
ance with this is our ﬁnding that local 
overexpression of IFN-γ in the knee joint 
signiﬁcantly enhanced FcγRI expression 
in the synovium. These results led us to 
speculate that when FcγRI is highly ex-
pressed as in IFN-γ-stimulated ICA, joint 
inﬂammation could be induced by this 
receptor. 
Figure 5 
MMP-mediated proteoglycan damage (VDIPEN expression) after injection of 
PBS, AdeGFP, or AdIFN-γ in WT controls and FcγRIII-/- mice (A) 3 days after 
arthritis onset. Note that IFN-γ signiﬁcantly elevated VDIPEN expression both 
in FcγRIII-/- and WT mice (A). Values represent the mean ± SEM of 6 mice. 
Representative sections demonstrating VDIPEN expression in AdIFN-γ in-
jected arthritic knee joints of WT controls (B) and FcγRIII-/- mice (C). (Orginal 
magniﬁcation x 400.) * = P<0.05, Mann-Whitney U Test. 
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 In the present study, the control virus 
also induced a slight increase in FcγRI 
expression. This is probably due to pro-
duction of low amounts of IFN-γ by mac-
rophages, as a response to the adenovirus 
[28]. This enhanced FcγRI expression 
can also account for the somewhat higher 
cell inﬂux found in arthritic knee joints 
injected with AdeGFP compared with the 
PBS injected group. 
 T cells or T cell-derived cytokines are 
also able to regulate FcγR expression on 
macrophages either directly [29] or indi-
rectly by producing cytokines like IFN-γ 
[30]. This can explain why during a T cell-
mediated arthritis like antigen-induced 
arthritis (AIA), joint inﬂammation has 
been shown to follow a FcγRI-dependent 
pathway [12], whereas FcγRIII depend-
ency is completely lost. In contrast, in 
non-T cell IC-mediated arthritis models, 
like the K/BxN model or our own passive 
IC model [11,31], joint inﬂammation was 
highly FcγRIII-dependent. 
 The increase in joint inﬂammation 
in FcγRIII-/- mice after onset of IFN-γ-
stimulated IC arthritis was not due to a 
direct effect of IFN-γ, since overexpres-
sion of IFN-γ in naive knee joints induced 
a negligible amount of joint inﬂammation 
[17]. 
 Since the percentage of macrophages 
is related to the severity of cartilage de-
struction [3,4], and no difference in in-
ﬂammatory mass was present between 
WT control and FcγRIII-/- mice when 
IFN-γ was overexpressed, comparison of 
cartilage damage between these groups 
was simpliﬁed. MMPs mediate severe 
cartilage destruction found in IC-medi-
ated arthritis. IL-1 induces chondrocytes 
to release latent MMPs that are stored in 
the cartilage matrix [32,33]. Moreover, 
synovial macrophages and ﬁbroblasts are 
also involved in the production of latent 
MMPs [34]. Activation of pro-MMPs 
leads to destruction of proteoglycans 
and collagen type II ﬁbers that form the 
cartilage matrix [13-15]. The factors in-
volved in activation proMMPs are still not 
identiﬁed. However, recent studies using 
FcγR-deﬁcient mice have shown that 
FcγRs are crucial in activation of latent 
MMPs [11,12]. 
 Using FcγRIII-/- mice, we now dem-
onstrated that FcγRI can mediate carti-
lage destruction by metalloproteinases. 
Up-regulation of FcγRI compensated ab-
sence of FcγRIII, resulting in comparable 
amounts of VDIPEN in cartilage layers of 
FcγRIII-/- mice and WT controls. Earlier, 
we found that IFN-γ overexpression in 
FcγRI-/- mice during ICA also enhanced 
VDIPEN expression [17]. Combining 
these results, it can be concluded that both 
FcγRI and FcγRIII have the potency to 
mediate MMP-mediated proteoglycan 
destruction.   
 Normally, the concentration of IFN-γ, 
which preferentially induces FcγRI ex-
pression and to a lesser extent FcγRIII, is 
low during experimental arthritis. How-
ever, during T cell dependent AIA, a shift 
of FcγRIII towards FcγRI was observed. 
FcγRI became the dominant recep-
tor involved in MMP-cartilage damage, 
whereas FcγRIII dependency was com-
pletely lost [12]. In the present study, we 
found that the presence of high amounts 
of IFN-γ within the knee joint not only 
results in a shift in expression levels from 
FcγRIII to FcγRI, but also induces a 
strong up-regulation of FcγRIII. This 
may explain why FcγRIII still plays a role 
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in MMP-mediated cartilage destruction 
under these conditions. 
 Apart from differences in the amount 
and/or balance of the two activating 
FcγRs expressed within the synovium, 
there may also be a difference in the 
potency of the two receptors to drive 
severe cartilage destruction. In contrast to 
FcγRIII, FcγRI is a high afﬁnity recep-
tor for IgG. Binding of IgG-ICs results 
in production of oxygen radicals, which 
have been shown to be potent regulators 
of gene-activation through redox-sign-
aling [35,36]. This may be reﬂected by 
chondrocyte death, another parameter for 
severe cartilage damage, which appeared 
to be signiﬁcantly aggravated during 
IFN-γ-stimulated arthritis. Previously, we 
found that in FcγRI-/- mice, chondrocyte 
death remained low even in the presence 
of IFN-γ [17], indicating that FcγRI is 
the crucial FcγR receptor mediating this 
process. The speciﬁc role for FcγRI in 
chondrocyte death was conﬁrmed in the 
present study, since IFN-γ overexpression 
in FcγRIII-/- mice resulted in high levels 
of chondrocyte death similar to those in 
controls. Since FcγRI is exclusively ex-
pressed on macrophages [37], this proves 
that macrophage activation is crucial in 
the induction of chondrocyte death. 
 Binding of IgG to FcγRI leads to 
intracellular signaling involving activa-
tion of phospholipase D-1 (PLD-1), and 
eventually leads to activation of the nico-
tinamide adenine dinucleotide phosphate 
(NADPH) oxidase [38]. IFN-γ itself or 
products of FcγRI signaling might further 
augment NADPH-oxidase function. El-
evation of the oxidative burst may lead to 
high concentrations of the relatively long-
lived hydrogen peroxide (H
2
O
2
) [39]. 
H
2
O
2
 is able to act on more distant targets 
and easily penetrates through cell mem-
branes and has been shown to kill cells by 
apoptosis [40]. In accordance with this, 
overproduction of the glycolytic enzyme 
glucose oxidase in the knee joint gener-
ated high levels of H
2
O
2
 and caused severe 
chondrocyte death [41].
 Increased expression of FcγRI by IFN-γ 
is also found in RA patients. A previous 
study by Quayle et al. [42] reported that 
neutrophils isolated from synovial ﬂuid 
of RA patients expressed higher levels of 
FcγRI, whereas no surface expression of 
FcγRI was detected on  blood neutrophils 
from either patients or from healthy con-
trols. This indicates that FcγRI expression 
is induced when inﬂammatory cells enter 
the diseased joint. Furthermore, it was 
found that stimulation of neutrophils from 
healthy controls with RA synovial ﬂuid 
induced FcγRI expression and this stimu-
lating effect could be abrogated by addi-
tion of anti-IFN-γ antibody [42]. This in-
crease in FcγRI expression by IFN-γ may 
affect the ability to respond to IgG-con-
taining ICs, which are abundantly present 
in synovial ﬂuid and synovium from RA 
patients [5,6]. The present study under-
lines that enhanced FcγRI expression 
by IFN-γ in arthritic knee joints indeed 
alters the arthritic response, resulting in 
increased severity of cartilage destruction 
in experimental IC-mediated arthritis.
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121 IL-13 reduces cartilage destruction in IC-arthritis
During immune complex-mediated arthritis (ICA) severe cartilage destruction 
is mediated by Fcγ receptors (FcγRs) (mainly FcγRI), cytokines (e.g.IL-1), and 
enzymes (matrix metalloproteinases (MMPs)). IL-13, a T helper 2 (Th2) cy-
tokine abundantly found in synovial ﬂuid of patients with rheumatoid arthritis, 
has been shown to reduce joint inﬂammation and bone destruction during ex-
perimental arthritis. However, the effect on severe cartilage destruction has not 
been studied in detail. We have now investigated the role of IL-13 in chondro-
cyte death and MMP-mediated cartilage damage during ICA. IL-13 was locally 
overexpressed in knee joints after injection of an adenovirus encoding IL-13 
(AxCAhIL-13), one day before arthritis onset; injection of AxCANI (an empty 
adenoviral construct) was used as a control. IL-13 signiﬁcantly increased the 
amount of inﬂammatory cells in the synovial lining and the joint cavity, by 30 
to 60% at day 3 after ICA onset. Despite the enhanced inﬂammatory response, 
chondrocyte death was diminished by two-thirds at days 3 and 7. The mRNA 
level of FcγRI, a receptor shown to be crucial in the induction of chondrocyte 
death, was signiﬁcantly downregulated in synovium. Furthermore, MMP-me-
diated cartilage damage, measured as neoepitope (VDIPEN) expression using 
immunolocalization, was halved. In contrast, mRNA levels of MMP-3, -9, -12 
and –13 were signiﬁcantly higher and IL-1 protein, which induces production 
of latent MMPs, was increased ﬁvefold by IL-13. This study demonstrates that 
IL-13 overexpression during ICA diminished both chondrocyte death and MMP-
mediated VDIPEN expression, even though joint inﬂammation was enhanced.
 One of the main pathological features 
of rheumatoid arthritis is marked destruc-
tion of cartilage [1]. This destruction starts 
with reversible proteoglycan depletion, 
which is followed by irreversible cartilage 
degradation deﬁned as chondrocyte death 
and breakdown of collagen type II even-
tually leading to matrix erosion. The latter 
is mainly induced by matrix metallopro-
teinases (MMPs), which generate speciﬁc 
cleavage sites within matrix molecules 
[2,3]. MMPs are secreted in an inactive 
form by IL-1-stimulated chondrocytes, 
synovial macrophages, and ﬁbroblasts [4-
6]. Activation of MMPs is still poorly un-
derstood, but MMP activity is primarily 
found in experimental immune complex 
(IC)-dependent arthritis models.
 Immunoglobulin G (IgG)-containing 
ICs can activate macrophages upon rec-
ognition by Fcγ receptors (FcγRs). Three 
classes of murine FcγRs can be distin-
guished: FcγRI, II, and III. Triggering 
FcγRI and III activates cellular responses, 
whereas FcγRII is an inhibitory recep-
tor [7]. Previous studies have showed 
that activating FcγRI and III are crucial 
in induction of severe cartilage destruc-
tion, since chondrocyte death and MMP-
mediated cartilage damage were absent 
in FcγR-deﬁcient mice after induction 
of immune complex-mediated arthritis 
(ICA) [8]. Furthermore, cartilage damage 
is aggravated by local overexpression of the 
proinﬂammatory T helper (Th)1 cytokine 
interferon (IFN)-γ [9]. This increase in 
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cartilage destruction was observed only in 
IC-dependent arthritis models [9]. FcγRI 
was found to be crucial in the induction of 
chondrocyte death, whereas both FcγRI 
and III mediated MMP-induced VDIPEN 
expression [9]. 
 Since the Th1 cytokine IFN-γ worsens 
the arthritic response by up-regulation of 
the activating FcγRs, overexpression of a 
Th2 cytokine during arthritis might be 
protective, because of down-regulation 
of these receptors. In earlier studies, we 
found that adenoviral overexpression of 
IL-4 resulted in reduced MMP-mediated 
cartilage damage and chondrocyte death 
during ICA and arthritis induced by col-
lagen type II [10,11]. IL-4 is regarded as 
a potent anti-inﬂammatory cytokine by 
direct inhibition of proinﬂammatory cy-
tokines such as IFN-γ, IL-1, and tumour 
necrosis factor α [12]. However, IL-4 
protein and mRNA are hardly detected 
in synovial ﬂuid and synovium of rheu-
matoid arthritis patients [13]. In contrast, 
IL-13 is expressed in rheumatoid arthritis 
synovial ﬂuid and synovial ﬂuid macro-
phages and resembles many functions of 
IL-4 [14,15]. Systemic overexpression 
of IL-13 in collagen type II-induced ar-
thritis and local overexpression of IL-13 
in rat adjuvant-induced arthritis reduced 
joint inﬂammation and bone destruction 
[16,17]. However, the effect of IL-13 on 
cartilage destruction was not investigated 
in detail in these studies and remains to be 
elucidated.
 In the present study we investigated 
whether IL-13 inﬂuences the develop-
ment of chondrocyte death and MMP-
mediated VDIPEN expression in ICA. 
Subsequently, regulation of FcγRs, MMP, 
and IL-1 expression by IL-13 was studied, 
as these are important mediators in severe 
cartilage damage. 
 The present study demonstrates that 
overexpression of IL-13 in arthritic knee 
joints, reduces chondrocyte death and 
MMP-mediated VDIPEN expression de-
spite enhanced joint inﬂammation. Injec-
tion of an adenovirus encoding for IL-13 
diminished chondrocyte death, which 
correlated with down-regulation of FcγRI 
expression in the synovium. Reduction of 
MMP-mediated VDIPEN expression was 
not reﬂected by MMP mRNA and IL-1 
concentrations, as these were increased.
Material and Methods
Animals
 C57Bl/6 male mice (10 to 12 weeks 
old) were purchased from Elevage-Janvier 
(Le Genest Saint Isle, France). Mice were 
fed a standard diet and tapwater ad libi-
tum. Ethical approval was obtained from 
the research ethics committee of the Cen-
tral Animal Facility in Nijmegen.
Local gene transfer of IL-13
 The recombinant adenovirus encoding 
human IL-13 (AxCAhIL-13) was gener-
ated as described before [17-19] and an 
empty adenoviral construct (AxCANI) 
was used as control virus. AxCAhIL-13 
or AxCANI (1.107 plaque-forming units) 
was injected intra-articularly in naive 
knee joints. Patellae with adjacent syn-
ovium were dissected in a standardized 
manner [20] and synovial biopsies were 
taken with a biopsy punch (diameter of 3 
mm). Total RNA was extracted in 1 ml 
TRIzol reagent and used for quantitative 
PCR as described below. AxCAhIL-13 
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or AxCANI was injected intra-articularly 
one day before the induction of arthritis.
Induction of immune complex-me-
diated arthritis
 Rabbit polyclonal antibodies directed 
against lysozyme were injected intrave-
nously into mice. ICA was then passively 
induced by injecting 3 µg lysozyme cou-
pled to poly-L-lysine in 6 µl pyrogen-free 
saline into the knee joints. 
Histology of arthritic knee joints
 Total knee joints were dissected at days 
3 and 7 after the onset of arthritis. Joints 
were decalciﬁed, dehydrated, and embed-
ded in parafﬁn. Tissue sections (7 µm) 
were stained with hematoxylin and eosin. 
Histopathological changes were scored 
in two ways. Inﬂammation was graded 
on a scale from 0 (no inﬂammation) to 
3 (severe inﬂamed joint) as inﬂux of in-
ﬂammatory cells in synovium and joint 
cavity. Chondrocyte death was scored as 
the amount of empty lacunae expressed as 
a percentage of the total number of cells 
within the cartilage layers. 
Immunohistochemical detection of 
macrophages and polymorphonu-
clear neutrophils (PMNs) 
 Macrophages were detected using a 
speciﬁc antibody against F4/80, a murine 
macrophage membrane antigen [21]. 
PMNs were visualized using NIMPR14, 
a speciﬁc rat anti-mouse monoclonal 
antibody [22]. Primary antibodies were 
detected using rabbit anti-rat IgG and 
avidin-horseradish-peroxidase conjugate. 
Finally, sections were counterstained with 
hematoxylin. Macrophage and PMN sub-
sets were quantitatively measured using 
an image analysis system. The inﬂamma-
tory cell mass was selected by hand and 
the amount of positive features present in 
this area was displayed using a computer 
imaging system. Three sections of each 
knee joint were measured and the mean 
was calculated. We report the amount 
of positive features per 100,000 µm2 in-
ﬂammatory cell mass in the synovium.
Immunohistochemical VDIPEN 
staining
 Sections were digested with protei-
nase-free chondroitinase ABC (0.25 
units/ml in 0.1 M Tris HCl, pH 8.0 
(Sigma, Zwijndrecht, The Netherlands)) 
to remove the side chains of proteogly-
cans followed by incubation with afﬁn-
ity-puriﬁed rabbit anti-VDIPEN IgG 
[23]. The primary antibody was de-
tected using biotinylated goat anti-rabbit 
IgG, and avidin-streptravidin-peroxi-
dase (Elite kit, Vector, Burlingame, 
CA, USA). Counterstaining was done 
with orange G (2%). Areas of immunos-
taining were expressed as a percentage of 
the total cartilage surface. 
Quantitative detection of FcγR 
and MMP mRNA using RT-PCR
 Speciﬁc mRNA-levels for FcγRI, II, 
and III and MMP-3, -9, -12, -13, and 
-14 were detected using the ABI/PRISM 
7000 Sequence Detection System (ABI/
PE, Foster City, CA). Brieﬂy, 1 µg of 
synovial RNA was used for RT-PCR. 
mRNA was reverse transcribed to cDNA 
using oligodT primers. cDNA (1/100) 
was used in one PCR ampliﬁcation. 
PCR was performed in SYBR Green 
Master Mix using the following ampli-
ﬁcation protocol: 2 minutes at 50°C fol-
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lowed by 40 cycles of 15 seconds at 95°C 
and 1 minute at 60°C with data collec-
tion in the last 30 seconds. Message for 
murine FcγRI, II, and III and MMP-3, 
-9, -12, -13, and –14 was ampliﬁed using 
the primers listed in Table 1 (Biolegio, 
Malden, The Netherlands) at a ﬁnal con-
centration of 300 nM. Relative quantiﬁ-
cation of the PCR signals was performed 
by comparing the cycle threshold value 
(Ct) of the FcγR and MMP genes in 
the different samples after correction of 
the GAPDH content for each individual 
sample.
Determination of cytokine and 
chemokine concentrations
 To determine concentrations of IL-13, 
IL-1β, KC (a mouse homologue for human 
IL-8), and macrophage inﬂammatory pro-
tein 1α in patella washouts, synovial spec-
imens were isolated in a standard manner 
[20] and incubated in 200 µl RPMI 1640 
medium (GIBCO BRL, Breda, The 
Netherlands) for 1 hour at room tempera-
ture. Cytokine and chemokine concentra-
tions were determined using the BioPlex 
system from BioRad (Hercules, CA, USA) 
for the Luminex multi-analyte system and 
expressed as pg/ml.
Statistical analysis
 Differences between experimental 
groups were tested for signiﬁcance using 
the Mann-Whitney U test. P values less 
than 0.05 were considered statistically sig-
niﬁcant.
Results
Local IL-13 expression in naive 
knee joints using adenoviral gene 
transfer
 The expression of IL-13 was deter-
mined in synovial washouts at days 1, 2, 3, 
and 7 after injection of the AxCAhIL-13 
virus. IL-13 reached a concentration of 
0.4 ng/ml after 24 hours. Values increased 
to 2 ng/ml at day 2 and remained high 
up to 7 days after injection (Figure 1A). 
IL-13 was not detected after injection of 
AxCANI.
 We next investigated whether injection 
of the adenoviral IL-13 construct causes 
joint inﬂammation by itself. Using his-
tology, we found that IL-13 overexpres-
Table 1. Primers for detection of murine FcγR and MMP  
   mRNA.
      
  Primer Sequence (5’ - 3’) 
   
GAPDH 
Up GGCAAATTCAACGGCACA 
Low GTTAGTGGGGTCTCGCTCCTG
FcγRI  
Up ACACAATGGTTTATCAACGGAACA 
Low TGGCCTCTGGGATGCTATAACT
FcγRII  
Up GACAGCCGTGCTAAATCTTGCT
Low GTGTCACCGTGTCTTCCTTGAG
FcγRIII  
Up GACAGGCAGAGTGCAGCTCTT
Low TGTCTTCCTTGAGCACCTGGAT
MMP-3  
Up TGGAGCTGATGCATAAGCCC
Low TGAAGCCACCAACATCAGGA
MMP-9  
Up GGAACTCACACGACATCTTCCA
Low GAAACTCACACGCCAGAAGAATTT
MMP-12 
Up GGACATGAAGCGTGAGGATGT
Low GAAGTCTCCGTGAGCTCCAAAT
MMP-13 
Up ACCTTGTGTTTGCAGAGCACTAACTT
Low CTTCAGGATTCCCGCAAGAGT
MMP-14 
Up AAGGCTGATTTGGCAACCAT
Low GTCCCAAACTTATCCGGAACAC 
Primer sequences used for RT-PCR on synovium. 
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sion in naive knee joints did not recruit 
inﬂammatory cells at days 1, 2, 3, and 7 
(Figure 1C). Injection of AxCANI re-
sulted in minor cell inﬂux in the synovial 
lining and joint cavity (Figure 1B), which 
was not detectable from day 2 onwards.  
IL-13 overexpression during ICA 
enhances joint inﬂammation and 
alters the composition of the cell 
mass  
 To investigate whether IL-13 overex-
pression ameliorated the arthritic response, 
we injected AxCAhIL-13 one day before 
ICA induction. Joint inﬂammation was 
studied 3 and 7 days after arthritis onset.
 IL-13 overexpression signiﬁcantly in-
creased the inﬂammatory cell mass in 
joint cavity and synovium, by 60% and 
30%, respectively, 3 days after arthritis 
induction (Figure 2A). After 7 days, 
joint inﬂammation seemed to normal-
ize in the IL-13 group (Figure 2B). 
 To further investigate inﬂammatory 
cell types attracted by IL-13, PMNs and 
macrophages were detected using spe-
ciﬁc NIMPR14 and F4/80 antibodies 
respectively using immunolocalization. 
At day 3, the amount of PMNs and mac-
rophages was not markedly altered by 
IL-13 (Figure 3A and B). At day 7, how-
ever, the amount of PMNs in the syno-
vial lining was 10 times higher (Figure 
3A), whereas the amount of macrophag-
es in the IL-13 group was half that in 
Figure 1  
Adenoviral vector-mediated IL-13 expression in knee joints of C57Bl/6 mice. 
(A) Naive knee joints and (B) total knee joint sections 24 hours after injection 
of AxCANI (adenovirus encoding nog gene) or (C) AxCAhIL-13 (adenovirus 
encoding IL-13). Injection of AxCAhIL-13 resulted in 0.4 ng/ml IL-13 at day 1, 
which increased to 5.5 ng/ml by day 7 (A). Injection of AxCANI resulted in a 
mild thickening of the synovial lining (S), and some invading inﬂammatory 
cells in the joint cavity (JC) (B), whereas no inﬂammation was observed after 
AxCAhIL-13 injection (C). Plotted values are means ± SEM of data from 5 mice. 
* P < 0.05. Original magniﬁcation 200X. F, femur ; P, patella.
Figure 2 
Joint inﬂammation in arthritic knee joints of C57Bl/6 mice injected with 
AxCANI (adenovirus encoding no gene) or AxCAhIL-13 (adenovirus encoding 
IL-13). At (A) day 3 and (B) day 7 after the onset of immune complex-mediated 
arthritis. The inﬂammatory cell mass was signiﬁcantly enhanced by IL-13, in 
both the joint cavity and the synovium 3 days after arthritis induction. Bars 
show the means ± SEM for 10 mice. Signiﬁcance was evaluated using the 
Mann-Whitney U test. *, P<0.05.
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the mice without IL-13 (Figure 3B).
KC concentration in synovial 
washouts is augmented by IL-13
 A possible mechanism by which IL-13 
can increase joint inﬂammation in the 
presence of ICs is elevation of chemokine 
production. To investigate this, synovial 
washouts were done on days 3 and 7, and 
the chemokines KC (chemotactic for neu-
trophils) and macrophage inﬂammatory 
protein 1α (chemotactic for macrophages) 
were measured. Local IL-13 overexpres-
sion increased KC concentrations 4- and 
18-fold, respectively, at days 3 and 7 after 
arthritis induction, which correlates with 
the high amount of PMNs (Table 2). 
Macrophage inﬂammatory protein 1α 
concentrations at day 3 were comparable 
between the control and IL-13 groups. At 
day 7, macrophage inﬂammatory protein 
1α expression was slightly increased by 
IL-13 (Table 2). 
IL-13 strongly inhibits chondrocyte 
death during ICA: down-regulation 
of FcγRI
 Because IL-13 enhanced the inﬂam-
matory response, we next investigated 
the effect of IL-13 overexpression on 
cartilage destruction. A characteristic 
feature of irreversible cartilage damage is 
chondrocyte death; this was scored as the 
percentage of empty lacunae relative to 
the total amount of chondrocytes present 
in various cartilage layers in the knee 
joint.  
 Three days after ICA induction, 
chondrocyte death, expressed as the mean 
for 6 cartilage layers in the knee joint, 
was very low in the IL-13 group (5%) 
and signiﬁcantly less than in the control 
Figure 3 
Immunohistochemical detection of inﬂammatory cells in knee joints of mice 
with immune complex-mediated arthritis (ICA). (A) Polymorphonuclear 
neutrophils (PMNs) and (B) macrophages in synovium 3 and 7 days after in-
jection of AxCANI or AxCAhIL-13. PMNs were detected using the speciﬁc rat 
anti-mouse monoclonal antibody NIMPR14, and macrophages were detected 
using an antibody against the membrane marker F4/80. At day 7, the amount 
of NIMPR14-positive features was signiﬁcantly higher in the synovium of Ax-
CAhIL-13 injected arthritic knee joints, while the amount of F4/80 positive 
features was signiﬁcantly lower. The bars represent means ± SEM for 10 mice. 
Data were evaluated using the Mann-Whitney U test. *, P<0.05.
Table 2 Eﬀect of IL-13 on chemokine concentrations 
    (pg/ml) in arthritic knee joints in mice
   
  KC     MIP-1α 
ICA day 3 
 AxCANI      56 ±8    303 ±6.8
 AxCAhIL-13 196 ±31*       344 ±96
ICA day 7 
 AxCANI      10 ±6    157 ±25
 AxCAhIL-13 184 ±26*       268 ±98
Concentrations of KC and MIP-1α were detected in synovial washouts of ar-
thritic knee joints 3 and 7 days after arthritis induction. KC concentrations 
were signiﬁcantly higher in arthritic knee joints injected with AxCAhIL-13 
both at day 3 and 7. *, P<0.05 in comparison with AxCANI. 
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arthritic knee joints, which showed 25% 
chondrocyte death (Figure 4A). At day 
7, chondrocyte death was even more 
signiﬁcantly reduced (65%) in compari-
son with the control group (Figure 4A). 
 In a previous study, we found that 
FcγRI is the dominant receptor medi-
ating chondrocyte death during ICA 
[9]. We speculated that the decreased 
chondrocyte death might be caused by 
down-regulation of FcγRI by IL-13. For 
that reason, we determined the effect 
of IL-13 on mRNA levels of all three 
classes of FcγRs in synovium. Cycle 
values of FcγRI, II, and III in synovium 
of arthritic knee joints injected with 
AxCANI were subtracted from cycle 
values of FcγRs after AxCAhIL-13 in-
jection. Interestingly, FcγRI mRNA 
level was decreased by IL-13 at day 3 
after ICA induction (∆Ct = 2), and was 
still slightly down-regulated at day 7 
(∆Ct = 0,5). In contrast, FcγRII and 
FcγRIII were up-regulated by IL-13, at 
both days 3 and 7 after ICA induction 
(Figure 4B).
IL-13 increases IL-1 production 
and MMP mRNA levels in the 
arthritic knee joint
 Cartilage matrix degradation is 
largely mediated by MMPs. Production 
of latent MMPs is mainly regulated by 
IL-1 and this cytokine has been shown 
to be crucial in the generation of MMP-
mediated neoepitopes [23]. The produc-
tion of IL-1 was determined in synovial 
washouts of arthritic knee joints at both 
days 3 and 7. At day 3, IL-1 concentra-
tion was between 450 and 500 pg/ml 
in both the control and the IL-13 group. 
However, at day 7, the IL-1 level was 
reduced in the control group but re-
mained high in the IL-13 group (con-
trol; 54 pg/ml vs IL-13; 255 pg/ml). 
 This sustained IL-1 production at 
day 7 may result in high concentrations 
of MMPs in synovium. Levels of MMP-
3, -9, -12, -13, and -14 mRNA were de-
tected by quantitative PCR. MMP-12 
mRNA levels were increased 10-fold 
and 8-fold by IL-13 at days 3 and 7, re-
spectively, after the onset of ICA. At day 
7, mRNA levels of MMP-3, -9, and -13 
were also signiﬁcantly increased in the 
IL-13 group (Table 3).
Figure 4 
Chondrocyte death in the knee joints of mice with immune complex-medi-
ated arthritis (ICA). (A) At day 3 and 7 in arthritic knee joints injected with 
AxCANI or AxCAhIL-13 and (B) expression proﬁles of Fcγ receptor I (FcγRI), 
II, and III mRNA levels induced by IL-13 in synovium. IL-13 signiﬁcantly de-
creased chondrocyte death, both at day 3 and at day 7 (A). Cycle threshold 
(Ct) values of FcγRI, II, and III in arthritic knee joints injected with AxCANI 
were subtracted from the Ct values for FcγRs after injection  of AxCAhIL-13. 
Ct values were corrected for GAPDH content for each individual sample. (B) 
FcγRI mRNA level was down-regulated by IL-13, whereas an up-regulation 
was observed for both FcγRII and III (B). Bars represent means ± SEM for 10 
mice. Mann-Whitney U test. * P<0.05. 
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MMP-mediated VDIPEN expression 
is reduced by IL-13 overexpression
 Increased IL-1 and MMP concentra-
tions may induce enhanced MMP-medi-
ated proteoglycan degradation and this 
was further investigated by detection of 
VDIPEN neoepitope expression in the 
cartilage. In the control group, 35% of 
the cartilage surface expressed VDIPEN 
neoepitopes after 3 days (Figure 5). Injec-
tion with AxCAhIL13 reduced VDIPEN 
expression by 43%, as only 20% VDIPEN 
expression was found in the IL-13 group. 
The inhibitory effect of IL-13 was still 
present at day 7 after arthritis induction, as 
only 10% VDIPEN expression was found 
in the IL-13 group compared to 25% in 
the control group (Figure 5). 
Discussion
 In the present study, we have shown 
that local gene transfer of IL-13 reduced 
severe cartilage destruction deﬁned as 
chondrocyte death and MMP-mediated 
aggrecan damage during ICA. 
 Local IL-13 overexpression during 
IC-dependent arthritis enhanced joint 
inﬂammation. To exclude the possibil-
ity that IL-13 itself induces inﬂux of in-
ﬂammatory cells, as is found when IL-13 
is overexpressed in the lung [24,25], 
AxCAhIL-13 was injected in naive knee 
joints. We observed that IL-13 overex-
pression in the knee joint did not recruit 
inﬂammatory cells. This observation 
indicates that overexpression of IL-13 
induces elevated joint inﬂammation in 
combination with IC triggering. In our 
IC-dependent arthritis model, we showed 
that joint inﬂammation is determined by 
Table 3 Eﬀect of IL-13 on MMP mRNA levels in synovium of mice with ICA
  
   ICA day 3    ICA day 7 
               AxCANI           AxCAhIL-13            AxCANI            AxCAhIL-13 
MMP-3  5.7±0.3  7.1±0.8  4.2±0.5  6.1±0.2*
MMP-9  5.1±0.2  4.8±0.3  0.2±0.6  3.9±0.5*
MMP-12  0.6±0.4  5.8±1.1*  0.9±1  8.1±0.9*
MMP-13  3.2±0.2  2.7±0.3  4.3±0.3  6.4±0.3 *
MMP-14  3.7±0.4  4.9±0.8  3.7±1  3.7±0.6
     
Expression proﬁle of MMP-3, -9, -12, -13, and –14 mRNA levels after injection of AxCANI or AxCAhIL-13 in synovial biopsies isolated at day 3 and day 7 after 
arthritis onset. The Ct values for MMP genes in naive knee joints were subtracted from the Ct values for MMPs at day 3 and 7 after arthritis onset. Ct values were 
corrected for GAPDH content for each individual sample.  Note that MMP-3, -9, -12, and –13 mRNA levels were signiﬁcantly increased at day 7 by IL-13, and the 
MMP-12 mRNA level was already elevated at day 3. Values represent the means ± SEM for 5 mice. * P<0.05, Mann-Whitney U-test. 
Figure 5 
Matrix metalloproteinase-mediated aggrecan damage in knee joints of mice 
with immune complex-mediated arthritis. VDIPEN expression at day 3 and 7 
after ICA induction in knee joints injected with AxCANI or AxCAhIL-13. Note 
that VDIPEN expression was reduced by IL-13 both at day 3 and day 7. Values 
represent the mean ± SEM for 10 mice. * P<0.05, Mann-Whitney U test.  
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activating FcγRIII [26]. In the present 
study, we ﬁnd that IL-13 increased ex-
pression of FcγRIII within the synovium, 
which is not in line with the study show-
ing that IL-13 decreases FcγRIII expres-
sion on human monocytes [27]. However, 
regulation of FcγR expression on mouse 
macrophages by IL-13 has not been de-
scribed. IL-13 has high similarity with 
IL-4, which can increase FcγRIII expres-
sion on murine mast cells [28]. Binding of 
IC to FcγRIII on macrophage lining cells 
leads to activation, resulting in elevated 
inﬂux of inﬂammatory cells. 
 We further found that overexpression 
of IL-13 in arthritic knee joints particu-
larly increased the amount of PMNs. This 
is in line with earlier studies in which it 
was shown that stimulation of FcγRIII 
induces release of PMN attracting chem-
okines as IL-8, resulting in neutrophil 
accumulation [29-31]. The proinﬂamma-
tory action of IL-13 found in the present 
study seems to be dependent on costimu-
lation with ICs to trigger arthritis onset, 
since local overexpression of IL-13 during 
T cell-mediated rat adjuvant-induced ar-
thritis diminishes joint inﬂammation [17]. 
In the latter model, ICs do not play a role. 
 Whether IL-13 decreases or enhances 
joint inﬂammation may also be depend-
ent on systemic or local overexpression. 
Systemic overexpression of IL-13 during 
collagen type II-induced arthritis, in 
which FcγRIII is also required for ar-
thritis development [32], decreased joint 
inﬂammation [16]. An explanation may 
be that systemic overexpression of IL-13 
hampers the development of the immune 
response by induction of isotype switch-
ing to the nonarthritogenic IgG4 and 
IgE [33,34], thereby ameliorating the ar-
thritic response. Induction of immunity 
is hardly affected by local overexpression, 
as was shown when injection of AdIL-4 
(adenovirus encoding IL-4) in knee joints 
during arthritis induced by collagen type 
II markedly increased the amount of in-
ﬂammatory cells [11].  
 Cartilage destruction during ICA is 
mostly related to joint inﬂammation. De-
spite the enhanced inﬂux of inﬂammatory 
cells, however, a signiﬁcant reduction of 
chondrocyte death was induced by IL-13. 
Chondrocyte death may be the result of 
increased production of oxygen radicals, as 
reactive oxygen species can mediate apop-
tosis [35]. In a previous study, we showed 
that there is a prominent role for FcγRI 
mediating chondrocyte death during 
ICA. In FcγRI-deﬁcient mice, chondro-
cyte death was almost absent. When the 
Th1 cytokine IFN-γ was overexpressed, 
a signiﬁcant increase in chondrocyte 
death was observed, which was depend-
ent on FcγRI [9]. Stimulation of FcγRI 
leads to production of oxygen radicals 
via NADPH-oxidase [36]. In the present 
study, we ﬁnd that in knee joints injected 
with AxCAhIL-13, FcγRI expression 
remained low, whereas in knee joints in-
jected with control virus, FcγRI expres-
sion level was enhanced in the synovium. 
The decrease in chondrocyte death might 
be due to a reduced FcγRI concentra-
tion. Moreover, it has been shown that 
IL-13 itself down-regulates production 
of oxygen radicals by inﬂammatory cells, 
since IL-13 can inhibit protein kinase C-
triggered respiratory burst in monocytes 
[37]. The inhibiting effect of IL-13 on 
oxygen radical production seemed to be 
monocyte-dependent, as no reduction 
was found in PMNs [38]. 
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 In addition, IL-13 also reduced MMP-
mediated VDIPEN neoepitope expres-
sion. It has been reported that IL-13 
diminishes the breakdown of collagen 
and proteoglycans from bovine carti-
lage, by regulation of MMP expression 
[39]. Several mechanisms may inhibit 
MMP-mediated cartilage destruction, 
as regulation of MMPs occurs at three 
different levels: MMP synthesis, activa-
tion of latent enzyme, and MMP-inhibi-
tion. IL-1 is a prominent cytokine con-
trolling the production of latent MMPs 
[40] and diminished production of IL-1 
might reduce MMP-mediated cartilage 
damage. We found, however, that IL-13 
overexpression in arthritic knee joints 
strongly increased IL-1β concentrations. 
IL-13 is described as an anti-inﬂamma-
tory cytokine, which in general reduces 
IL-1β production [14,27,41]. However, 
the effect of IL-13 on IL-1 production 
by IC-stimulated macrophages has not 
been described to date. In addition to 
macrophages, ﬁbroblasts and PMNs are 
also present in the knee joint at day 7 
after the onset of arthritis.
 The sustained production of IL-1 by 
IL-13 may indeed stimulate MMP pro-
duction, as reﬂected by enhanced MMP-
3, -9, -12, and -13 mRNA levels 7 days 
after ICA induction in AxCAhIL-13-
injected arthritic knee joints. MMP-12 
mRNA level was already increased at 
day 3 after the onset of arthritis. It has 
been shown that MMP-12 expression is 
IL-13 dependent and that MMP-12 is a 
critical downstream mediator and regu-
lator of IL-13-induced responses [42,43]. 
Furthermore, IL-13 induction of MMP-
2, -9, and -13 is at least partly mediated 
by MMP-12 [43], indicating that MMP-
12 might be a crucial enzyme inducing 
MMP-mediated cartilage damage. 
 Furthermore, IL-13 might inter-
fere at the level of activation of MMPs. 
MMPs are secreted in a latent form and 
activation occurs after cleavage of a 
propeptide. Factors that activate latent 
MMPs are still unknown. However, 
MMP-mediated VDIPEN expression is 
mainly found in IC-dependent arthritis 
models, in which FcγRs are of utmost 
importance. Down-regulation of the ac-
tivating FcγRs might reduce VDIPEN 
expression. Indeed, we found that IL-13 
strongly diminished FcγRI expression in 
synovium. Another mechanism involved 
in activation of MMPs, is production of 
oxygen radicals. As mentioned above, 
stimulation of FcγRI results in assem-
bly of the NADPH-oxidase complex, 
which produces oxygen radicals [36]. 
Additionally, oxygen metabolites can 
be converted into H
2
O
2
, which can ac-
tivate latent pro-MMPs [44,45]. Taken 
together, decreased FcγRI expression 
reduces the production of oxygen radi-
cals, which apart from chondrocyte pro-
tection may also result in diminished 
MMP-mediated VDIPEN expression.
 The present study shows that IL-13 
is a potent cytokine that protects the 
cartilage matrix against degradation 
during ICA. In addition, these results 
indicate that regulation of the expres-
sion of FcγR, particularly FcγRI, might 
be involved in this process. Therefore, 
modulation of FcγRI by Th2 cytokines 
seems to be a promising therapeutic tool 
diminishing cartilage damage in rheu-
matoid arthritis. 
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137 Oxygen radicals mediate cartilage damage in ICA
In previous studies we found that FcγRI determines chondrocyte death and matrix 
metalloproteinase (MMP)-mediated cartilage destruction during IFN-γ-regu-
lated immune complex-mediated arthritis (ICA). Binding of immune complexes 
(IC) to FcγRI leads to prominent oxygen radical production. In the present study, 
we now investigated the contribution of NADPH-oxidase driven oxygen radical 
production to cartilage destruction using P47phox-/- mice lacking a functional 
NADPH-oxidase complex. Induction of a passive IC-mediated arthritis in knee 
joints of P47phox-/- resulted in signiﬁcant elevation of joint inﬂammation at day 
3 when compared with wild-type (WT) controls as studied by histology. How-
ever, when IFN-γ was overexpressed by injection of adenoviral-IFN-γ in the 
knee joint before ICA induction, the inﬂammatory cell mass was comparable at 
both days 3 and 7, which comprised mainly macrophages in both mouse strains. 
Proteoglycan depletion in the cartilage layers of the knee joints was similar at 
days 3 and 7 in both groups. Aggrecan breakdown in cartilage caused by MMPs 
was further studied by immunolocalisation of MMP-mediated neoepitopes 
(VDIPEN). VDIPEN expression was  signiﬁcantly lower (between 30-60%) in 
IFN-γ stimulated  P47phox-/- at day 7. This despite the strong up-regulation of 
mRNA levels of  various MMPs such as MMP-3, -9, -12, and -13 in synovia 
of P47phox-/-, as measured with quantitative RT-PCR . The latter suggests that 
oxygen radicals are involved in activation of latent MMPs.  Chondrocyte death, 
determined as percentage of empty lacunae in articular cartilage, varied between 
20-60% at day 3 and 30-80% at day 7 in WT mice, but was completely blocked 
in P47phox-/- at both time-points. FcγRI mRNA expression was signiﬁcantly 
lower, whereas FcγRII and FcγRIII were higher in P47phox-/- when compared 
with controls. NADPH-oxidase driven oxygen radical production determines 
chondrocyte death and aggravates MMP-mediated cartilage destruction during 
IFN-γ-stimulated IC-mediated arthritis. Up-regulation  of FcγRI by oxygen 
radicals may contribute to cartilage destruction.  
 During rheumatoid arthritis (RA), 
large amounts of inﬂammatory cells, 
mainly macrophages, migrate into 
the synovial layer [1]. Many of these 
macrophages become activated by as 
yet unknown mechanisms. Activated 
macrophages produce cytokines such 
as TNF-α and IL-1 and enzymes like 
matrix metalloproteinases (MMPs), 
which can mediate severe cartilage de-
struction. A strong correlation was found 
between the number of activated macro-
phages and cartilage erosion [2]. Impor-
tant triggers of macrophage activation 
are IgG-containing immune complexes 
(ICs) which are found in large amounts 
in joints of many RA patients [3]. In pre-
vious studies, we have found that severe 
cartilage destruction mainly developed 
when ICs were present [4]. Severe car-
tilage destruction is thereby deﬁned as 
chondrocyte death and cartilage matrix 
destruction. The latter is induced pre-
dominantly by MMPs, which are re-
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leased in a latent form. Upon activation 
these enzymes degrade the collagen type 
II network in the cartilage, resulting in 
irreversible erosion [5]. During IC-me-
diated arthritides, synovial macrophages 
appeared to be dominant players in the 
induction of severe cartilage destruction 
[6]. 
 IgG-containing ICs communicate 
with macrophages using Fcγ receptors 
(FcγR). Three classes have been described 
in the mouse and previous studies in our 
lab showed that absence of the activating 
FcγRI and III completely abrogated severe 
cartilage destruction [7-9]. 
 The mechanism by which FcγR medi-
ate chondrocyte death and MMP-medi-
ated cartilage destruction is not known. 
However, recently we have found that 
FcγRI is the dominant activating FcγR 
causing cartilage destruction [10-11]. 
In T cell-driven IC-mediated arthritis, 
chondrocyte death in FcγRI-/- was com-
pletely abrogated, whereas MMP-mediat-
ed cartilage destruction was signiﬁcantly 
diminished [12]. Moreover, IC-mediated 
arthritis stimulated by local overexpres-
sion of the T cell factor IFN-γ showed 
pronounced chondrocyte death, which 
was also completely mediated by FcγRI 
[13]. 
 Binding of IC to FcγRI causes intra-
cellular signaling and triggers activation 
of the multicomponent enzyme nicoti-
namide adenine dinucleotide phosphate 
(NADPH)-oxidase, which catalyzes the 
production of oxygen species [14]. The 
latter have been shown to be involved 
in cell death [15-16] and activation of 
MMPs [17]. The transmembrane cyto-
chrome b558 plays a active central role 
in the NADPH-oxidase complex and it 
is comprised of two subunits: gp91phox 
and p22phox. P47phox is the cytosolic 
component of the NADPH-oxidase com-
plex that translocates to the membrane 
and associates with cytochrome b556 to 
form the active complex that catalyzes 
the reduction of oxygen to superoxide. 
Functionally p47phox increases the bind-
ing of P67phox to cytochrome b556 by 
approximately 100 fold [18-20]. IFN-γ 
strongly stimulates p91 but also expres-
sion of FcγRI. Binding of ICs to FcγRI 
further increases NADPH-oxidase activ-
ity [21]. Phospholipase D-1 (PLD-1) has 
been shown to be an important mediator 
between FcγRI signaling and activation 
of NADPH-oxidase [14,22]. The com-
bination of IFN-γ and FcγRI stimulation 
may therefore result in a strong stimula-
tion of NADPH-oxidase catalyzing large 
amounts of superoxide production.
 In the present study, we investigated 
the effect of NADPH-oxidase driven 
oxygen radicals in the generation of 
severe cartilage destruction during 
IFN-γ-accelerated IC-mediated arthritis. 
For that purpose p47phox gene-deﬁcient 
mice were used which are unable to form 
a functional NADPH-oxidase complex 
[23] and therefore are unable to produce 
oxygen species by the NADPH-oxidase 
pathway. Other oxygen radical produc-
ing pathways however, remain intact. We 
ﬁnd that chondrocyte death was com-
pletely abrogated, whereas MMP-medi-
ated cartilage destruction was signiﬁ-
cantly inhibited. FcγRI expression was 
signiﬁcantly downregulated, whereas 
on the contrary, MMP gene expression 
in the synovium was higher suggesting 
that oxygen radicals are involved in the 
activation step of MMPs. 
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Material and Methods
Animals
 Mice deﬁcient for the NADPH-oxi-
dase complex (p47phox-/-) generated as 
described previously [23], lack the cy-
tosolic p47phox subunit of the NADPH-
oxidase multicomponent system. The 
knock-out (KO) mice were backcrossed 
to the C57BL6 background for 15 gen-
erations and C57BL/6 ( Jackson Labo-
ratory, Bar Harbour,ME) were used 
as wild-type (WT) controls. In some 
experiments p47phox-/- mice of inter-
cross progeny (C57BL/6 X 129Sv) were 
used with their proper controls. Colo-
nies were maintained at the National 
Institutes of Health (Bethesda,MD). 
All mice were housed under speciﬁed 
pathogen-free conditions during breed-
ing and experiments. Mice received 
autoclaved chow and acidiﬁed water ad 
libitum. Only mice that were healthy 
were used in the experiments and were 
age-matched (10 to 20 weeks) and sex 
matched for each set of experiments. All 
experiments were approved by local au-
thorities of Animal Care and Use Com-
mittee.
In vivo overexpression of IFN-γ 
using an adenoviral construct
 The recombinant adenovirus encod-
ing murine IFN-γ (AdIFN-γ) was gen-
erated as described before [24]. Knee 
joints of naive mice were intra-articular-
ly injected with 6 µl of AdIFN-γ (1.107 
pfu). At different time points (day 3 
and 7), patellae with adjacent synovium 
were dissected in a standardized manner 
[25] and synovium biopsies were taken 
using a biopsy punch with a diameter of 
3 mm. Total RNA was extracted in 1 ml 
TRIzol reagent and used for quantita-
tive PCR as described below. AdIFN-γ 
was intra-articularly injected one day 
before arthritis induction. 
Induction of immune complex- 
mediated arthritis
 Immune complex-mediated arthritis 
(ICA) was passively induced by injecting 
3 µg poly-L-lysine coupled lysozyme in 
the knee joints of mice that had previ-
ously (16 hours earlier) received, intra-
venously, polyclonal antibodies directed 
against lysozyme. These antibodies were 
raised in rabbits. 
Histology of arthritic knee joints
 Total knee joints of mice were isolat-
ed 3 and 7 days after arthritis onset. Knee 
joints were decalciﬁed, dehydrated, and 
embedded in parafﬁn. Tissue sections (7 
µm) were stained with hematoxylin and 
eosin. Histopathological changes were 
scored using the following parameters. 
Inﬂammation was graded on a scale 
from 0 (no inﬂammation) to 3 (severe 
inﬂamed joint) as inﬂux of inﬂamma-
tory cells in synovium and joint cavity. 
 To study proteoglycan depletion 
from cartilage matrix, sections were 
stained with safranin O followed by 
counterstaining with fast green. Prote-
oglycan depletion (loss of red staining) 
from various cartilage layers was deter-
mined using an arbitrary scale from 0-3. 
Normal cartilage was taken as 0 value, 
whereas cartilage fully depleted of pro-
teoglycans was taken as maximal 3 value. 
Chondrocyte death was determined in 
total knee joint sections stained with 
hematoxylin and eosin and expressed as 
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percentage of the area of the cartilage 
containing empty lacunae in relation 
to the total area. All experiments were 
scored separately and independently 
from each other. 
Immunohistochemical detection 
of the identiﬁcation marker of 
macrophages  
 F4/80, a murine macrophage mem-
brane antigen, was detected using a 
speciﬁc rat anti-mouse F4/80 antibody. 
Primary antibodies were detected using 
rabbit anti-rat IgG and avidin-horserad-
ish peroxidase conjugate. Finally, sec-
tions were counterstained with Mayer’s 
hematoxylin (Merck, Germany). 
Immunolocalization of MMP-  
induced neoepitope (VDIPEN)
 For immunohistochemical analysis 
of MMP-induced neoepitopes, sec-
tions were deparafﬁnized, rehydrated 
and digested with chondroitinase ABC 
(Sigma, 0.25 U/ml, 0.1 M Tris-HCL 
pH 8.0) for 1 hour at 37°C to remove 
chondroitine sulphate from the prote-
oglycans. Sections were then treated 
with 1% H
2
O
2
 in methanol for 20 min-
utes and subsequently 5 minutes with 
0.1% (v/v) triton X-100 in PBS. After 
incubation with 1.5% (v/v) normal goat 
serum for 20 minutes, sections were 
incubated with afﬁnity-puriﬁed anti-
VDIPEN IgG overnight at 4°C. These 
antibodies were kindly provided by 
Irwin Singer and Ellen Bayne (Merck 
Research Laboratories, Rahway, USA) 
and have been extensively characterized 
before [26, 27]. In addition, sections 
were incubated with biotinylated goat 
anti-rabbit IgG and binding detected 
using avidine-peroxidase staining (Elite 
kit, Vector Labs, Inc., Burlingham). In-
duction of the peroxidase product was 
detected using nickel enhancement and 
counterstaining was performed with 
orange G (2%) for 5 minutes.
Quantitative RT-PCR
 RNA was isolated using 1 ml 
of TRIzol reagent (Life Technolo-
gies, Breda, The Netherlands). Spe-
ciﬁc mRNA levels for various MMPs 
(MMP- 2, -3, -9,-12, and -13), their 
inhibitors (TIMP-1, -2, -3, and -4) and 
FcγR (FcγRI, II, and III) were quan-
tiﬁed using the ABI/PRISM 7000 
Sequence Detection System (ABI/PE, 
Foster City, CA). Brieﬂy, 1 µg of syn-
ovial RNA was used for reverse tran-
scriptase-PCR. mRNA was reverse-
transcribed to cDNA using oligodT 
primers and 1/100 of the cDNA was 
used in one PCR ampliﬁcation. PCR 
was performed in SYBR Green Master 
Mix using the following ampliﬁcation 
protocol: 2 minutes at 50°C followed by 
40 cycles of 15 seconds at 95°C and 1 
minute at 60°C with data collection in 
the last 30 seconds. Message for murine 
GAPDH, MMPs, MMP inhibitors 
and FcγR was ampliﬁed using speciﬁc 
primers (Biolegio, Malden, The Neth-
erlands) for  these molecules at a ﬁnal 
concentration of 300 nmol/L. Rela-
tive quantiﬁcation of the PCR signals 
was performed by comparing the cycle 
threshold (Ct) value of the various mol-
ecules in the different samples after cor-
rection of the GAPDH content for each 
individual sample to rule out confound-
ing by variation of the RNA puriﬁca-
tion and reverse transcriptase step.
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Results
During IC-mediated arthritis 
joint inﬂammation is downregu-
lated by oxygen radicals, which is 
compensated by IFN-γ
 To investigate the effect of NADPH-
oxidase driven oxygen radical production 
on joint inﬂammation, ICA was induced 
in knee joints of P47phox-/- and their 
wild-type (WT) controls. Total knee 
joint sections were stained with hema-
toxylin/eosin and the amount of inﬂam-
matory cells present within the synovium 
(inﬁltrate) and joint cavity (exudate) were 
determined using an abitrary scale rang-
ing from  0-3. At day 3 after induction of 
ICA, joint inﬂammation was signiﬁcantly 
higher in P47phox-/- when compared with 
WT controls (Figure 1), indicating that 
oxygen radicals inhibit IC-mediated joint 
inﬂammation. 
 In addition, the effect of IFN-γ on 
joint inﬂammation was investigated by in-
jecting an adenoviral construct encoding 
IFN-γ into knee joints of P47phox-/- and 
their WT controls, one day before ICA 
induction. Earlier studies have shown 
that IFN-γ does not elevate joint inﬂam-
mation during ICA, whereas cartilage 
destruction is signiﬁcantly enhanced 
[13]. The latter is strongly correlated to 
upregulation of FcγRI. We found that 
the amount of inﬂammatory cell mass 
was comparable in IFN-γ-stimulated 
knee joints of P47Phox-/- and their WT 
controls, both at days 3 and 7 after ICA 
induction (Figure 2A-C).
 Apart from the amount, also the cell 
type of the inﬁltrated cells may be dif-
ferent. To determine the contribution of 
the macrophage, which is the dominant 
cell type involved in cartilage destruction 
within this model, sections were stained 
with antibodies directed against F4/80. 
At day 7 after IFN-γ-stimulated ICA in-
duction, high but comparable amounts 
of F4/80-positive cells were detected in 
Figure 1
Joint inﬂammation 3 days after induction of ICA in P47phox-/- and their WT 
controls. The amount of cells present in the synovium (inﬁltrate) and in the 
joint cavity (exudate) was determined using an arbitrary scale from 0-3 (0, no 
cells; 1, minor; 2, moderate; 3, maximal). The amount of cells was determined 
blindly by two independent observers. Data are the mean ± SD of 8 animals. 
Signiﬁcance was tested using the Wilcoxon rank test (*, P<0.05).
Figure 2
Joint inﬂammation 3 and 7 days after induction of IFN-γ-stimulated ICA in 
P47phox-/- and their WT controls. The amount of cells present in the synovium 
(inﬁltrate) and in the joint cavity (exudate) was determined using an arbi-
trary scale from 0-3 (see Figure 1 for deﬁnition). Note that there is a compa-
rable cell mass in arthritic knee joints of P47phox-/- and WT controls. (A and 
C versus WT control B). Signiﬁcance was tested using the Wilcoxon rank test 
(*,P<0.05). Original magniﬁcations, x 100. F,femur ; P=patella. 
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both P47phox-/- mice and their WT con-
trols. Between 70-80% of the inﬂamma-
tory cells, both in inﬁltrate and exudate 
showed clear F4/80 staining (Figure 3A). 
Moreover, large amounts of  F4/80 posi-
tive macrophages attached to cartilage 
surfaces at sites where erosion was detect-
ed (Figure 3B). 
Oxygen radicals are not involved 
in mediating early proteoglycan 
depletion
 During ICA, mild cartilage destruc-
tion starts with the release of proteogly-
cans (PG) from the surface of the cartilage 
layers. To investigate this early cartilage 
destruction which is mainly mediated 
by aggrecanases, total knee joint sections 
were stained with safranin O. Loss of red 
staining (a measure for PG loss) was scored 
in various cartilage layers of the knee 
joint (medial and lateral femur, tibia and 
patella) using an arbitrary scale from 0-3. 
At day 3 after IFN-γ-stimulated arthritis 
induction, PG loss in arthritic WT knee 
joints varied from 1 in the patella up to 3 
in the lateral and medial femur. At day 7 
after ICA induction, nearly maximal PG 
loss was found in all cartilage layers in-
vestigated. Comparable PG depletion was 
found in arthritic P47phox-/- knee joints 
both at day 3 and day 7 after arthritis 
induction (Figure 4A and B), suggest-
ing that NADPH-oxidase driven oxygen 
radicals do not alter aggrecanase-activity, 
which is responsible for PG loss. Arthritic 
knee joints which were not injected with 
AdIFN-γ also showed maximal PG loss 
which was not different between the two 
strains (data not shown).  
Oxygen radicals aggravate MMP-
mediated cartilage destruction 
during IFN-γ-stimulated ICA
 As PG loss was not different between 
P47phox-/- and WT controls, we addition-
ally investigated the more severe cartilage 
Figure 3
Expression of the macrophage marker F4/80 7 days after induction of IFN-γ-
stimulated ICA. Note that 70-80% of the inﬁltrated cells within the synovium 
consist of macrophages (A). F4/80 positive macrophages attached to the car-
tilage surface and were found in the lacunae of erosion pits (B, see arrows). 
Original magniﬁcation, x 400. F,femur; JS,joint space.
Figure 4
PG depletion in cartilage layers of total knee joint sections 3 (A) and 7 (B) days 
after induction of IFN-γ-stimulated ICA in P47phox-/- and their WT controls. 
PG depletion was scored as loss of red staining in tibia, femur, and patella 
using an arbitrary scale from 0-3. No signiﬁcant diﬀerence in PG loss was 
found at day 3 (A) or day 7 (B) between wild-type controls and P47phox-/- 
mice. Data are expressed as loss of red staining when compared to control 
cartilage layers and represent the mean ± SD of 8 mice. Signiﬁcance was 
tested using the Wilcoxon rank test (*, P<0.05). MT, medial tibia; LT,lateral 
tibia; LF, lateral femur; MT, medial tibia; MF,medial femur; P,patella.       
143 Oxygen radicals mediate cartilage damage in ICA
matrix destruction mediated by MMPs. 
For this purpose, the amount of MMP-
speciﬁc neoepitope VDIPEN expressed 
within various cartilage layers within the 
knee joint was determined by immunos-
taining using speciﬁc anti-VDIPEN anti-
bodies. A progressive amount of VDIPEN 
staining was observed at day 7 when com-
pared to day 3 in cartilage layers of IFN-
γ-stimulated arthritic WT knee joints but 
not in P47phox-/- knee joints (Figure 5A 
and B). 
 In WT controls, the amount of VDIPEN 
staining varied from 5% in the patella up to 
55% in the lateral femur, 3 days after arthri-
tis induction. In P47phox-/- mice, VDIPEN 
staining in various cartilage layers was com-
parable to WT controls at that time-point 
(Figure 5A). At day 7 after arthritis induc-
tion, VDIPEN staining varied between 
10 and 80% in WT controls. Interestingly, 
in knee joints of arthritic P47phox-/-, 
VDIPEN staining was signiﬁcantly lower 
in lateral femur, medial femur and lateral 
tibia (respectively  50%, 60% and 50% re-
duction) (Figure 5B and C versus D) and 
values were similar as found at day 3.   
Oxygen radicals downregulate 
MMP mRNA levels within the 
inﬂamed synovium during IFN-γ-
stimulated ICA
 An important source of MMPs in-
volved in cartilage destruction may be 
derived from the inﬂamed synovium. 
To investigate whether oxygen radicals 
Figure 5
VDIPEN staining in knee joints of P47phox-/- and their wild-type controls, 3 (A) and 7 (B) days after IFN-γ-stimulated  ICA. VDIPEN staining was signiﬁcantly lower 
at day 7 in lateral and medial femur and lateral tibia of P47phox-/- mice (B and photographs D versus C). Data represent the mean ± SD of  8mice. Signiﬁcance was 
tested using the Wilcoxon rank test (*, P<0.05). MT, medial tibia; LT, lateral tibia; MF, medial femur; LF, lateral femur; P, Patella. Original magniﬁcation, x 100.   
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alter the expression of MMPs within the 
inﬂamed synovium, well-deﬁned  syno-
vial specimen were isolated at days 3 and 7 
after arthritis induction and mRNA levels 
of various MMPs (MMP-2,-3,-9,-12, and 
-13) and their inhibitors (TIMP-1,-2,-3, 
and -4) were determined using quantita-
tive RT-PCR. At day 3 after IFN-γ-accel-
erated ICA, moderate expression (∆Ct 4 to 
8 cycles) of all MMPs was measured in WT 
mice. TIMP-1 and -2 were moderately 
expressed, in contrast to TIMP-3 and -4 
which were almost absent. At day 7, MMP-
2, -9, and -13 were still highly expressed 
and only MMP-3 and 12 were signiﬁcantly 
downregulated (Figure 6A and B). TIMP-
1, but not TIMP-2, was signiﬁcantly lower 
at day 7 (Figure 6C and D). In synovium 
of  day 3 arthritic P47phox-/- knee joints, 
MMP-2 was higher and MMP-9 lower 
when compared with WT controls (Figure 
6A). TIMP-1 and -2 expression was some-
what lower, not reaching signiﬁcance 
(Figure 6C). At day 7, P47phox-/-, when 
compared with WT controls, showed a 
signiﬁcant elevation of MMP-3, -9, and -
13 (Figure 6B), whereas also TIMP-1 and 
-2 were somewhat increased (Figure 6D). 
Oxygen radicals increase FcγRI 
and decrease FcγRII and III during 
IFN-γ-stimulated ICA 
 In previous studies, we have found 
that activating FcγR (mainly FcγRI) are 
important in the activation step of latent 
Figure 6 
Expression of mRNA levels of various 
MMPs (MMP-2,-3,-9,-12, and -13) and 
their inhibitors (TIMP-1,-2,-3,and -4) 
in synovia of arthritic P47phox-/- and 
WT knee joints. Synovium was isolated 
3 and 7 days after IFN-γ-stimulated 
arthritis. The cycle threshold (Ct) value 
of the various MMP and TIMP genes 
was corrected for GAPDH content. Note 
that at day 7, signiﬁcant elevated levels 
of MMP-3, -9, and -13 were found in 
P47phox-/- mice when compared with 
controls (B). TIMP-1 and 2 were also 
somewhat elevated, although to a 
lesser extend than MMPs (D).  No sig-
niﬁcant diﬀerences were found at day 3 
(A and C). Signiﬁcance was tested using 
the Wilcoxon rank test (*, P<0.05).
Figure 7
Expression of mRNA levels of various FcγR (FcγRI, -II, and -III) in synovia of 
arthritic P47phox-/- and WT knee joints. Synovium was isolated 7 days after 
IFN-γ-stimulated arthritis. The cycle threshold (Ct) value of the various FcγR 
genes was corrected for GAPDH content and for values in naive knee joints. 
Note the signiﬁcant lower levels of FcγRI and elevated levels of FcγRII and 
III in P47phox-/- mice when compared with controls. Signiﬁcance was tested 
using the Wilcoxon rank test (*, P<0.05).
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MMPs [13]. To further investigate wheth-
er oxygen radicals are involved in the 
regulation of FcγR expression, mRNA 
levels of the three FcγR classes were de-
termined  in synovia isolated 7 days after 
induction of IFN-γ-stimulated ICA. In 
WT mice, FcγRI and II were upregulated 
(∆Ct 4 and 2, respectively), whereas ex-
pression of FcγRIII was decreased (∆Ct 
2) when compared to naive knee joints. 
In P47phox-/-, FcγRI was downregulated 
(∆Ct 4), whereas FcγRII and III were both 
strongly upregulated (∆Ct 6) (Figure 7).  
Oxygen radicals determine 
chondrocyte death during IFN-γ-
stimulated ICA
 Apart from MMP-mediated carti-
lage destruction, chondrocyte death is 
an important parameter of severe car-
Figure 8
Chondrocyte death in various cartilage layers of knee joints of P47phox-/- and their WT controls at day 3 after ICA induction (A) and at day 3 (B ) and day 7 (C) after 
IFN-γ-stimulated  ICA. Chondrocyte death was expressed as percentage of empty lacunae. Note that without IFN-γ, no chondrocyte is observed. At day 7 after 
induction of IFN-γ-stimulated arthritis, in WT controls  chondrocyte death  was clearly present, whereas in P47phox-/- chondrocyte death was completely absent 
(C and E versus control D). Signiﬁcance was tested using the Wilcoxon rank test (*, P<0.05). MT, medial tibia; LT,lateral tibia; LF, lateral femur; MT, medial tibia; 
MF, medial femur; P, patella; F, femur. Original magniﬁcation, x 400.
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tilage destruction. In previous studies 
we found that during IFN-γ-stimulated 
ICA, chondrocyte death was dependent 
on FcγRI. As binding of IC to FcγRI 
results in substantial oxygen radical pro-
duction [14], which subsequently leads 
to a signiﬁcant up-regulation of this re-
ceptor, we further investigated whether 
NADPH-oxidase driven oxygen radical 
production indeed mediates chondrocyte 
death within this model. The amount of 
empty lacunae (expressing chondrocyte 
death) within various cartilage layers of 
the knee joint was determined and ex-
pressed as a percentage of the total amount 
of chondrocytes present. Without IFN-γ 
overexpression, chondrocyte death was 
not found in WT and P47phox-/- arthritic 
knee joints (Figure 8A). In contrast, when 
AdIFN-γ was injected before arthritis in-
duction, chondrocyte death was tremen-
dously increased to 40 and 60% in the lat-
eral and medial femur, respectively, and to 
20 and 40% in the lateral and medial tibia, 
respectively, at day 3 in WT mice (Figure 
8B). At day 7, chondrocyte death was even 
higher (between 60-70% and 20-70% in 
femur and tibia, respectively) (Figure 8C 
and D). Interestingly, arthritic knee joints 
of  IFN-γ-stimulated P47phox-/-, although 
joint inﬂammation was comparable to that 
found in WT mice, chondrocyte death 
was completely absent at day 3 and very 
low at day 7 (between 2-5% and 5-8% in 
tibia and femur, respectively (Figure 8B, 
C, and E). Absence of chondrocytes may 
lead to cartilage erosion. However, at day 
7 after IFN-γ-stimulated ICA, erosion 
was still mild in cartilage layers of WT 
arthritic knee joints. Erosion pits were 
only found in  the superﬁcial layers of 
the medial and lateral tibia. Furthermore, 
clear attachment of macrophages to the 
cartilage surface was observed. Cartilage 
layers in arthritic P47phox-/- knee joints 
showed similar attachment of macrophag-
es and mild erosion, although chondro-
cyte death was absent (Figure 8E). 
Discussion
 In the present study, we ﬁnd that in 
the absence of NADPH-oxidase gener-
ated oxygen radicals, IC-mediated joint 
inﬂammation was signiﬁcantly enhanced. 
This might be due to a disturbed IC-clear-
ance, since removal of ICs from the joint 
determines the severity of  arthritis [28]. 
This is in line with a previous study, which 
showed that oxygen radicals are crucial 
in clearance of foreign particles like cell 
walls of micro-organisms [29]. In a pre-
vious study, we have found that injection 
of zymosan directly into the knee joint of 
P47phox-/- mice caused a strongly elevated 
joint inﬂammation due to retarded clear-
ance and resulted in prominent granuloma 
formation within the synovia of these 
mice [30]. In the present study, we ﬁnd 
that IFN-γ overexpression in the knee 
joint of P47phox-/- before ICA induction 
prevented the raise in  joint inﬂammation 
and no granuloma formation was found. 
IFN-γ is a potent inducer of receptors 
involved in phagocytosis like FcγR and 
complement receptors and might lead to 
an efﬁcient removal of ICs, responsible for 
on-going arthritis within the knee joints 
of  P47phox-/- mice. Macrophages form 
the dominant cell type within this model 
and these cells express large amounts of 
FcγR which are largely responsible for 
IC clearance, but also for activation of 
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the lining cells which drive arthritis [31]. 
Interestingly, synovial expression of the 
inhibitory FcγRII, which has been shown 
to be the dominant FcγR involved in IC 
clearance [32] was upregulated in the 
synovium of IFN-γ-stimulated arthritic 
P47phox-/- knee joints. Because FcγRII 
is not dependent on oxygen radicals for 
efﬁcient clearance, increase of FcγRII ex-
pression may lead to a more efﬁcient IC-
clearance. 
 Although the amount of inﬁltrated 
macrophages was not different between 
arthritic P47phox-/- and WT knee joints, 
destruction of the cartilage matrix by 
metalloproteinases was lower in the ab-
sence of oxygen radicals. Cytokines like 
IL-1 and TNF-α activate chondrocytes 
and synoviocytes to produce MMPs 
which are released in an inactive form. 
These latent enzymes need an activation 
step before they can degrade the cartilage 
matrix. MMP-3 is the crucial MMP in-
volved in activation of MMP-13, which 
forms the rate-limiting MMP in degrada-
tion of the collagen type II matrix result-
ing in erosion of the cartilage matrix [5]. 
IFN-γ overexpression strongly increased 
MMP expression in the synovium. This 
may be regulated directly by IFN-γ or 
indirectly by up-regulation of FcγR ex-
pression and their subsequent activation 
by ICs.  In the present  study we ﬁnd that 
inﬂamed synovia of IFN-γ-stimulated 
arthritic P47phox-/- knee joints showed 
a strong up-regulation of various MMPs 
like MMP-3, -9, -12, and -13. TIMP-1 
and TIMP-2 were only marginally up-
regulated, whereas TIMP-3 and -4 were 
completely absent. This suggests that 
oxygen radicals inhibit gene expression of 
MMPs. As MMP-mediated cartilage de-
struction was lower in arthritic P47phox-/- 
knee joints, whereas MMP expression in 
the synovium appeared higher, this may 
indicate that oxygen radicals are also in-
volved in their activation. Oxygen radicals 
have earlier been shown to activate latent 
MMP like MMP-2 [17]. In the present 
study we also ﬁnd that oxygen radicals 
up-regulate FcγRI expression. Binding of 
ICs to FcγRI leads to increased oxygen 
radical production [14] and may form an 
ampliﬁcation step in the activation of pro-
MMPs. 
 An interesting difference in contribu-
tion of oxygen radicals to MMP-medi-
ated cartilage damage in P47phox-/- mice 
was found between arthritis induced by 
zymosan (ZIA) or by ICs. During IFN-γ-
stimulated ICA, oxygen radicals enhance, 
whereas during ZIA, they inhibit  MMP-
mediated cartilage damage. An explana-
tion for this discrepancy may be the cell 
type involved in mediating cartilage de-
struction. During ZIA, a high numbers of 
PMNs inﬁltrate into the joint. These cells 
do not  attach to the cartilage surface and 
release large amounts of enzymes. Crucial 
enzymes released by PMNs are elastase 
and cathepsin G, which are highly capable 
of penetrating the cartilage due to their 
highly positive charge and are then able 
to stimulate pro-MMP into their active 
form causing VDIPEN neoepitopes [33]. 
Under normal circumstances elastase 
activity is inhibited by synovial ﬂuid in-
hibitors like α2-macroglobulin and no 
VDIPEN staining can be detected within 
the cartilage layers [4]. However, in the 
absence of oxygen radicals the number of 
inﬁltrated PMNs was strongly increased 
during ZIA [30] and the amount of elastase 
may then overrule the inhibiting capacity 
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of α2-macroglobulin in the synovial ﬂuid. 
In contrast to ZIA, during IFN-γ-stimu-
lated ICA the dominant inﬁltrating cell is 
the macrophage which strongly  attaches 
to the  surface of the cartilage. Produc-
tion of oxygen radicals such as hydrogen 
peroxide generated after stimulation of 
FcγR by ICs [14] and the presence of su-
peroxide dismutase, may then  be of cru-
cial importance in regulating activation of 
pro-MMPs in the cartilage matrix.  Hy-
drogen peroxide has a relatively long half-
live and is able to activate pro-MMPs [17]. 
Synovial ﬂuid contains large amounts of 
inhibitors of hydrogen peroxide like cata-
lase [34]. However, due to the close prox-
imity of the activated macrophage to the 
cartilage surface, hydrogen peroxide may 
escape from this inhibitor, which due to 
its large size (240kD) is not able to pen-
etrate into the cartilage matrix [35].
 Another parameter of severe cartilage 
destruction is chondrocyte death, which 
was  completely abrogated in the absence 
of NADPH-oxidase driven oxygen radi-
cals. Chondrocyte death may be medi-
ated  by oxygen radicals released by the 
chondrocyte itself or by the inﬂamed 
synovium. Chondrocytes do express 
NADPH-oxidase [36] and cytokines such 
as IL-1 are potent inducers of oxygen 
radicals in chondrocytes [37]. Production 
of intra-cellular hydrogen peroxide inside 
the chondrocyte can cause disruption of 
the mitochondrial membrane leading to 
apoptosis [38].  However, previous stud-
ies in our lab have shown that FcγR-acti-
vated synovium is of crucial importance 
in mediating chondrocyte death [39]. 
During IFN-γ-stimulated ICA, the inﬁl-
trated macrophages become activated by 
ICs mainly via FcγR. In the mouse knee 
joint, FcγRI is exclusively expressed by 
macrophages, and not by neutrophils, and 
becomes strongly upregulated by IFN-γ. 
Binding of IC to particularly FcγRI, and 
in lesser extend to FcγRIII, leads to pro-
duction of oxygen radicals. Apart from 
FcγRI stimulation, IFN-γ itself has been 
shown to upregulate P91 and P47 com-
ponents of the NADPH-oxidase complex, 
which may contribute to the enhanced 
superoxide generation [40]. Besides the 
NADPH-oxidase pathway, P47phox-/- 
may produce oxygen radicals by alternate 
pathways [23]. However, IFN-γ alone had 
no effect on chondrocyte death. Moreover, 
it has been shown that IFN-γ does not up-
regulate alternative ways of oxygen radical 
production in P47phox-/- mice [23]. This 
indicates that chondrocyte death is com-
pletely mediated via the NADPH-oxidase 
complex. IFN-γ induces up-regulation of 
NADPH-oxidase components and FcγRI 
[41], and stimulation of FcγRI by ICs may 
additionally lead to an enormous increase 
in oxygen radical production mediating 
cartilage destruction. Hydrogen peroxide 
may again  be the most plausible oxygen 
species mediating chondrocyte death. 
Hydrogen peroxide can easily penetrate 
through cell membranes. Earlier studies 
have shown that hydrogen peroxide, when 
injected into mouse knee joints, was able 
to induce considerable chondrocyte death, 
which may be induced by apoptosis [42]. 
Hydrogen peroxide activates the opening 
of the mitochondrial permeability transi-
tion pore and the release of cytochrome 
C [43]. In the cytoplasm, cytochrome C 
in combination with Apaf-1 activates cas-
pase-9 leading to the activation of caspase-
3 and subsequent apoptosis [44 ]. 
 NADPH-oxidase and p47phox phos-
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phorylation is strongly increased in leuco-
cytes derived from synovial ﬂuid of RA 
patients [45]. Cytokines such as IFN-γ 
are potent candidates for up-regulation of 
NADPH-oxidase [41]. Moreover, ICs are 
found in considerable amounts in joints 
of many RA patients. These ICs may be 
responsible for a large part of NADPH-
oxidase activation via FcγRI stimulation, 
resulting in major amounts of oxygen 
radicals. The latter may mediate part of 
the severe cartilage destruction. As FcγRI-
mediated oxygen radical production may 
play a major role in mediating cartilage 
destruction during arthritis, this receptor 
may form a crucial target in combatting 
this crippling disease.    
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 Rheumatoid arthritis (RA) is a chronic 
inﬂammatory joint disease, which is char-
acterized by uncontrolled proliferation of 
synoviocytes and massive inﬁltration of 
leucocytes. The perpetuation of synovitis 
often results in erosion of cartilage and 
bone. Although RA is considered as an 
autoimmune disease, the auto-antigen is 
still unknown. It is thought however, that 
immune complexes (IC) play a dominant 
role in the pathogenesis of RA by activa-
tion of macrophages via binding to Fcγ 
receptors (FcγRs). 
 The aim of this thesis was to investigate 
the role of the individual FcγRs in joint 
inﬂammation and cartilage destruction 
and to study whether regulation of FcγR 
expression is able to modulate the severity 
of cartilage damage.
 In chapter 2, we showed that in T 
cell-mediated antigen-induced arthritis 
(AIA) FcγRI and FcγRIII are redundant in 
mediating synovial inﬂammation, whereas 
FcγRI and not FcγRIII is the dominant 
activating receptor involved in severe 
cartilage destruction. Furthermore, we 
demonstrated that the inhibiting FcγRII is 
crucial in negative regulation of both acute 
and chronic inﬂammation and late severe 
cartilage damage. Differences in severity 
of arthritis in FcγRI-/- and FcγRIII-/- mice 
were not due to impaired T  and B cell-
mediated immunity, whereas in FcγRII-/- 
mice the humoral response was enhanced 
compared with their wild-type (WT) 
controls. Subsequently, we investigated the 
mechanism by which FcγRII inhibited the 
arthritic response (chapter 3). We found 
that in absence of activating FcγRs, FcγRII 
reduced arthritis not only by inhibiting ac-
tivating FcγRs, but also by removal of ICs 
via endocytosis. AIA was induced in mice 
lacking all three FcγRs (FcγRI/II/III-/-) 
and in mice lacking both activating FcγRI 
and III (FcγRI/III-/-) in which FcγRII is 
still present. In FcγRI/III-/- mice, joint 
inﬂammation was almost absent. Remark-
ably, in FcγRI/II/III-/- mice, arthritis was 
tremendously increased compared with 
WT controls. Signiﬁcant accumulation of 
IgG was observed only in arthritic knee 
joints of FcγRI/II/III-/- mice, suggesting 
that endocytosis and clearance of ICs was 
impaired in absence of FcγRII. In vitro 
studies using macrophages expressing only 
FcγRII (FcγRI/III-/-) showed prominent 
endocytosis of preformed soluble ICs. In 
total absence of FcγRs (FcγRI/II/III-/-), 
macrophages completely failed to endo-
cytose ICs. Although joint inﬂammation 
was much higher in arthritic knee joints 
of FcγRI/II/III-/- mice and the inﬁltrated 
inﬂammatory cells were activated, severe 
cartilage destruction was completely pre-
vented in contrast to the marked cartilage 
destruction (MMP-mediated VDIPEN 
expression and chondrocyte death) found 
in WT controls. 
 The individual role of FcγRs was fur-
ther studied in arthritis solely provoked by 
ICs using the passively induced immune 
complex-mediated arthritis (ICA) (chap-
ter 4). In FcγRIII-/- mice, inﬂux and ac-
tivation of inﬂammatory cells was largely 
blocked and resulted in reduced cartilage 
destruction expressed as MMP-mediated 
VDIPEN expression and chondrocyte 
death. In FcγRI-/- mice, joint inﬂamma-
tion was similar when compared with WT 
arthritic knee joints. However, chondro-
cyte death and VDIPEN expression were 
signiﬁcantly lower, indicating that ac-
tivation of FcγRI is crucial in cartilage 
damage. In FcγRII-/- mice, the arthritic 
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response was markedly elevated as both 
joint inﬂammation and irreversible carti-
lage damage were enhanced. 
 In AIA as well as ICA, FcγRI ap-
peared to be the crucial receptor in de-
velopment of severe cartilage destruction, 
since absence of FcγRI did not alter the 
inﬂammatory response, whereas irrevers-
ible cartilage destruction was signiﬁcantly 
reduced. Moreover, in the T cell-medi-
ated AIA, which is a Th1 driven disease, 
cartilage destruction was more severe and 
completely dependent on FcγRI. Th1 
cells release interferon (IFN)-γ, which 
is known to induce marked up-regula-
tion of FcγRI and this might explain why 
FcγRI becomes prominent in cartilage 
destruction during AIA. In chapter 5, 
we demonstrated that local overexpres-
sion of IFN-γ in the knee joint during 
ICA, using an adenovirus, indeed deterio-
rated irreversible cartilage damage. This 
was only found in arthritis mediated by 
ICs, and not when arthritis was induced 
by zymosan. IFN-γ did not affect the 
amount of inﬂammatory cells, but altered 
the composition of the cell mass as the 
percentage of macrophages expressing 
markers for a proinﬂammatory pheno-
type was elevated. FcγRI mRNA level in 
synovium was signiﬁcantly augmented by 
IFN-γ. Whether this contributed to the 
severity of cartilage damage was studied 
using FcγRI-/- mice. Interestingly, despite 
IFN-γ overexpression, chondrocyte death 
remained low in arthritic FcγRI-/- knee 
joints, indicating that FcγRI speciﬁcally 
mediated chondrocyte death. On the 
contrary, IFN-γ enhanced MMP-medi-
ated VDIPEN expression similarly as 
found in WT controls, suggesting that 
the activating FcγRIII is able to compen-
sates absence of FcγRI. To elucidate the 
role of FcγRIII further, IFN-γ was also 
overexpressed in FcγRIII-/- mice before 
ICA induction (chapter 6). FcγRIII de-
pendency of joint inﬂammation within 
this model was completely abrogated by 
IFN-γ, resulting in comparable joint in-
ﬂammation in FcγRIII-/- mice and WT 
controls. Levels of macrophage-attract-
ant MIP-1α were increased by IFN-γ and 
correlated with the higher percentage of 
macrophages found both in WT controls 
and FcγRIII-/- mice. Enhanced VDIPEN 
expression and chondrocyte death were 
also observed in FcγRIII-/- mice. Com-
bining the results from chapter 5 and 6, 
we demonstrated that IFN-γ increased the 
severity of cartilage destruction mainly 
via up-regulation of activating FcγRs. 
Both activating FcγRs mediated MMP-
dependent VDIPEN expression, whereas 
FcγRI speciﬁcally induced chondrocyte 
death. 
 In chapter 7, we showed that over-
expression of the Th2 cytokine IL-13 
reduced cartilage destruction. In arthritic 
knee joints injected with adenovirus ex-
pressing IL-13, the amount of inﬂamma-
tory cells was elevated and higher num-
bers of polymorphonuclear neutrophils 
(PMNs) were observed. Chondrocyte 
death was however diminished, which 
correlated with downregulation of FcγRI 
mRNA level in synovium. MMP-medi-
ated VDIPEN expression was also de-
creased, although MMP mRNA and IL-1 
protein levels were enhanced. The latter 
suggests that IL-13 may interfere at the 
level of activation of pro-MMPs, instead 
of decreasing the amount of MMPs.
 In the studies mentioned above, we 
demonstrated that FcγRs are of crucial 
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importance in the development of irre-
versible cartilage damage and that regula-
tion of FcγR expression by cytokines is 
able to modulate the severity of cartilage 
destruction. Moreover, a prominent role 
for FcγRI was found mediating irrevers-
ible cartilage destruction. It is known 
that binding of ICs to FcγRI results in 
prominent oxygen radical production by 
the NADPH-oxidase complex. Whether 
NADPH-oxidase driven oxygen radical 
production is involved in development of 
chondrocyte death and MMP-mediated 
proteoglycan damage was investigated in 
chapter 8. Therefore IFN-γ-stimulated 
IC-arthritis was elicited in mice lack-
ing the P47-subunit (P47phox-/-), which 
is necessary for a functional NADPH-
oxidase complex. Joint inﬂammation 
was similar in P47phox-/- mice and WT 
controls when IFN-γ was overexpressed. 
However, chondrocyte death and MMP-
mediated cartilage destruction were sig-
niﬁcantly lower which was accompanied 
by decreased FcγRI mRNA levels in 
synovium. This study suggests that pro-
duction of oxygen radicals via NADPH-
oxidase after stimulation of activating 
FcγRI might contribute to chondrocyte 
death and MMP-mediated VDIPEN ex-
pression.
Final considerations
 This thesis demonstrates that activa-
tion of FcγRs by IgG-containing ICs in 
the joint determines inﬂammation and ir-
reversible cartilage destruction. 
 In many RA patients, IgG-ICs are 
abundantly expressed in synovial ﬂuid, 
synovium and cartilage [1,2], and there-
fore FcγRs may be crucial in the pathol-
ogy found in RA. Recently, it was found 
that antibodies directed against citrulli-
nated proteins are highly speciﬁc for RA. 
Besides being used as diagnostic factor, 
these antibodies may form ICs locally in 
the joint, thereby activating macrophages 
by binding FcγRs.
 In this thesis, two IC-dependent arthri-
tis models were used to study the role of 
FcγRs. In selective FcγR-deﬁcient mice, 
antigen-induced arthritis (AIA), regu-
lated by both ICs and T cells, or immune 
complex-mediated arthritis (ICA), solely 
provoked by ICs, was elicited. In AIA, ir-
reversible cartilage destruction was specif-
ically FcγRI dependent, whereas in ICA, 
both activating FcγRI and III mediated 
cartilage destruction. The discrepancy 
in FcγR dependency may be explained 
by contribution of the T cells and their 
cytokines, as this is the most striking 
difference between these models. How-
ever, the role of antibody isotypes was not 
investigated. The three classes of FcγRs 
have different afﬁnities for the various 
IgG subclasses [3,4] and the isotype of an-
tibodies found within the arthritis model 
might  also contribute to FcγR depend-
ency of the model. In our passive ICA 
model, antibodies derived from rabbits are 
used, which can activate all three murine 
FcγRs. On the contrary, in AIA, mice are 
immunized resulting in antibodies of var-
ious IgG subclasses, which bind to FcγRs 
with different afﬁnity. To study the role of 
antibodies in arthritis further, we are now 
developing antibodies of various isotypes 
directed against lysozyme, which can than 
be used to elucidate the individual role 
of of the individual isotypes in eliciting 
arthritis and cartilage destruction. How-
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ever, expression of FcγRs present in the 
joint remains of crucial importance in the 
arthritic process.
 The inhibiting FcγRII negatively reg-
ulated joint inﬂammation and cartilage 
damage both in AIA and ICA, which is 
in line with studies describing the inhib-
iting role of FcγRII in collagen-induced 
arthritis [5,6]. FcγRII not only reduced 
the arthritic response by inhibiting the 
activating FcγRs, a function generally 
highlighted. We now demonstrated for 
the ﬁrst time in vivo that in absence of ac-
tivating FcγRs, the inhibiting FcγRII still 
functions as an important downregulator 
of synovial inﬂammation by clearance 
of immune complexes. These results in-
dicate that up-regulation of this inhibit-
ing Fc receptor may repress the arthritic 
response and development of cartilage 
destruction, and therefore may be a very 
promising approach for therapy. Increased 
expression of FcγRII can be achieved by 
cytokines such as IL-4 and IL-13 [7], or 
by local gene transfer of FcγRII using 
adenoviral constructs [8]. Recently, we 
developed an adenovirus expressing the 
inhibiting FcγRII and tested this con-
struct in vitro. We found that FcγRIIb ex-
pressed by the adenovirus was functional, 
since non-phagocytic COS-1 cells were 
able to phagocytose IgG-coated sheep 
erythrocytes when transfected. The ef-
fects of FcγRII overexpression during the 
arthritic response is momentarily under 
investigation.
 In mouse, detection of FcγR protein 
expression is still difﬁcult due to lack of 
speciﬁc antibodies recognizing individual 
FcγRs. Therefore, regulation of FcγR 
expression by cytokines in the knee joint 
was studied on mRNA level. FcγRII and 
III protein can be detected by the mono-
clonal 2.4G2 [9], which can be used for 
immunohistochemistry and ﬂowcytom-
eter analysis. Only recently, an antibody 
was developed against murine FcγRI 
[10], which enables detection of FcγRI by 
ﬂowcytometer analysis. To further extend 
our knowledge of regulation of FcγR ex-
pression locally in the knee joint during 
arthritis, speciﬁc antibodies for immuno-
histochemistry need to be developed.   
 As FcγRI is crucial in development of 
irreversible cartilage destruction in ex-
perimental T cell dependent IC-mediated 
arthritis, it will be interesting to investi-
gate the contribution of this receptor in 
cartilage destruction found in RA patients. 
Recently, we demonstrated in our lab, that 
expression of both FcγRII and III in RA 
synovium correlated with inﬂammation 
[11]. This link between FcγRIII expres-
sion in RA synovium and inﬂammation 
was also found in experimental arthritis, 
as FcγRIII is the dominant receptor me-
diating joint inﬂammation in the passive 
IC-arthritis. Cartilage destruction in RA 
affected joints can be measured by detec-
tion of cartilage degradation products like 
type II collagen in synovial ﬂuids [12] or 
by cartilage oligomeric matrix protein 
(COMP) levels in serum [13]. To study 
whether FcγRI is also involved in cartilage 
destruction during RA, FcγRI expression 
in RA synovium or on inﬂammatory cells 
present in synovial ﬂuid can be correlated 
to cartilage degradation products present 
in synovial ﬂuid or serum.   
 In this thesis, it was found that activat-
ing FcγRs are crucial in the development 
of cartilage destruction. Moreover, a spe-
ciﬁc role for FcγRI was found mediating 
chondrocyte death. It remains to be elu-
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cidated by what mechanisms activation 
of FcγRs induces cartilage destruction, 
and whether there are differences in 
FcγRI and FcγRIII signaling. Signal-
ing of Fc Rs involved in phagocytosis 
is extensively studied, however, signal 
transduction resulting in MMP produc-
tion or other factors involved in carti-
lage damage remains to be elucidated.To 
investigate whether there are differences 
in signaling between the two activat-
ing FcγRs, macrophages derived from 
FcγRI or FcγRIII deﬁcient mice can 
be used. Differences in gene expression 
after stimulation with ICs can be detect-
ed on mRNA level using gene-analysis, 
a technique by which forty-ﬁve thou-
sand genes are screened [14]. Recently, 
kinase arrays are developed which fa-
cilitates the analysis of phosphorylation 
of proteins, hereby giving information 
on signal pathways triggered after FcγR 
activation [15]. These techniques can 
be used to gain more insight in mecha-
nisms speciﬁcally involved in cartilage 
degradation, triggered after activation 
of FcγRI. Further characterization of 
cartilage destruction processes activated 
after stimulation via FcγRs is of high 
interest as new target proteins can be 
discovered that allow us to speciﬁcally 
block cartilage destruction, without dis-
turbance of the phagocytotic capacity of 
FcγRs which is necessary for adequate 
clearance of ICs. 
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 Reumatoïde artritis (RA) is een chro-
nische gewrichtsontsteking, die vaak 
gepaard gaat met ernstige destructie van 
kraakbeen en bot, wat uiteindelijk kan 
leiden tot blijvende invaliditeit. RA komt 
voor bij ongeveer 1% van de wereldbev-
olking en het ziekteverloop wordt geken-
merkt door actieve en rustige perioden. 
Hoewel de oorzaak van RA nog steeds 
niet bekend is, wordt het beschouwd 
als een auto-immuunziekte waarbij een 
afweerreactie tegen lichaamseigen stof-
fen (auto-antigenen) optreedt. Nadere 
analyse van ontstoken gewrichten wijst 
uit dat er verschillende celtypen aanwezig 
zijn, zoals macrofagen, T cellen en plas-
macellen. Ook worden er in de gewrich-
ten antilichaam-antigeen complexen (im-
muuncomplexen, ICs) gevonden. Er zijn 
verschillende typen antilichamen bekend, 
te weten IgA, IgM, IgE, IgD en IgG en 
hierdoor kunnen er verschillende soorten 
ICs worden gevormd. In het gewricht van 
RA patiënten worden veel IgG-bevattende 
ICs gevonden. Deze IgG-ICs activeren 
bepaalde cellen, de macrofagen, hetgeen 
leidt tot productie van ontstekingsmedia-
toren zoals interleukine 1 (IL-1), tumor 
necrosis factor (TNF)-α en enzymen 
zoals matrix metalloproteinasen (MMPs). 
IgG-ICs kunnen aan macrofagen binden 
via speciale eiwitten aanwezig op het 
celoppervlak, de Fcγ receptoren (FcγRs). 
Er zijn drie verschillende typen FcγRs, 
genaamd FcγRI, II, en III. Binding van 
ICs aan FcγRI of FcγRIII leidt tot acti-
vatie van macrofagen, terwijl binding aan 
FcγRII de macrofaag juist inactiveert. 
 Om het RA proces te bestuderen 
wordt er gebruik gemaakt van proe-
fdiermodellen. Een van die modellen is 
immuuncomplex artritis (ICA). In dit 
model worden muizen ingespoten met 
antilichamen die het eiwit lysozym herk-
ennen. Vervolgens wordt lysozym in het 
kniegewricht geïnjecteerd, waarin dan 
locaal ICs ontstaan. Deze ICs activeren 
de macrofagen die de binnenbekleding 
van het gewricht vormen, hetgeen leidt 
tot migratie van ontstekingscellen naar 
het gewricht. Een tweede experimenteel 
model is de antigeen-geïnduceerde artri-
tis (AIA), waarbij niet alleen ICs een rol 
spelen maar ook T cellen. Muizen worden 
geïmmuniseerd tegen een eiwit (mBSA) 
waardoor er antilichamen en T cellen die 
dit eiwit herkennen worden geproduceerd. 
Na drie weken wordt het eiwit in het 
kniegewricht geïnjecteerd, dat vervolgens 
door binding aan antilichamen ICs vormt 
en een ontstekingsreactie in gang zet. 
 In beide modellen zal de ontsteking 
in het gewricht leiden tot onherstelbare 
afbraak van kraakbeen. Deze ernstige 
kraakbeenschade wordt niet gevonden 
wanneer artritis wordt geïnduceerd door 
injectie van gist- of bacterie-deeltjes. Dit 
wijst erop dat ICs noodzakelijk lijken te 
zijn in het ontstaan van onherstelbare 
kraakbeenschade. Kraakbeen bestaat 
uit een matrix van proteoglycanen en 
collagenen die geproduceerd worden 
door kraakbeencellen, de chondrocyten. 
Kraakbeenschade begint met verlies van 
proteoglycanen uit de kraakbeen matrix. 
Wanneer het proces van kraakbeenschade 
voortduurt worden collagenen afgebro-
ken en gaan chondrocyten dood. Dit kan 
uiteindelijk leiden tot het verdwijnen van 
de kraakbeenlaag (erosie). 
 In deze studie werd de functie van de 
drie verschillende FcγRs in het ontstaan 
van gewrichtsontsteking en kraakbeen-
schade tijdens artritis bestudeerd. Ook 
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werd er onderzocht of veranderingen 
in FcγR expressie de ernst van kraak-
beenschade kan beïnvloeden en via welk 
mechanisme binding van ICs aan FcγRs 
kan leiden tot onherstelbare kraakbeen-
schade.
 Allereerst werd de rol van de drie in-
dividuele FcγRs in een T cel afhankelijk 
immuuncomplex artritis model (antigeen-
geïnduceerde artritis, (AIA)) bestudeerd 
(hoofdstuk 2). Hiervoor werd gebruik 
gemaakt van muizen die speciﬁek FcγRI, 
FcγRII, of FcγRIII missen (FcγRI-/-, 
FcγRII-/-, FcγRIII-/- muizen), doordat in 
het genoom deze genen zijn uitgeschakeld. 
Ondanks afwezigheid van FcγRI of Fc-
γRIII (FcγRI-/- en FcγRIII-/-), resulteerde 
injectie van mBSA in een ontstekings-
reactie vergelijkbaar met die in controle 
muizen. Onherstelbare kraakbeenschade 
gedeﬁnieerd als chondrocyt dood en 
matrix metalloproteinase (MMP) geïndu-
ceerde neo-epitope (VDIPEN) expressie, 
was in FcγRI-/- muizen sterk verminderd. 
In FcγRIII-/- muizen was de kraakbeen-
schade gelijk aan die gevonden in controle 
muizen. Muizen zonder de remmende 
FcγRII ontwikkelden zowel ernstigere 
ontsteking als onherstelbare kraakbeen-
schade. Deze resultaten laten zien dat de 
ontstekingsreactie tijdens de AIA bepaald 
wordt door FcγRI en III. Onherstelbare 
kraakbeenschade daarentegen, is volledig 
afhankelijk van FcγRI. FcγRII is een be-
langrijke remmer van zowel ontsteking als 
kraakbeenschade die ontstaat tijdens AIA. 
 In hoofdstuk 3 werd bestudeerd op 
welke manier FcγRII ontsteking en kraak-
beenschade tijdens AIA remt. Hiervoor 
werden muizen gebruikt zonder FcγRs 
(FcγRI/II/III-/-) en muizen met alleen 
de remmende FcγRII (FcγRI/III-/-). In 
FcγRI/III-/- muizen met artritis waren 
nauwelijks ontstekingscellen te zien in 
het kniegewricht. Opmerkelijk was dat 
in FcγRI/II/III-/- muizen de ontstek-
ing juist veel ernstiger was. Verder was 
er ophoping van IgG antilichamen in 
de gewrichten zichtbaar, hetgeen erop 
kan duiden dat ICs minder goed worden 
opgeruimd. Dit werd onderzocht door 
opname van ﬂuorescerende ICs door 
macrofagen te bestuderen. Macrofagen 
met alleen FcγRII op het celoppervlak 
(FcγRI/III-/-) konden deze ICs effectief 
op te nemen, terwijl macrofagen zonder 
FcγRs (FcγRI/II/III-/-) geen ICs opna-
men. Ondanks de ernstige ontsteking 
in kniegewrichten van FcγRI/II/III-/- 
muizen, was ernstige destructie van het 
kraakbeen volledig afwezig. Dit laatste 
bewijst opnieuw dat activerende FcγRs 
cruciaal zijn in het ontstaan van kraak-
beenschade.
 De functie van de FcγRs werd daarna 
onderzocht in een passief geïnduceerd 
immuuncomplex artritis model (ICA) 
(hoofdstuk 4). In afwezigheid van 
FcγRIII waren ontsteking en macro-
faag activatie sterk verminderd. FcγRI 
speelde geen rol in ontsteking. Ook 
in dit model resulteerde afwezigheid 
van de remmende receptor (FcγRII-/-) 
in een ernstigere ontsteking. Onher-
stelbare kraakbeenschade was zowel in 
FcγRI-/- als in FcγRIII-/- muizen sterk 
verminderd, terwijl deze schade in 
FcγRII-/- muizen juist enorm vererg-
erde. 
 In hoofdstuk 2 en 4 laten we zien dat 
afwezigheid van FcγRI zowel in AIA als 
in ICA, resulteert in sterk verminderde 
onherstelbare kraakbeenschade. In het 
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T cel afhankelijke artritis model was de 
irreversibele kraakbeenschade ernstiger 
en compleet afhankelijk van FcγRI. Een 
verklaring voor het laatste kan zijn dat T 
cellen cytokinen produceren die de ex-
pressie van FcγRI verhogen, waardoor de 
bijdrage van deze receptor in het ontstaan 
van kraakbeenschade belangrijker wordt. 
Een bekend T cel cytokine dat FcγRI 
expressie verhoogt, is interferon (IFN)-γ. 
In hoofdstuk 5 hebben we het effect van 
IFN-γ op ernstige kraakbeenschade bes-
tudeerd en hebben we onderzocht welke 
rol FcγRI hierin speelde. IFN-γ werd tot 
overexpressie gebracht door injectie van 
een adenoviraal construct in het kniege-
wricht waarna ICA werd opgewekt. Door 
aanwezigheid van IFN-γ tijdens ICA 
werd de irreversibele kraakbeenschade 
inderdaad veel ernstiger. Dit effect van 
IFN-γ werd alleen gevonden in experi-
mentele artritis geïnduceerd door ICs. Of 
de toename in onherstelbare kraakbeen-
schade werd veroorzaakt door verhoging 
van FcγRI expressie, werd bestudeerd 
in FcγRI-/- muizen. Ondanks aanwezig-
heid van IFN-γ tijdens ICA, werd er 
nauwelijks chondrocyt dood gevonden 
in FcγRI-/- kniegewrichten. MMP-geïn-
duceerde VDIPEN expressie in kniege-
wrichten van FcγRI-/- muizen werd wel 
verhoogd door IFN-γ. Dit laatste kan 
worden veroorzaakt door de activerende 
FcγRIII, hetgeen vervolgens werd bestu-
deerd in FcγRIII-/- muizen (hoofdstuk 
6). Door aanwezigheid van IFN-γ tijdens 
ICA, werd de ontstekingsmassa in Fc-
γRIII-/- kniegewrichten vergelijkbaar aan 
die aanwezig in  controle kniegewrichten. 
IFN-γ verhoogde zowel chondrocyt dood 
als MMP-geïnduceerde VDIPEN expres-
sie in muizen zonder FcγRIII. 
 De resultaten van hoofdstuk 5 en 6 
laten zien dat door aanwezigheid van 
het Th1 cytokine IFN-γ, irreversibele 
kraakbeenschade ernstiger wordt tijdens 
IC afhankelijke artritis. Verder werd gev-
onden dat FcγRI en III betrokken zijn bij 
MMP-geïnduceerde VDIPEN expressie. 
Chondrocyt dood daarentegen is geheel 
afhankelijk van FcγRI. 
 Naast Th1 cytokinen zijn er ook Th2 
cytokinen. Deze cytokinen hebben besch-
ermende eigenschappen. In hoofdstuk 7 
werd onderzocht welk effect het Th2 cy-
tokine IL-13 op ernstige kraakbeenschade 
heeft wanneer het tijdens artritis tot over-
expressie werd gebracht. Een adenoviraal 
construct coderend voor IL-13, werd in-
gespoten in het kniegewricht, een dag voor 
ICA inductie. Ondanks dat beschreven is 
dat IL-13 ontsteking remt, verhoogde IL-
13 de hoeveelheid ontstekingscellen in het 
gewricht. Echter, chondrocyt dood werd 
verminderd door IL-13 en ook werd er 
een verlaagde expressie van FcγRI in syn-
ovium gevonden. Overexpressie van IL-13 
reduceerde eveneens MMP-geïnduceerde 
VDIPEN expressie in de kraakbeenmatrix. 
Dit kan veroorzaakt zijn door een verlag-
ing van de MMP productie. Het tegeno-
vergestelde werd gevonden, aangezien 
de hoeveelheid MMPs in het synovium 
juist verhoogd was. MMPs kunnen alleen 
kraakbeenschade veroorzaken nadat ze 
zijn geactiveerd. Een mogelijkheid is dat 
IL-13 de activering van MMPs remt, het-
geen resulteert in verlaging van MMP 
geïnduceerde kraakbeenschade.
 De hierboven beschreven studies 
laten zien dat FcγRs belangrijk zijn in 
het ontstaan van ontsteking en kraak-
beenschade tijdens artritis. De ernst van 
kraakbeenschade kan worden beïnvloed 
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via regulatie van FcγR expressie door 
cytokinen. Een belangrijke rol voor 
FcγRI werd gevonden in het ontstaan 
van chondrocytdood. Een mogelijke 
wijze waarop binding van ICs aan FcγRI 
leidt tot chondrocytdood is door middel 
van productie van zuurstofradicalen 
door het NADPH-oxidase complex. In 
hoofdstuk 8 werd gekeken welke rol 
zuurstofradicalen spelen in kraakbeende-
structie tijdens artritis. Hiervoor werden 
muizen gebruikt die het eiwit P47 missen 
(P47phox-/- muizen) waardoor geen func-
tioneel NADPH-oxidase complex kan 
worden gevormd en dus ook geen zu-
urstofradicalen. In kniegewrichten van 
deze muizen werd IFN-γ tot overexpres-
sie gebracht tijdens ICA. Ondanks de 
vergelijkbare ontsteking in P47phox-/- en 
controle muizen, waren chondrocyt dood 
en MMP geïnduceerde VDIPEN expres-
sie signiﬁcant verlaagd in afwezigheid 
van zuurstofradicalen. Deze data sug-
gereren dat productie van zuurstofradi-
calen via het NADPH-oxidase complex 
verantwoordelijk is voor een deel van de 
chondrocytdood en MMP geïnduceerde 
kraakbeenafbraak.           
 In dit proefschrift tonen we aan dat 
FcγRs een belangrijke rol spelen in het 
ontstaan van ernstige kraakbeenschade 
tijdens IC artritis. Uitschakelen van de 
activerende FcγRs of het verhogen van de 
remmende FcγR in gewrichten van RA 
patiënten zou kraakbeenschade kunnen 
verminderen. Dit zou leiden tot minder 
vergroeiingen, waardoor invaliditeit van 
RA patiënten kan worden voorkomen.
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Chapter 1, Figure 2: 
Parameters of severe cartilage destruction. Irreversible cartilage damage is 
characterized by chondrocyte death, MMP-mediated degradation, and ero-
sion of the cartilage surface. Chapter 3, Figure 4:
Presence of  IgG-containing ICs, detected by immunolocalization, in knee 
joints of various KO mice, 7 days after induction of antigen-induced arthritis. 
Note that IgG is present in large amounts in arthritic FcγRI/II/III-/- knee joints 
when compared to their WT controls (D versus WT control C). No diﬀerence 
in amounts of IgG was found in arthritic knee joints of FcγRI/III-/- when com-
pared to their controls (B versus WT control A). Original magniﬁcation, X 100. 
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Chapter 3, Figure 5
Presence of heat-aggregated IgG detected by immunolocalization, 8 hours 
after injection in knee joints of various KO mice. Heat-aggregated rabbit IgG 
is less eﬃciently cleared (arrow) when injected in FcγRI/II/III-/- knee joints in 
comparison to WT controls 2 (D versus WT control C). No diﬀerences are found 
between knee joints of FcγRI/III-/- and their WT controls (B versus WT control 
A). Original magniﬁcation, X 100.
Chapter 3, Figure 7B and C:
Expression of activation markers MRP8 and 14 in synovial lining and joint 
cavity in FcγRI/II/III-/- and their WT controls at day 7 after AIA induction. Note 
the signiﬁcantly higher expression of both MRP8 (A and C versus WT control 
B) and MRP14 (A). Data are the mean of 7 mice. Signiﬁcance was tested using 
the Wilcoxon rank test (*, P<0.05). Original magniﬁcation, X 400.  
Chapter 3 Chapter 3
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Chapter 6, Figure 2C and D: 
Macrophages in the synovial lining (A, inﬁltrate) and in the joint cavity (B, ex-
udate) and myeloid-related protein 8 (MRP8) in WT controls (C) and FcγRIII-
/- mice (D), 3 days after ICA induction. Macrophages were detected using an 
antibody against F4/80. Note that after injection of AdIFN-γ, the percentage 
of macrophages was comparable in WT controls and FcγRIII-/- mice, whereas 
injection of PBS or AdeGFP resulted in signiﬁcantly less macrophages in 
FcγRIII-/- mice. Values represent the mean ± SEM of 6 mice. Representative 
sections showing MRP8 localization which was comparable in arthritic knee 
joints of WT control (C) and FcγRIII-/- (D) mice. (Original magniﬁcation X 200.) 
* = P<0.05, Mann-Whitney U test.
Chapter 4, Figure 2A-F: 
Localization of myeloid-related protein 8 (MRP8) in the synovial lining and 
joint cavity at day 3 after ICA induction in FcγRI-/- (B), FcγRIII-/- (D), and FcγRII-
/- (F) mice versus their wildtype controls (A, C, and E, respectively). Note the 
signiﬁcantly lower MRP8 expression in FcγRIII-/- in the synovial lining (D 
versus C) and in the joint cavity (H) compared with WT controls, whereas 
similar expression was found in FcγRI-/- and controls (B versus A, and in G). 
Signiﬁcantly higher MRP8 expression was found in FcγRII-/- versus controls 
both in the synovial lining (F versus E) and joint cavity (I). Bars show the mean 
and SD of 10 mice. * = P < 0.05, using the Wilcoxon rank test. I = intima lining 
(see Figure 1 for other deﬁnitions). (Original magniﬁcation X 400 in A-F). 
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Chapter 8, Figure 3:
Expression of the macrophage marker F4/80 7 days after induction of IFN-γ-
stimulated ICA. Note that 70-80% of the inﬁltrated cells within the synovium 
consist of macrophages (A). F4/80 positive macrophages attached to the car-
tilage surface and were found in the lacunae of erosion pits (B, see arrows). 
Original magniﬁcation, X 400. F,femur; JS,joint space.
Chapter 8, Figure 8 D and E:
Chondrocyte death in various cartilage layers of knee joints of P47phox-/- and 
their WT controls at day 3 after ICA induction (A) and at day 3 (B ) and day 7 (C) 
after IFN-γ-stimulated  ICA. Chondrocyte death was expressed as percentage 
of empty lacunae. Note that without IFN-γ, no chondrocyte is observed. At 
day 7 after induction of IFN-γ-stimulated arthritis, in WT controls  chondro-
cyte death  was clearly present, whereas in P47phox-/- chondrocyte death was 
completely absent (C and E versus control D). Signiﬁcance was tested using 
the Wilcoxon rank test (*, P<0.05). MT, medial tibia; LT,lateral tibia; LF, lat-
eral femur; MT, medial tibia; MF, medial femur; P, patella; F, femur. Original 
magniﬁcation, X 400.
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